No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d4r17D_, 1.0000, 0.00, 1.000, 235, 235, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2, d4r17R_, 0.9999, 0.00, 1.000, 235, 235, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3, d5bxlR_, 0.9997, 0.10, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-G170A MUTANT
4, d5bxlD_, 0.9997, 0.10, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-G170A MUTANT
5, d5fgaD_, 0.9996, 0.11, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
6, d5fg9R_, 0.9996, 0.11, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
7, d5fg9D_, 0.9996, 0.11, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
8, d5fg7D_, 0.9996, 0.11, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-T1A MUTANT
9, d5d0wR_, 0.9996, 0.11, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT
10, d5d0wD_, 0.9996, 0.11, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT
11, d5czaR_, 0.9996, 0.11, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT
12, d5czaD_, 0.9996, 0.11, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT
13, d4ya4R_, 0.9996, 0.11, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT
14, d4ya4D_, 0.9996, 0.11, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT
15, d4ya1R_, 0.9996, 0.10, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT
16, d4ya1D_, 0.9996, 0.10, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT
17, d4y9yR_, 0.9996, 0.10, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT
18, d4y9yD_, 0.9996, 0.10, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT
19, d4y8rR_, 0.9996, 0.11, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT
20, d4y8rD_, 0.9996, 0.11, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT
21, d4y8mR_, 0.9996, 0.11, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
22, d4y8mD_, 0.9996, 0.11, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
23, d4qvyR_, 0.9996, 0.11, 1.000, 235, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
24, d4qvyD_, 0.9996, 0.11, 1.000, 235, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
25, d5laiR_, 0.9995, 0.12, 1.000, 235, 235, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
26, d5laiD_, 0.9995, 0.12, 1.000, 235, 235, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
27, d5fgaR_, 0.9995, 0.11, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
28, d5cz6R_, 0.9995, 0.12, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
29, d5cz6D_, 0.9995, 0.12, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
30, d5cgfR_, 0.9995, 0.12, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT
31, d5cgfD_, 0.9995, 0.12, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT
32, p4y6vR_, 0.9995, 0.13, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
33, p4y6vD_, 0.9995, 0.13, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
34, d4qvlR_, 0.9995, 0.12, 1.000, 235, 235, YCP IN COMPLEX WITH BORTEZOMIB
35, d4qvlD_, 0.9995, 0.12, 1.000, 235, 235, YCP IN COMPLEX WITH BORTEZOMIB
36, d4quyR_, 0.9995, 0.12, 1.000, 235, 235, YCP BETA5-A49S-MUTANT
37, d4quyD_, 0.9995, 0.12, 1.000, 235, 235, YCP BETA5-A49S-MUTANT
38, p4quxR_, 0.9995, 0.12, 1.000, 235, 235, YCP BETA5-A49T-MUTANT
39, p4quxD_, 0.9995, 0.12, 1.000, 235, 235, YCP BETA5-A49T-MUTANT
40, d5l5rR_, 0.9994, 0.14, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
41, d5l5rD_, 0.9994, 0.14, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
42, d5l5bR_, 0.9994, 0.13, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
43, d5l5bD_, 0.9994, 0.13, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
44, d5l5aR_, 0.9994, 0.13, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
45, d5l5aD_, 0.9994, 0.13, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
46, d5bxnR_, 0.9994, 0.13, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
47, d5bxnD_, 0.9994, 0.13, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
48, d4z1lR_, 0.9994, 0.13, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
49, d4z1lD_, 0.9994, 0.13, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
50, d4qw1R_, 0.9994, 0.14, 1.000, 235, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
51, d4qw1D_, 0.9994, 0.14, 1.000, 235, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
52, p4qvwR_, 0.9994, 0.14, 1.000, 235, 235, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
53, p4qvwD_, 0.9994, 0.14, 1.000, 235, 235, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
54, d4qv7R_, 0.9994, 0.14, 1.000, 235, 235, YCP BETA5-A50V MUTANT
55, d4qv7D_, 0.9994, 0.14, 1.000, 235, 235, YCP BETA5-A50V MUTANT
56, d4qv1R_, 0.9994, 0.13, 1.000, 235, 235, YCP BETA5-M45A MUTANT
57, d4qv1D_, 0.9994, 0.13, 1.000, 235, 235, YCP BETA5-M45A MUTANT
58, d5l6bR_, 0.9993, 0.15, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
59, d5l6bD_, 0.9993, 0.15, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
60, d5l5uR_, 0.9993, 0.15, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
61, d5l5uD_, 0.9993, 0.15, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
62, d5bouR_, 0.9993, 0.14, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
63, d5bouD_, 0.9993, 0.14, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
64, d4rurR_, 0.9993, 0.15, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
65, d4rurD_, 0.9993, 0.15, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
66, d4qzzR_, 0.9993, 0.14, 1.000, 235, 235, YCP IN COMPLEX WITH OMURALIDE
67, d4qzzD_, 0.9993, 0.14, 1.000, 235, 235, YCP IN COMPLEX WITH OMURALIDE
68, d4qv8R_, 0.9993, 0.14, 1.000, 235, 235, YCP BETA5-C52F MUTANT
69, d4qv8D_, 0.9993, 0.14, 1.000, 235, 235, YCP BETA5-C52F MUTANT
70, d4qv6R_, 0.9993, 0.15, 1.000, 235, 235, YCP BETA5-A49V MUTANT
71, d4qv6D_, 0.9993, 0.15, 1.000, 235, 235, YCP BETA5-A49V MUTANT
72, d4qv4R_, 0.9993, 0.14, 1.000, 235, 235, YCP BETA5-M45T MUTANT
73, d4qv4D_, 0.9993, 0.14, 1.000, 235, 235, YCP BETA5-M45T MUTANT
74, p4qv0R_, 0.9993, 0.14, 1.000, 235, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT
75, p4qv0D_, 0.9993, 0.14, 1.000, 235, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT
76, p6gopR_, 0.9992, 0.15, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
77, p6gopD_, 0.9992, 0.15, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
78, d5lttR_, 0.9992, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
79, d5lttD_, 0.9992, 0.15, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
80, d5l6aR_, 0.9992, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
81, d5l6aD_, 0.9992, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
82, d5l65R_, 0.9992, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
83, d5l65D_, 0.9992, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
84, d5l5wR_, 0.9992, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
85, d5l5wD_, 0.9992, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
86, d5l5fR_, 0.9992, 0.15, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
87, d5l5fD_, 0.9992, 0.15, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
88, d5l5eR_, 0.9992, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
89, d5l5eD_, 0.9992, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
90, d5l5dR_, 0.9992, 0.15, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
91, d5l5dD_, 0.9992, 0.15, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
92, d5cz7R_, 0.9992, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
93, d5cz7D_, 0.9992, 0.15, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
94, p4y8nR_, 0.9992, 0.15, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
95, p4y8nD_, 0.9992, 0.15, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
96, p4y69R_, 0.9992, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
97, p4y69D_, 0.9992, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
98, d4r18R_, 0.9992, 0.15, 1.000, 235, 235, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
99, d4r18D_, 0.9992, 0.15, 1.000, 235, 235, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
100, d4qvpR_, 0.9992, 0.16, 1.000, 235, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
101, d4qvpD_, 0.9992, 0.16, 1.000, 235, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
102, d4qv9D_, 0.9992, 0.16, 1.000, 235, 235, YCP BETA5-C63F MUTANT
103, d5lajR_, 0.9991, 0.17, 1.000, 235, 235, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
104, d5lajD_, 0.9991, 0.17, 1.000, 235, 235, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
105, d5l67R_, 0.9991, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
106, d5l67D_, 0.9991, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
107, d5l66R_, 0.9991, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
108, d5l66D_, 0.9991, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
109, d5l63R_, 0.9991, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
110, d5l63D_, 0.9991, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
111, d5l62R_, 0.9991, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
112, d5l62D_, 0.9991, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
113, d5l5zR_, 0.9991, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
114, d5l5zD_, 0.9991, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
115, d5l5xR_, 0.9991, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
116, d5l5xD_, 0.9991, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
117, d5l5pR_, 0.9991, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
118, d5l5pD_, 0.9991, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
119, d5l5oR_, 0.9991, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
120, d5l5oD_, 0.9991, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
121, d5l5iR_, 0.9991, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
122, d5l5iD_, 0.9991, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
123, d5l5hR_, 0.9991, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
124, d5l5hD_, 0.9991, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
125, p4ya5R_, 0.9991, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
126, p4ya5D_, 0.9991, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
127, p4y8tR_, 0.9991, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
128, p4y8tD_, 0.9991, 0.16, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
129, d4r00D_, 0.9991, 0.17, 1.000, 235, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
130, p4qwuR_, 0.9991, 0.17, 1.000, 235, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
131, p4qwuD_, 0.9991, 0.17, 1.000, 235, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
132, d4qvnR_, 0.9991, 0.16, 1.000, 235, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
133, d4qvnD_, 0.9991, 0.16, 1.000, 235, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
134, d4qv9R_, 0.9991, 0.16, 1.000, 235, 235, YCP BETA5-C63F MUTANT
135, d4qv5R_, 0.9991, 0.17, 1.000, 235, 235, YCP BETA5-M45I MUTANT
136, d4qv5D_, 0.9991, 0.16, 1.000, 235, 235, YCP BETA5-M45I MUTANT
137, p4qv3R_, 0.9991, 0.17, 1.000, 235, 235, YCP BETA5-M45V MUTANT
138, p4qv3D_, 0.9991, 0.17, 1.000, 235, 235, YCP BETA5-M45V MUTANT
139, d5m2bR_, 0.9990, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
140, d5m2bD_, 0.9990, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
141, d5l6cR_, 0.9990, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
142, d5l6cD_, 0.9990, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
143, d5l68R_, 0.9990, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
144, d5l68D_, 0.9990, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
145, d5l64R_, 0.9990, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
146, d5l64D_, 0.9990, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
147, d5l61R_, 0.9990, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
148, d5l61D_, 0.9990, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
149, d5l5yR_, 0.9990, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
150, d5l5yD_, 0.9990, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
151, d5l5tR_, 0.9990, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
152, d5l5tD_, 0.9990, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
153, d5l5sR_, 0.9990, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
154, d5l5sD_, 0.9990, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
155, d5l5jR_, 0.9990, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
156, d5l5jD_, 0.9990, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
157, d5fg7R_, 0.9990, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-T1A MUTANT
158, d5dkjR_, 0.9990, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
159, d5dkjD_, 0.9990, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
160, d5d0xR_, 0.9990, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
161, d5d0xD_, 0.9990, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
162, d5d0tR_, 0.9990, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
163, d5d0tD_, 0.9990, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
164, p4y8uR_, 0.9990, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
165, p4y8uD_, 0.9990, 0.17, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
166, p4y6aR_, 0.9990, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
167, p4y6aD_, 0.9990, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
168, d4r00R_, 0.9990, 0.17, 1.000, 235, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
169, d4qw0R_, 0.9990, 0.17, 1.000, 235, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
170, d4qw0D_, 0.9990, 0.17, 1.000, 235, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
171, d4qltR_, 0.9990, 0.18, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
172, d4qltD_, 0.9990, 0.18, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
173, d4no1R_, 0.9990, 0.17, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
174, d4no1D_, 0.9990, 0.17, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
175, d5l5qR_, 0.9989, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
176, d5l5qD_, 0.9989, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
177, d5l54R_, 0.9989, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
178, d5l54D_, 0.9989, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
179, d5cz4R_, 0.9989, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
180, d5cz4D_, 0.9989, 0.18, 1.000, 235, 235, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
181, d4qvqR_, 0.9989, 0.19, 1.000, 235, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
182, d4qvqD_, 0.9989, 0.19, 1.000, 235, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
183, d4qvmR_, 0.9989, 0.19, 1.000, 235, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
184, d4qvmD_, 0.9989, 0.19, 1.000, 235, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
185, d4qlsR_, 0.9989, 0.18, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
186, d4qlsD_, 0.9989, 0.18, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
187, d4qlqR_, 0.9989, 0.19, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
188, d4qlqD_, 0.9989, 0.19, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
189, d4no8R_, 0.9989, 0.19, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
190, d4no8D_, 0.9989, 0.19, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
191, d3nzjR_, 0.9989, 0.19, 1.000, 242, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
192, d3nzjD_, 0.9989, 0.19, 1.000, 242, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
193, d5l60R_, 0.9988, 0.19, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
194, d5l60D_, 0.9988, 0.19, 1.000, 235, 235, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
195, d5l5vR_, 0.9988, 0.19, 1.000, 235, 235,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
196, d5l5vD_, 0.9988, 0.19, 1.000, 235, 235,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
197, p4ya7R_, 0.9988, 0.19, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
198, p4ya7D_, 0.9988, 0.19, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
199, p4ya3R_, 0.9988, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
200, p4y9zR_, 0.9988, 0.19, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
201, p4y9zD_, 0.9988, 0.19, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
202, p4y8gR_, 0.9988, 0.19, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
203, p4y8gD_, 0.9988, 0.19, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
204, p4y77R_, 0.9988, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
205, p4y77D_, 0.9988, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
206, p4y75R_, 0.9988, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
207, p4y75D_, 0.9988, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
208, d4r02R_, 0.9988, 0.19, 1.000, 235, 235, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
209, d4qz5D_, 0.9988, 0.20, 1.000, 235, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
210, d3nzwR_, 0.9988, 0.20, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
211, d3nzwD_, 0.9988, 0.20, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
212, d3hyeR_, 0.9988, 0.19, 1.000, 242, 235, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
213, d3hyeD_, 0.9988, 0.19, 1.000, 242, 235, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
214, d3gptR_, 0.9988, 0.20, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
215, d3gptD_, 0.9988, 0.19, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
216, d5l69R_, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
217, d5l69D_, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
218, d5jhrR_, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
219, d5jhrD_, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
220, p5fghR_, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
221, p5fghD_, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
222, p4ya9R_, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
223, p4ya9D_, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
224, p4ya3D_, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
225, p4ya2R_, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
226, p4ya2D_, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
227, p4y8sR_, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
228, p4y8sD_, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
229, p4y8pR_, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
230, p4y8pD_, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
231, p4y8jR_, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
232, p4y8jD_, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
233, p4y8hR_, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
234, p4y8hD_, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
235, p4y84R_, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
236, p4y84D_, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
237, p4y7wD_, 0.9987, 0.21, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
238, p4y70R_, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
239, p4y70D_, 0.9987, 0.20, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
240, d4qz5R_, 0.9987, 0.20, 1.000, 235, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
241, p4qz4R_, 0.9987, 0.20, 1.000, 235, 235, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
242, p4qz4D_, 0.9987, 0.20, 1.000, 235, 235, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
243, d4qvvR_, 0.9987, 0.20, 1.000, 235, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
244, d4qvvD_, 0.9987, 0.20, 1.000, 235, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
245, d3gpwR_, 0.9987, 0.20, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
246, d3gpwD_, 0.9987, 0.20, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
247, d5dkiR_, 0.9986, 0.21, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
248, d5dkiD_, 0.9986, 0.21, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
249, p4ya0R_, 0.9986, 0.21, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
250, p4ya0D_, 0.9986, 0.21, 1.000, 235, 235, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
251, p4y8lR_, 0.9986, 0.21, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
252, p4y8lD_, 0.9986, 0.21, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
253, p4y7yD_, 0.9986, 0.21, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
254, p4y7wR_, 0.9986, 0.21, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
255, p4y74R_, 0.9986, 0.21, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
256, p4y74D_, 0.9986, 0.21, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
257, d4qz6R_, 0.9986, 0.21, 1.000, 235, 235, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
258, d4qz6D_, 0.9986, 0.21, 1.000, 235, 235, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
259, d4qz3R_, 0.9986, 0.21, 1.000, 235, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
260, d4qz3D_, 0.9986, 0.21, 1.000, 235, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
261, d4qwxR_, 0.9986, 0.21, 1.000, 235, 235, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
262, d4qwxD_, 0.9986, 0.21, 1.000, 235, 235, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
263, d4q1sR_, 0.9986, 0.21, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
264, d4nnwR_, 0.9986, 0.21, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
265, d4nnwD_, 0.9986, 0.21, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
266, d4nnnR_, 0.9986, 0.21, 1.000, 235, 235, YCP IN COMPLEX WITH MG132
267, d4nnnD_, 0.9986, 0.21, 1.000, 235, 235, YCP IN COMPLEX WITH MG132
268, d4ltcD_, 0.9986, 0.21, 1.000, 242, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
269, d4jsuR_, 0.9986, 0.21, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
270, d4jsuD_, 0.9986, 0.21, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
271, d3tddR_, 0.9986, 0.21, 1.000, 242, 235, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
272, d3tddD_, 0.9986, 0.21, 1.000, 242, 235, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
273, d5d0vR_, 0.9985, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
274, d5d0vD_, 0.9985, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
275, p5cgiR_, 0.9985, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
276, p5cgiD_, 0.9985, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
277, p5cggR_, 0.9985, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
278, p5cggD_, 0.9985, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
279, p4y8qR_, 0.9985, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
280, p4y8qD_, 0.9985, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
281, p4y8kR_, 0.9985, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
282, p4y8kD_, 0.9985, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
283, p4y8iR_, 0.9985, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
284, p4y8iD_, 0.9985, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
285, p4y82R_, 0.9985, 0.21, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
286, p4y82D_, 0.9985, 0.21, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
287, p4y80R_, 0.9985, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
288, p4y80D_, 0.9985, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
289, p4y7yR_, 0.9985, 0.21, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
290, d4qwlR_, 0.9985, 0.22, 1.000, 235, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
291, d4qwlD_, 0.9985, 0.22, 1.000, 235, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
292, d4qw6R_, 0.9985, 0.22, 1.000, 235, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
293, d4qw6D_, 0.9985, 0.22, 1.000, 235, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
294, p4qw5R_, 0.9985, 0.22, 1.000, 235, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
295, p4qw5D_, 0.9985, 0.22, 1.000, 235, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
296, d4qluR_, 0.9985, 0.22, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
297, d4qluD_, 0.9985, 0.22, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
298, d4no9R_, 0.9985, 0.22, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
299, d4no9D_, 0.9985, 0.22, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
300, p4no6R_, 0.9985, 0.22, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
301, p4no6D_, 0.9985, 0.22, 1.000, 235, 235, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
302, d4lqiR_, 0.9985, 0.21, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
303, d4lqiD_, 0.9985, 0.21, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
304, d3shjR_, 0.9985, 0.22, 1.000, 242, 235, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
305, d3shjD_, 0.9985, 0.22, 1.000, 242, 235, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
306, d3nzxR_, 0.9985, 0.22, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
307, d3nzxD_, 0.9985, 0.22, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
308, d2gplD_, 0.9985, 0.22, 1.000, 242, 235, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
309, d5l55D_, 0.9984, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
310, d5l52R_, 0.9984, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
311, d5l52D_, 0.9984, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
312, d5jhsR_, 0.9984, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
313, d5jhsD_, 0.9984, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
314, d5fggR_, 0.9984, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
315, d5d0zR_, 0.9984, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
316, d5d0zD_, 0.9984, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
317, d5d0sR_, 0.9984, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
318, d5d0sD_, 0.9984, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
319, d5cz9R_, 0.9984, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
320, d5cz9D_, 0.9984, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
321, p5cghR_, 0.9984, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
322, p5cghD_, 0.9984, 0.22, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
323, p4y8oR_, 0.9984, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
324, p4y8oD_, 0.9984, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
325, d4r02D_, 0.9984, 0.23, 1.000, 235, 235, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
326, p4qzwR_, 0.9984, 0.22, 1.000, 235, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
327, p4qzwD_, 0.9984, 0.22, 1.000, 235, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
328, d4qwrD_, 0.9984, 0.23, 1.000, 235, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
329, d4qwiD_, 0.9984, 0.23, 1.000, 235, 235, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
330, d4qw7R_, 0.9984, 0.22, 1.000, 235, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
331, d4qw7D_, 0.9984, 0.22, 1.000, 235, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
332, d4qw4R_, 0.9984, 0.23, 1.000, 235, 235, YCP IN COMPLEX WITH CARFILZOMIB
333, d4qw4D_, 0.9984, 0.23, 1.000, 235, 235, YCP IN COMPLEX WITH CARFILZOMIB
334, d4qlvR_, 0.9984, 0.22, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
335, d4qlvD_, 0.9984, 0.22, 1.000, 235, 235, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
336, d4q1sD_, 0.9984, 0.22, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
337, d4ltcR_, 0.9984, 0.23, 1.000, 242, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
338, p4jt0R_, 0.9984, 0.22, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
339, p4jt0D_, 0.9984, 0.22, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
340, d4jsqR_, 0.9984, 0.22, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
341, d4jsqD_, 0.9984, 0.22, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
342, d4j70R_, 0.9984, 0.22, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
343, d4j70D_, 0.9984, 0.22, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
344, d4intD_, 0.9984, 0.23, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
345, p3un4R_, 0.9984, 0.22, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
346, p3un4D_, 0.9984, 0.22, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
347, d3mg0R_, 0.9984, 0.22, 1.000, 242, 235, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
348, d2gplR_, 0.9984, 0.22, 1.000, 242, 235, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
349, d2fakR_, 0.9984, 0.23, 1.000, 242, 235, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
350, d2fakD_, 0.9984, 0.22, 1.000, 242, 235, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
351, d5l55R_, 0.9983, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
352, d5fggD_, 0.9983, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
353, d5fgfR_, 0.9983, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
354, d5fgfD_, 0.9983, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
355, d5ahjD_, 0.9983, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
356, p4y81R_, 0.9983, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
357, p4y81D_, 0.9983, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
358, p4y7xR_, 0.9983, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
359, p4y7xD_, 0.9983, 0.23, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
360, d4qz7R_, 0.9983, 0.23, 1.000, 235, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
361, d4qz7D_, 0.9983, 0.23, 1.000, 235, 235, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
362, p4qz0R_, 0.9983, 0.23, 1.000, 235, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
363, p4qz0D_, 0.9983, 0.23, 1.000, 235, 235, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
364, d4qwrR_, 0.9983, 0.23, 1.000, 235, 235, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
365, d4qwiR_, 0.9983, 0.23, 1.000, 235, 235, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
366, p4qwfR_, 0.9983, 0.23, 1.000, 235, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
367, p4qwfD_, 0.9983, 0.23, 1.000, 235, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
368, d4intR_, 0.9983, 0.23, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
369, p4gk7R_, 0.9983, 0.23, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
370, p4gk7D_, 0.9983, 0.23, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
371, d5fhsR_, 0.9982, 0.24, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
372, d5fhsD_, 0.9982, 0.24, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
373, d5fgeR_, 0.9982, 0.24, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
374, d5fgeD_, 0.9982, 0.24, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
375, d5cz8R_, 0.9982, 0.24, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
376, d5cz8D_, 0.9982, 0.24, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
377, d5ahjR_, 0.9982, 0.24, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
378, p4y78R_, 0.9982, 0.24, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
379, p4y78D_, 0.9982, 0.24, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
380, p4y6zR_, 0.9982, 0.24, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
381, p4y6zD_, 0.9982, 0.24, 1.000, 235, 235, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
382, d4qzxR_, 0.9982, 0.24, 1.000, 235, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
383, d4qzxD_, 0.9982, 0.24, 1.000, 235, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
384, d4qz2R_, 0.9982, 0.24, 1.000, 235, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
385, d4qz2D_, 0.9982, 0.24, 1.000, 235, 235, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
386, d4qxjR_, 0.9982, 0.24, 1.000, 235, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
387, d4qxjD_, 0.9982, 0.24, 1.000, 235, 235, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
388, d4qw3R_, 0.9982, 0.24, 1.000, 235, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
389, d4qw3D_, 0.9982, 0.24, 1.000, 235, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
390, d4inrD_, 0.9982, 0.24, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
391, d4fzcR_, 0.9982, 0.24, 1.000, 242, 235, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
392, d4fzcD_, 0.9982, 0.24, 1.000, 242, 235, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
393, d3okjR_, 0.9982, 0.24, 1.000, 242, 235, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
394, d3okjD_, 0.9982, 0.24, 1.000, 242, 235, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
395, d3mg0D_, 0.9982, 0.24, 1.000, 242, 235, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
396, d3dy3R_, 0.9982, 0.24, 1.000, 242, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
397, d3dy3D_, 0.9982, 0.24, 1.000, 242, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
398, d5cz5R_, 0.9981, 0.25, 1.000, 235, 235, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
399, d5cz5D_, 0.9981, 0.25, 1.000, 235, 235, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
400, d4qwkR_, 0.9981, 0.25, 1.000, 235, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
401, d4qwjR_, 0.9981, 0.25, 1.000, 235, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
402, d4qwjD_, 0.9981, 0.25, 1.000, 235, 235, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
403, d3d29R_, 0.9981, 0.25, 1.000, 242, 235, PROTEASOME INHIBITION BY FELLUTAMIDE B
404, d3d29D_, 0.9981, 0.25, 1.000, 242, 235, PROTEASOME INHIBITION BY FELLUTAMIDE B
405, d2f16D_, 0.9981, 0.25, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
406, d5fgiR_, 0.9980, 0.25, 1.000, 235, 235, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
407, d5fgiD_, 0.9980, 0.25, 1.000, 235, 235, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
408, d5fgdR_, 0.9980, 0.25, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
409, d5fgdD_, 0.9980, 0.25, 1.000, 235, 235, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
410, p4qz1R_, 0.9980, 0.25, 1.000, 235, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
411, p4qz1D_, 0.9980, 0.25, 1.000, 235, 235, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
412, d4qwkD_, 0.9980, 0.25, 1.000, 235, 235, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
413, p4qbyR_, 0.9980, 0.25, 1.000, 235, 235, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
414, p4qbyD_, 0.9980, 0.25, 1.000, 235, 235, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
415, d4inrR_, 0.9980, 0.25, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
416, d3un8D_, 0.9980, 0.25, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
417, p3e47R_, 0.9980, 0.25, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
418, p3e47D_, 0.9980, 0.25, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
419, d2f16R_, 0.9980, 0.25, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
420, p4fzgR_, 0.9979, 0.26, 1.000, 242, 235, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
421, p4fzgD_, 0.9979, 0.26, 1.000, 242, 235, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
422, d3gpjR_, 0.9979, 0.26, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
423, d3gpjD_, 0.9979, 0.26, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
424, d3dy4R_, 0.9979, 0.26, 1.000, 242, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
425, d3dy4D_, 0.9979, 0.26, 1.000, 242, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
426, d1rypE_, 0.9979, 0.26, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
427, d4hrdR_, 0.9978, 0.26, 1.000, 242, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
428, d4hrdD_, 0.9978, 0.27, 1.000, 242, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
429, p4qwsR_, 0.9977, 0.27, 1.000, 235, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
430, p4qwsD_, 0.9977, 0.27, 1.000, 235, 235, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
431, d4hnpD_, 0.9977, 0.27, 1.000, 242, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
432, d3un8R_, 0.9977, 0.27, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
433, d2zcyR_, 0.9977, 0.27, 1.000, 242, 235, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
434, d2zcyD_, 0.9977, 0.27, 1.000, 242, 235, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
435, d1rypS_, 0.9977, 0.27, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
436, p4inuD_, 0.9976, 0.27, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
437, d3bdmR_, 0.9975, 0.28, 1.000, 242, 235, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
438, d3bdmD_, 0.9975, 0.28, 1.000, 242, 235, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
439, p4inuR_, 0.9974, 0.29, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
440, d4qwgR_, 0.9973, 0.30, 1.000, 235, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
441, d4qwgD_, 0.9973, 0.30, 1.000, 235, 235, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
442, d4eu2E_, 0.9973, 0.30, 1.000, 242, 235, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
443, d4hrcD_, 0.9972, 0.30, 1.000, 242, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
444, d4hnpR_, 0.9972, 0.30, 1.000, 242, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
445, p4x6zE_, 0.9971, 0.31, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
446, d1g65D_, 0.9971, 0.31, 1.000, 242, 235, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
447, d3wxrS_, 0.9970, 0.31, 1.000, 238, 235, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
448, d4hrcR_, 0.9968, 0.32, 1.000, 242, 235, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
449, d3mg4R_, 0.9968, 0.32, 1.000, 242, 235, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
450, d1g65R_, 0.9968, 0.32, 1.000, 242, 235, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
451, p5nifS_, 0.9967, 0.33, 1.000, 236, 235, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
452, d4eu2S_, 0.9967, 0.33, 1.000, 242, 235, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
453, p5nifE_, 0.9966, 0.33, 1.000, 236, 235, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
454, p4zzgS_, 0.9966, 0.33, 1.000, 236, 235, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
455, p4zzgE_, 0.9965, 0.34, 1.000, 236, 235, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
456, d3wxrE_, 0.9963, 0.34, 0.996, 239, 235, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
457, d3mg4D_, 0.9957, 0.41, 1.000, 242, 235, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
458, p4x6zS_, 0.9952, 0.41, 1.000, 242, 235, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
459, d3mg6R_, 0.9950, 0.43, 1.000, 242, 235, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
460, d3oevR_, 0.9948, 0.43, 1.000, 242, 235, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
461, d3mg8R_, 0.9946, 0.45, 1.000, 242, 235, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
462, d3mg7R_, 0.9942, 0.47, 1.000, 242, 235, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
463, d1jd2D_, 0.9940, 0.44, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
464, d3oeuD_, 0.9938, 0.47, 1.000, 242, 235, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
465, d3mg8D_, 0.9938, 0.47, 1.000, 242, 235, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
466, d3mg6D_, 0.9934, 0.50, 1.000, 242, 235, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
467, d1jd2Y_, 0.9934, 0.47, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
468, d3oevD_, 0.9933, 0.50, 1.000, 242, 235, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
469, d3mg7D_, 0.9933, 0.49, 1.000, 242, 235, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
470, d3oeuR_, 0.9922, 0.66, 0.996, 236, 235, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
471, p3jcpNA_, 0.9885, 0.62, 1.000, 242, 235, 
472, p3jcpN_, 0.9885, 0.62, 1.000, 242, 235, 
473, d3sdkD_, 0.9846, 0.55, 0.996, 233, 233, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
474, p5mp9E_, 0.9840, 0.73, 0.996, 242, 235, 26S PROTEASOME IN PRESENCE OF ATP (S1)
475, p3jcoNA_, 0.9828, 0.76, 1.000, 242, 235, 
476, p3jcoN_, 0.9828, 0.76, 1.000, 242, 235, 
477, p5mp9e_, 0.9824, 0.77, 1.000, 242, 235, 26S PROTEASOME IN PRESENCE OF ATP (S1)
478, d3sdkR_, 0.9820, 0.45, 1.000, 232, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
479, p5mpae_, 0.9781, 0.87, 0.996, 242, 235, 26S PROTEASOME IN PRESENCE OF ATP (S2)
480, p5mpaE_, 0.9752, 0.93, 0.996, 242, 235, 26S PROTEASOME IN PRESENCE OF ATP (S2)
481, p5wvkS_, 0.9740, 0.94, 1.000, 242, 235, 
482, d1g0uD_, 0.9739, 0.40, 0.983, 230, 230, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
483, d1z7qS1, 0.9736, 1.10, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
484, d1z7qE1, 0.9736, 1.10, 1.000, 242, 235, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
485, d1g0uR_, 0.9735, 0.42, 0.983, 230, 230, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
486, d4g4sE_, 0.9733, 1.07, 0.987, 249, 234, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
487, p5wvkZ_, 0.9730, 0.96, 1.000, 242, 235, 
488, d3sdiR_, 0.9714, 0.32, 1.000, 229, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
489, p1fntE_, 0.9711, 1.14, 0.996, 244, 235, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
490, p1fntS_, 0.9710, 1.14, 0.996, 244, 235, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
491, d4cr2E_, 0.9701, 1.04, 1.000, 243, 235, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
492, d3sdiD_, 0.9666, 0.35, 1.000, 228, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
493, d5le5R_, 0.9557, 0.60, 0.617, 233, 227, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
494, d5lf4R_, 0.9556, 0.61, 0.617, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
495, p5lezR_, 0.9556, 0.60, 0.617, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
496, p5leyR_, 0.9556, 0.60, 0.617, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
497, d5lf7R_, 0.9555, 0.61, 0.617, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
498, p5lf6R_, 0.9555, 0.61, 0.617, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
499, d5lf1R_, 0.9554, 0.61, 0.617, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
500, p5gjrKA_, 0.9554, 0.60, 0.617, 234, 227, 
501, d5lf3R_, 0.9553, 0.61, 0.617, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
502, d5lexR_, 0.9553, 0.61, 0.617, 233, 227, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
503, p5mpcE_, 0.9552, 1.31, 1.000, 242, 235, 
504, p5lezD_, 0.9552, 0.61, 0.617, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
505, p5lf0R_, 0.9551, 0.62, 0.617, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
506, p5gjrW_, 0.9550, 0.61, 0.617, 234, 227, 
507, d5lexD_, 0.9549, 0.62, 0.617, 233, 227, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
508, p5gjqF_, 0.9548, 0.62, 0.617, 234, 227, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
509, p5lf6D_, 0.9546, 0.63, 0.617, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
510, d5le5D_, 0.9546, 0.63, 0.617, 233, 227, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
511, p5leyD_, 0.9545, 0.64, 0.617, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
512, d5lf4D_, 0.9544, 0.64, 0.617, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
513, d5lf1D_, 0.9544, 0.64, 0.617, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
514, d5lf7D_, 0.9543, 0.64, 0.617, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
515, p5lf0D_, 0.9543, 0.64, 0.617, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
516, p5gjql_, 0.9542, 0.64, 0.617, 234, 227, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
517, p4r67u_, 0.9542, 0.64, 0.617, 234, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
518, d4r67S_, 0.9542, 0.64, 0.617, 234, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
519, p4r67g_, 0.9542, 0.64, 0.617, 234, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
520, d4r67E_, 0.9542, 0.64, 0.617, 234, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
521, d5lf3D_, 0.9541, 0.65, 0.617, 233, 227, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
522, d4r3oS_, 0.9536, 0.65, 0.617, 234, 227, HUMAN CONSTITUTIVE 20S PROTEASOME
523, d4r3oE_, 0.9536, 0.65, 0.617, 234, 227, HUMAN CONSTITUTIVE 20S PROTEASOME
524, p5mpbS_, 0.9535, 1.32, 0.996, 242, 235, 
525, p3unbf_, 0.9535, 0.66, 0.617, 233, 227, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
526, d3unbD_, 0.9535, 0.66, 0.617, 233, 227, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
527, d1iruS_, 0.9532, 0.67, 0.617, 234, 227, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
528, d1iruE_, 0.9532, 0.67, 0.617, 234, 227, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
529, p4cr4E_, 0.9531, 1.31, 1.000, 243, 235, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
530, d3unbR_, 0.9531, 0.67, 0.617, 233, 227, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
531, p6avoM_, 0.9529, 0.68, 0.617, 233, 227, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
532, p6avoH_, 0.9529, 0.68, 0.617, 233, 227, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
533, p5wviBA_, 0.9527, 1.31, 0.991, 243, 235, 
534, p3unbt_, 0.9524, 0.69, 0.617, 233, 227, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
535, p5l4gS_, 0.9519, 0.70, 0.617, 234, 227, 
536, p5l4gE_, 0.9508, 0.72, 0.617, 234, 227, 
537, p3uneR_, 0.9492, 0.76, 0.617, 233, 227, MOUSE CONSTITUTIVE 20S PROTEASOME
538, p3uneD_, 0.9490, 0.77, 0.617, 233, 227, MOUSE CONSTITUTIVE 20S PROTEASOME
539, d3unfR_, 0.9485, 0.78, 0.617, 233, 227, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
540, d3unfD_, 0.9485, 0.78, 0.617, 233, 227, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
541, p3unhR_, 0.9482, 0.79, 0.617, 233, 227, MOUSE 20S IMMUNOPROTEASOME
542, p3unhD_, 0.9482, 0.79, 0.617, 233, 227, MOUSE 20S IMMUNOPROTEASOME
543, p3unet_, 0.9482, 0.79, 0.617, 233, 227, MOUSE CONSTITUTIVE 20S PROTEASOME
544, p3unef_, 0.9472, 0.81, 0.617, 233, 227, MOUSE CONSTITUTIVE 20S PROTEASOME
545, p5mpcS_, 0.9449, 1.45, 1.000, 242, 235, 
546, p5a5bE_, 0.9401, 1.57, 1.000, 243, 235, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
547, p4cr3E_, 0.9401, 1.57, 1.000, 243, 235, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
548, d3unfP_, 0.9377, 1.73, 0.345, 248, 235, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
549, p3unfB_, 0.9377, 1.73, 0.345, 248, 235, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
550, d5le5B_, 0.9376, 1.74, 0.345, 248, 235, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
551, d5lf7B_, 0.9375, 1.74, 0.345, 248, 235, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
552, d5lf4B_, 0.9373, 1.75, 0.345, 248, 235, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
553, p3unhP_, 0.9373, 1.74, 0.345, 248, 235, MOUSE 20S IMMUNOPROTEASOME
554, p3unhB_, 0.9373, 1.74, 0.345, 248, 235, MOUSE 20S IMMUNOPROTEASOME
555, p5m32R_, 0.9372, 0.95, 0.562, 233, 226, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
556, p5m32D_, 0.9372, 0.95, 0.562, 233, 226, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
557, p5gjrIA_, 0.9369, 1.76, 0.340, 250, 235, 
558, d5lf3B_, 0.9368, 1.75, 0.345, 248, 235, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
559, p5leyB_, 0.9368, 1.75, 0.345, 248, 235, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
560, d5lf1B_, 0.9366, 1.76, 0.345, 248, 235, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
561, p5lezB_, 0.9366, 1.76, 0.345, 248, 235, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
562, p5gjrU_, 0.9365, 1.77, 0.340, 250, 235, 
563, d5lexB_, 0.9364, 1.76, 0.345, 248, 235, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
564, p3unbd_, 0.9364, 1.76, 0.345, 248, 235, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
565, p5lf0B_, 0.9362, 1.76, 0.345, 248, 235, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
566, p5lf6B_, 0.9361, 1.76, 0.345, 248, 235, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
567, d5le5P_, 0.9359, 1.78, 0.345, 247, 235, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
568, p3unbB_, 0.9356, 1.77, 0.345, 248, 235, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
569, d4r3oQ_, 0.9350, 1.79, 0.345, 250, 235, HUMAN CONSTITUTIVE 20S PROTEASOME
570, d4r3oC_, 0.9350, 1.79, 0.345, 250, 235, HUMAN CONSTITUTIVE 20S PROTEASOME
571, d4r67Q_, 0.9347, 1.79, 0.345, 250, 235, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
572, d4r67C_, 0.9347, 1.79, 0.345, 250, 235, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
573, p5lezP_, 0.9346, 1.81, 0.345, 247, 235, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
574, d5lf7P_, 0.9343, 1.80, 0.345, 247, 235, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
575, d5lf4P_, 0.9342, 1.81, 0.345, 248, 235, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
576, d5lf1P_, 0.9342, 1.81, 0.345, 248, 235, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
577, p3unbP_, 0.9340, 1.79, 0.345, 248, 235, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
578, p5lf6P_, 0.9339, 1.81, 0.345, 248, 235, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
579, p3uneP_, 0.9339, 1.77, 0.345, 248, 235, MOUSE CONSTITUTIVE 20S PROTEASOME
580, p3unbr_, 0.9338, 1.80, 0.345, 248, 235, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
581, p5lf0P_, 0.9337, 1.82, 0.345, 248, 235, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
582, d5lf3P_, 0.9336, 1.81, 0.345, 248, 235, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
583, p5leyP_, 0.9336, 1.82, 0.345, 247, 235, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
584, d5lexP_, 0.9334, 1.82, 0.345, 247, 235, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
585, d1iruQ_, 0.9331, 1.79, 0.340, 250, 235, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
586, p3uner_, 0.9330, 1.80, 0.345, 248, 235, MOUSE CONSTITUTIVE 20S PROTEASOME
587, d1iruC_, 0.9330, 1.79, 0.340, 250, 235, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
588, p3uned_, 0.9318, 1.81, 0.340, 248, 235, MOUSE CONSTITUTIVE 20S PROTEASOME
589, p3uneB_, 0.9313, 1.82, 0.345, 248, 235, MOUSE CONSTITUTIVE 20S PROTEASOME
590, p5vfsE_, 0.9287, 1.33, 0.612, 228, 227, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
591, d4intP_, 0.9284, 1.72, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
592, d4intB_, 0.9282, 1.72, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
593, d4r02P_, 0.9281, 1.72, 0.359, 244, 231, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
594, d4q1sP_, 0.9281, 1.73, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
595, d4lqiP_, 0.9278, 1.73, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
596, d4inrP_, 0.9278, 1.72, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
597, d1g65P_, 0.9278, 1.73, 0.359, 244, 231, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
598, p5vfsDA_, 0.9277, 1.34, 0.612, 228, 227, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
599, d4lqiB_, 0.9277, 1.73, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
600, d4inrB_, 0.9276, 1.72, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
601, d1g65B_, 0.9276, 1.74, 0.359, 244, 231, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
602, d4fzcP_, 0.9275, 1.74, 0.359, 244, 231, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
603, p5t0cW_, 0.9274, 1.43, 0.612, 228, 227, 
604, p5t0cCB_, 0.9274, 1.43, 0.612, 228, 227, 
605, d4fzcB_, 0.9274, 1.74, 0.359, 244, 231, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
606, p5vftK_, 0.9273, 1.40, 0.612, 228, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
607, d4jsuP_, 0.9273, 1.73, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
608, d4jsuB_, 0.9273, 1.73, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
609, d4jsqP_, 0.9273, 1.73, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
610, d4inuP_, 0.9273, 1.73, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
611, d3wxrQ_, 0.9273, 1.77, 0.359, 244, 231, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
612, d3tddP_, 0.9273, 1.73, 0.359, 244, 231, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
613, d2gplP_, 0.9273, 1.73, 0.359, 244, 231, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
614, d4jsqB_, 0.9272, 1.73, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
615, d3nzjP_, 0.9272, 1.73, 0.359, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
616, d2gplB_, 0.9272, 1.73, 0.359, 244, 231, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
617, d5lajP_, 0.9271, 1.73, 0.359, 244, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
618, d4hnpP_, 0.9271, 1.77, 0.359, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
619, p4gk7P_, 0.9271, 1.73, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
620, d3tddB_, 0.9271, 1.73, 0.359, 244, 231, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
621, d3hyeP_, 0.9271, 1.73, 0.359, 244, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
622, d2fnyP_, 0.9271, 1.73, 0.359, 244, 231,  
623, d2fnyB_, 0.9271, 1.73, 0.359, 244, 231,  
624, d5lajB_, 0.9270, 1.73, 0.359, 244, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
625, d4inuB_, 0.9270, 1.73, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
626, d3nzwP_, 0.9270, 1.74, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
627, d3nzjB_, 0.9270, 1.73, 0.359, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
628, d3hyeB_, 0.9270, 1.74, 0.359, 244, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
629, p4gk7B_, 0.9269, 1.73, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
630, d3nzwB_, 0.9269, 1.74, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
631, p5vfuV_, 0.9268, 1.41, 0.612, 228, 227, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
632, d4r18P_, 0.9268, 1.73, 0.359, 244, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
633, d4nnwP_, 0.9268, 1.74, 0.359, 244, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
634, d4nnwB_, 0.9268, 1.74, 0.359, 244, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
635, d4j70P_, 0.9268, 1.76, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
636, d4fzgP_, 0.9268, 1.74, 0.359, 244, 231, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
637, d4fzgB_, 0.9268, 1.74, 0.359, 244, 231, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
638, d3e47P_, 0.9268, 1.74, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
639, p4r18B_, 0.9267, 1.74, 0.359, 244, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
640, d4hnpB_, 0.9267, 1.75, 0.359, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
641, d3shjP_, 0.9267, 1.74, 0.359, 244, 231, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
642, d3e47B_, 0.9267, 1.74, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
643, d1rypQ_, 0.9267, 1.74, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
644, p4y9zP_, 0.9266, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
645, p4y8iP_, 0.9266, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
646, d4no9P_, 0.9266, 1.75, 0.359, 244, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
647, d4no9B_, 0.9266, 1.75, 0.359, 244, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
648, d4ltcP_, 0.9266, 1.75, 0.359, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
649, d3shjB_, 0.9266, 1.74, 0.359, 244, 231, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
650, p4y9zB_, 0.9265, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
651, p4y8sP_, 0.9265, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
652, p4y8sB_, 0.9265, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
653, p4y8jP_, 0.9265, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
654, p4y8jB_, 0.9265, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
655, p4y8iB_, 0.9265, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
656, p4y84P_, 0.9265, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
657, p4y7yP_, 0.9265, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
658, p4y7yB_, 0.9265, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
659, d4qz6P_, 0.9265, 1.74, 0.359, 244, 231, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
660, d4qz6B_, 0.9265, 1.74, 0.359, 244, 231, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
661, d4qz5P_, 0.9265, 1.74, 0.359, 244, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
662, d4eu2Q_, 0.9265, 1.75, 0.359, 244, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
663, d3dy4P_, 0.9265, 1.74, 0.359, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
664, d3d29P_, 0.9265, 1.74, 0.359, 244, 231, PROTEASOME INHIBITION BY FELLUTAMIDE B
665, d2fakP_, 0.9265, 1.74, 0.359, 244, 231, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
666, d2fakB_, 0.9265, 1.74, 0.359, 244, 231, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
667, d5cz8P_, 0.9264, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
668, d5cz8B_, 0.9264, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
669, p4y8lP_, 0.9264, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
670, p4y8lB_, 0.9264, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
671, p4y8hP_, 0.9264, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
672, p4y8gP_, 0.9264, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
673, p4y84B_, 0.9264, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
674, p4y7wP_, 0.9264, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
675, p4y70P_, 0.9264, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
676, p4y70B_, 0.9264, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
677, d4qzxP_, 0.9264, 1.74, 0.359, 244, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
678, d4qz5B_, 0.9264, 1.74, 0.359, 244, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
679, d4qz4P_, 0.9264, 1.74, 0.359, 244, 231, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
680, d4qz4B_, 0.9264, 1.74, 0.359, 244, 231, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
681, d4qz2P_, 0.9264, 1.74, 0.359, 244, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
682, d4qz2B_, 0.9264, 1.75, 0.359, 244, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
683, d4qw6P_, 0.9264, 1.74, 0.359, 244, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
684, d4qlsP_, 0.9264, 1.74, 0.359, 244, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
685, d4j70B_, 0.9264, 1.76, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
686, d4hrdP_, 0.9264, 1.76, 0.359, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
687, d4hrcB_, 0.9264, 1.77, 0.359, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
688, p3un4P_, 0.9264, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
689, p3un4B_, 0.9264, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
690, d3gpwP_, 0.9264, 1.74, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
691, d3dy4B_, 0.9264, 1.74, 0.359, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
692, d3dy3P_, 0.9264, 1.74, 0.359, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
693, d3dy3B_, 0.9264, 1.74, 0.359, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
694, d3d29B_, 0.9264, 1.74, 0.359, 244, 231, PROTEASOME INHIBITION BY FELLUTAMIDE B
695, d5jhrP_, 0.9263, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
696, d5fgfP_, 0.9263, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
697, p5cgiP_, 0.9263, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
698, p5cgiB_, 0.9263, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
699, d5cgfP_, 0.9263, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT
700, d4z1lP_, 0.9263, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
701, p4ya9P_, 0.9263, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
702, p4ya9B_, 0.9263, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
703, p4ya7P_, 0.9263, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
704, p4y8hB_, 0.9263, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
705, p4y8gB_, 0.9263, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
706, p4y80P_, 0.9263, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
707, p4y80B_, 0.9263, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
708, p4y7wB_, 0.9263, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
709, d4qzxB_, 0.9263, 1.74, 0.359, 244, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
710, d4qz0P_, 0.9263, 1.75, 0.359, 244, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
711, d4qxjP_, 0.9263, 1.74, 0.359, 244, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
712, d4qxjB_, 0.9263, 1.74, 0.359, 244, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
713, d4qwfP_, 0.9263, 1.74, 0.359, 244, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
714, d4qw7P_, 0.9263, 1.74, 0.359, 244, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
715, d4qw7B_, 0.9263, 1.75, 0.359, 244, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
716, d4qw6B_, 0.9263, 1.74, 0.359, 244, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
717, p4qlsB_, 0.9263, 1.75, 0.359, 244, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
718, d4qlqP_, 0.9263, 1.75, 0.359, 244, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
719, p4qlqB_, 0.9263, 1.75, 0.359, 244, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
720, d4jt0P_, 0.9263, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
721, d4jt0B_, 0.9263, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
722, d3nzxP_, 0.9263, 1.74, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
723, d3gpwB_, 0.9263, 1.74, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
724, d2f16P_, 0.9263, 1.74, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
725, d5jhsP_, 0.9262, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
726, d5jhrB_, 0.9262, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
727, d5fgfB_, 0.9262, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
728, d5fgaP_, 0.9262, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
729, d5cgfB_, 0.9262, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT
730, d4z1lB_, 0.9262, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
731, p4ya7B_, 0.9262, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
732, p4y8pP_, 0.9262, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
733, p4y78P_, 0.9262, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
734, p4y78B_, 0.9262, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
735, d4qzwP_, 0.9262, 1.74, 0.359, 244, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
736, d4qzwB_, 0.9262, 1.75, 0.359, 244, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
737, d4qz3P_, 0.9262, 1.75, 0.359, 244, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
738, d4qz3B_, 0.9262, 1.75, 0.359, 244, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
739, d4qz0B_, 0.9262, 1.75, 0.359, 244, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
740, d4qwrP_, 0.9262, 1.75, 0.359, 244, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
741, d4qwiP_, 0.9262, 1.74, 0.359, 244, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
742, d4qwiB_, 0.9262, 1.75, 0.359, 244, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
743, d4qwfB_, 0.9262, 1.75, 0.359, 244, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
744, d4qw4P_, 0.9262, 1.74, 0.359, 244, 231, YCP IN COMPLEX WITH CARFILZOMIB
745, d4qw4B_, 0.9262, 1.74, 0.359, 244, 231, YCP IN COMPLEX WITH CARFILZOMIB
746, d4nnnP_, 0.9262, 1.75, 0.359, 244, 231, YCP IN COMPLEX WITH MG132
747, d4nnnB_, 0.9262, 1.75, 0.359, 244, 231, YCP IN COMPLEX WITH MG132
748, d3un8P_, 0.9262, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
749, d3nzxB_, 0.9262, 1.74, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
750, d2f16B_, 0.9262, 1.74, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
751, d5lttP_, 0.9261, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
752, d5l52P_, 0.9261, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
753, d5l52B_, 0.9261, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
754, d5jhsB_, 0.9261, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
755, d5fgaB_, 0.9261, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
756, d5d0vP_, 0.9261, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
757, d5d0vB_, 0.9261, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
758, p4y8uP_, 0.9261, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
759, p4y8uB_, 0.9261, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
760, p4y8pB_, 0.9261, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
761, p4y8kP_, 0.9261, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
762, p4y7xP_, 0.9261, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
763, p4y7xB_, 0.9261, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
764, p4y74P_, 0.9261, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
765, p4y74B_, 0.9261, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
766, p4y69P_, 0.9261, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
767, d4qwxP_, 0.9261, 1.75, 0.359, 244, 231, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
768, d4qwxB_, 0.9261, 1.75, 0.359, 244, 231, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
769, d4qwrB_, 0.9261, 1.75, 0.359, 244, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
770, d4qwjP_, 0.9261, 1.75, 0.359, 244, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
771, d4qwjB_, 0.9261, 1.75, 0.359, 244, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
772, d4qw5P_, 0.9261, 1.75, 0.359, 244, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
773, d4qw5B_, 0.9261, 1.75, 0.359, 244, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
774, d4hrcP_, 0.9261, 1.61, 0.361, 244, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
775, d3okjP_, 0.9261, 1.74, 0.359, 244, 231, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
776, d3okjB_, 0.9261, 1.74, 0.359, 244, 231, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
777, d3bdmP_, 0.9261, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
778, d3bdmB_, 0.9261, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
779, d5lttB_, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
780, d5l5tP_, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
781, d5l5sP_, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
782, d5fhsP_, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
783, d5fgdP_, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
784, d5fgdB_, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
785, d5dkjP_, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
786, d5dkjB_, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
787, d5dkiP_, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
788, d5d0zP_, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
789, d5d0tP_, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
790, d5cz9P_, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
791, d5cz9B_, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
792, p4ya0P_, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
793, p4ya0B_, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
794, d4y9yP_, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT
795, d4y9yB_, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT
796, p4y8qP_, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
797, p4y8oP_, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
798, p4y8kB_, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
799, p4y77P_, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
800, p4y77B_, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
801, p4y6vP_, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
802, p4y69B_, 0.9260, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
803, d4qz1P_, 0.9260, 1.75, 0.359, 244, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
804, d4qz1B_, 0.9260, 1.75, 0.359, 244, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
805, d4qwlP_, 0.9260, 1.75, 0.359, 244, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
806, d4qwlB_, 0.9260, 1.75, 0.359, 244, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
807, d4qwkP_, 0.9260, 1.75, 0.359, 244, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
808, d3mg0P_, 0.9260, 1.75, 0.359, 244, 231, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
809, d3gptP_, 0.9260, 1.75, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
810, d2zcyP_, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
811, d2zcyB_, 0.9260, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
812, d5l68P_, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
813, d5l60P_, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
814, d5l60B_, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
815, d5l5tB_, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
816, d5l5sB_, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
817, d5l5iP_, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
818, d5l5iB_, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
819, d5l5eP_, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
820, d5l5eB_, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
821, d5fhsB_, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
822, d5fgiP_, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
823, d5fgeP_, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
824, d5fg9P_, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
825, d5fg9B_, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
826, d5dkiB_, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
827, d5d0zB_, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
828, d5d0xP_, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
829, d5d0tB_, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
830, d5cz7P_, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
831, d5cz5P_, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
832, d5bxlP_, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT
833, d5bxlB_, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT
834, d5bouP_, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
835, p4ya5P_, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
836, p4ya5B_, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
837, p4y8tP_, 0.9259, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
838, p4y8tB_, 0.9259, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
839, p4y8qB_, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
840, p4y8oB_, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
841, p4y82P_, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
842, p4y6vB_, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
843, p4x6zQ_, 0.9259, 1.74, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
844, d4rurP_, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
845, d4rurB_, 0.9259, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
846, d4qz7P_, 0.9259, 1.75, 0.359, 244, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
847, d4qwkB_, 0.9259, 1.75, 0.359, 244, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
848, d4qw0P_, 0.9259, 1.75, 0.359, 244, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
849, d4qw0B_, 0.9259, 1.75, 0.359, 244, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
850, d4qvwP_, 0.9259, 1.75, 0.359, 244, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
851, d4qvvP_, 0.9259, 1.75, 0.359, 244, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
852, d4quxP_, 0.9259, 1.75, 0.359, 244, 231, YCP BETA5-A49T-MUTANT
853, d3mg4P_, 0.9259, 1.76, 0.359, 244, 231, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
854, d3gptB_, 0.9259, 1.75, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
855, d5l68B_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
856, d5l65P_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
857, d5l65B_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
858, d5l5xP_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
859, d5l5xB_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
860, d5l5jP_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
861, d5l5jB_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
862, d5l55P_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
863, d5l55B_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
864, d5l54P_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
865, d5l54B_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
866, d5fgiB_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
867, d5fggP_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
868, d5fggB_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
869, d5fgeB_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
870, d5fg7P_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-T1A MUTANT
871, d5fg7B_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-T1A MUTANT
872, d5d0xB_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
873, d5d0sP_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
874, d5cz7B_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
875, d5cz6P_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
876, d5cz5B_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
877, d5cz4P_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
878, d5cz4B_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
879, p5cggP_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
880, d5bouB_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
881, p4ya3P_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
882, p4ya3B_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
883, p4ya2P_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
884, d4ya1P_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT
885, p4y8nP_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
886, p4y8nB_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
887, p4y82B_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
888, p4y81P_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
889, p4y75P_, 0.9258, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
890, d4r17P_, 0.9258, 1.75, 0.359, 244, 231, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
891, d4r00P_, 0.9258, 1.75, 0.359, 244, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
892, d4qz7B_, 0.9258, 1.75, 0.359, 244, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
893, d4qwuP_, 0.9258, 1.75, 0.359, 244, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
894, d4qwuB_, 0.9258, 1.75, 0.359, 244, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
895, d4qw1P_, 0.9258, 1.75, 0.359, 244, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
896, d4qvyP_, 0.9258, 1.75, 0.359, 244, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
897, d4qvyB_, 0.9258, 1.75, 0.359, 244, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
898, d4qvwB_, 0.9258, 1.75, 0.359, 244, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
899, d4qvvB_, 0.9258, 1.75, 0.359, 244, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
900, d4qvqP_, 0.9258, 1.75, 0.359, 244, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
901, d4qvqB_, 0.9258, 1.75, 0.359, 244, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
902, d4qvpP_, 0.9258, 1.75, 0.359, 244, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
903, d4qvpB_, 0.9258, 1.75, 0.359, 244, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
904, d4qv7P_, 0.9258, 1.75, 0.359, 244, 231, YCP BETA5-A50V MUTANT
905, d4quxB_, 0.9258, 1.75, 0.359, 244, 231, YCP BETA5-A49T-MUTANT
906, d4qltP_, 0.9258, 1.75, 0.359, 244, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
907, d5laiP_, 0.9257, 1.75, 0.359, 244, 231, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
908, d5laiB_, 0.9257, 1.75, 0.359, 244, 231, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
909, d5l5zP_, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
910, d5l5zB_, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
911, d5l5yP_, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
912, d5l5yB_, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
913, d5l5vP_, 0.9257, 1.75, 0.359, 244, 231,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
914, d5l5vB_, 0.9257, 1.75, 0.359, 244, 231,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
915, d5l5qP_, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
916, d5l5qB_, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
917, d5l5oP_, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
918, d5l5hP_, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
919, d5l5hB_, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
920, p5fghP_, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
921, d5d0sB_, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
922, d5czaP_, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT
923, d5cz6B_, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
924, p5cggB_, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
925, d4ya4P_, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT
926, p4ya2B_, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
927, d4ya1B_, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT
928, d4y8rP_, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT
929, d4y8rB_, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT
930, d4y8mP_, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
931, d4y8mB_, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
932, p4y81B_, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
933, p4y75B_, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
934, p4y6zP_, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
935, p4y6zB_, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
936, p4y6aP_, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
937, p4y6aB_, 0.9257, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
938, d4r17B_, 0.9257, 1.75, 0.359, 244, 231, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
939, d4r00B_, 0.9257, 1.75, 0.359, 244, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
940, d4qw1B_, 0.9257, 1.75, 0.359, 244, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
941, d4qvmP_, 0.9257, 1.75, 0.359, 244, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
942, d4qvlP_, 0.9257, 1.75, 0.359, 244, 231, YCP IN COMPLEX WITH BORTEZOMIB
943, d4qv8P_, 0.9257, 1.75, 0.359, 244, 231, YCP BETA5-C52F MUTANT
944, d4qv8B_, 0.9257, 1.75, 0.359, 244, 231, YCP BETA5-C52F MUTANT
945, d4qv7B_, 0.9257, 1.75, 0.359, 244, 231, YCP BETA5-A50V MUTANT
946, d4qv0P_, 0.9257, 1.75, 0.359, 244, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT
947, d4qluP_, 0.9257, 1.75, 0.359, 244, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
948, p4qltB_, 0.9257, 1.75, 0.359, 244, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
949, d5l6bP_, 0.9256, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
950, d5l6bB_, 0.9256, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
951, d5l67P_, 0.9256, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
952, d5l67B_, 0.9256, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
953, d5l5oB_, 0.9256, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
954, d5l5fP_, 0.9256, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
955, d5l5fB_, 0.9256, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
956, d5l5aP_, 0.9256, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
957, p5fghB_, 0.9256, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
958, d5d0wP_, 0.9256, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT
959, d5czaB_, 0.9256, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT
960, d4ya4B_, 0.9256, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT
961, d4qzzP_, 0.9256, 1.75, 0.359, 244, 231, YCP IN COMPLEX WITH OMURALIDE
962, d4qwsP_, 0.9256, 1.75, 0.359, 244, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
963, d4qwsB_, 0.9256, 1.75, 0.359, 244, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
964, d4qvmB_, 0.9256, 1.75, 0.359, 244, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
965, d4qvlB_, 0.9256, 1.75, 0.359, 244, 231, YCP IN COMPLEX WITH BORTEZOMIB
966, d4qv3P_, 0.9256, 1.75, 0.359, 244, 231, YCP BETA5-M45V MUTANT
967, d4qv3B_, 0.9256, 1.75, 0.359, 244, 231, YCP BETA5-M45V MUTANT
968, d4qv0B_, 0.9256, 1.75, 0.359, 244, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT
969, d4quyP_, 0.9256, 1.75, 0.359, 244, 231, YCP BETA5-A49S-MUTANT
970, p4qluB_, 0.9256, 1.75, 0.359, 244, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
971, p6gopP_, 0.9255, 1.76, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
972, p6gopB_, 0.9255, 1.76, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
973, p5vftk_, 0.9255, 1.46, 0.612, 228, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
974, d5l6cP_, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
975, d5l6cB_, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
976, d5l69P_, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
977, d5l69B_, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
978, d5l64P_, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
979, d5l64B_, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
980, d5l63P_, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
981, d5l63B_, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
982, d5l62P_, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
983, d5l62B_, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
984, d5l5uP_, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
985, d5l5pP_, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
986, d5l5pB_, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
987, d5l5dP_, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
988, d5l5aB_, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
989, d5d0wB_, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT
990, p5cghP_, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
991, p5cghB_, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
992, d4qzzB_, 0.9255, 1.75, 0.359, 244, 231, YCP IN COMPLEX WITH OMURALIDE
993, d4qvnP_, 0.9255, 1.75, 0.359, 244, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
994, d4qv9P_, 0.9255, 1.75, 0.359, 244, 231, YCP BETA5-C63F MUTANT
995, d4quyB_, 0.9255, 1.75, 0.359, 244, 231, YCP BETA5-A49S-MUTANT
996, d4no6P_, 0.9255, 1.75, 0.359, 244, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
997, d4no6B_, 0.9255, 1.75, 0.359, 244, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
998, d3un8B_, 0.9255, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
999, d5l66P_, 0.9254, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1000, d5l66B_, 0.9254, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1001, d5l61P_, 0.9254, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1002, d5l5wP_, 0.9254, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1003, d5l5wB_, 0.9254, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1004, d5l5uB_, 0.9254, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1005, d5l5dB_, 0.9254, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1006, d4qvnB_, 0.9254, 1.76, 0.359, 244, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1007, d4qv9B_, 0.9254, 1.75, 0.359, 244, 231, YCP BETA5-C63F MUTANT
1008, d4qv4P_, 0.9254, 1.75, 0.359, 244, 231, YCP BETA5-M45T MUTANT
1009, d5m2bP_, 0.9253, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1010, d5m2bB_, 0.9253, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1011, d5l61B_, 0.9253, 1.75, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1012, d5ahjP_, 0.9253, 1.76, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1013, d5ahjB_, 0.9253, 1.76, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1014, d4qw3P_, 0.9253, 1.76, 0.359, 244, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1015, d4qw3B_, 0.9253, 1.76, 0.359, 244, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1016, d4qv5P_, 0.9253, 1.75, 0.359, 244, 231, YCP BETA5-M45I MUTANT
1017, d4qv4B_, 0.9253, 1.75, 0.359, 244, 231, YCP BETA5-M45T MUTANT
1018, d4qv1P_, 0.9253, 1.75, 0.359, 244, 231, YCP BETA5-M45A MUTANT
1019, d4qv1B_, 0.9253, 1.75, 0.359, 244, 231, YCP BETA5-M45A MUTANT
1020, d4hrdB_, 0.9253, 1.77, 0.359, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1021, d4qv5B_, 0.9252, 1.75, 0.359, 244, 231, YCP BETA5-M45I MUTANT
1022, d5bxnP_, 0.9251, 1.76, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1023, d5bxnB_, 0.9251, 1.76, 0.359, 244, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1024, d4qwgP_, 0.9251, 1.75, 0.359, 244, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1025, d4qwgB_, 0.9251, 1.75, 0.359, 244, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1026, d4qv6P_, 0.9251, 1.76, 0.359, 244, 231, YCP BETA5-A49V MUTANT
1027, d4ltcB_, 0.9251, 1.77, 0.359, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1028, d3gpjP_, 0.9251, 1.76, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1029, d3gpjB_, 0.9251, 1.76, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1030, d1rypC_, 0.9251, 1.76, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1031, d5l6aP_, 0.9250, 1.76, 0.359, 244, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1032, d5l6aB_, 0.9250, 1.76, 0.359, 244, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1033, d5l5rP_, 0.9250, 1.76, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1034, d5l5bP_, 0.9250, 1.76, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1035, d5l5bB_, 0.9250, 1.76, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1036, d4r02B_, 0.9250, 1.76, 0.359, 244, 231, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1037, d4qv6B_, 0.9250, 1.76, 0.359, 244, 231, YCP BETA5-A49V MUTANT
1038, p4q1sB_, 0.9250, 1.76, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1039, d5l5rB_, 0.9249, 1.76, 0.359, 244, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1040, p4zzgQ_, 0.9249, 1.77, 0.359, 242, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1041, d3wxrC_, 0.9249, 1.75, 0.351, 242, 231, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1042, d3mg0B_, 0.9249, 1.76, 0.359, 244, 231, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1043, p5nifQ_, 0.9248, 1.77, 0.359, 242, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1044, d4qlvP_, 0.9247, 1.77, 0.359, 244, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1045, d4no8P_, 0.9247, 1.76, 0.359, 244, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1046, p4zzgC_, 0.9246, 1.77, 0.359, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1047, p4qlvB_, 0.9246, 1.77, 0.359, 244, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1048, d4no8B_, 0.9246, 1.76, 0.359, 244, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1049, d4no1P_, 0.9246, 1.76, 0.359, 244, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1050, p4qbyP_, 0.9245, 1.76, 0.359, 244, 231, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1051, d4no1B_, 0.9245, 1.76, 0.359, 244, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1052, p5nifC_, 0.9244, 1.78, 0.359, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1053, p4x6zC_, 0.9244, 1.76, 0.359, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1054, p4qbyB_, 0.9244, 1.77, 0.359, 244, 231, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1055, d4eu2C_, 0.9243, 1.77, 0.359, 244, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1056, p5vfuJA_, 0.9236, 1.51, 0.612, 228, 227, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1057, d1jd2W_, 0.9236, 1.77, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1058, d1jd2B_, 0.9235, 1.77, 0.359, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1059, d3mg4B_, 0.9234, 1.78, 0.359, 244, 231, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1060, p5mp9c_, 0.9221, 1.75, 0.359, 244, 231, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1061, p3jcpLA_, 0.9220, 1.80, 0.359, 244, 231, 
1062, p3jcpL_, 0.9220, 1.80, 0.359, 244, 231, 
1063, d1g0uA_, 0.9213, 1.54, 0.330, 246, 227, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1064, p5mp9C_, 0.9212, 1.76, 0.359, 244, 231, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1065, d1g0uO_, 0.9212, 1.55, 0.330, 246, 227, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1066, d1j2qB_, 0.9204, 1.83, 0.411, 237, 231, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1067, d1jd2V_, 0.9202, 1.56, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1068, d1rypP_, 0.9201, 1.57, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1069, d3sdiO_, 0.9200, 1.56, 0.330, 246, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1070, d1z7qQ1, 0.9200, 1.74, 0.361, 243, 230, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1071, d1z7qC1, 0.9200, 1.74, 0.361, 243, 230, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1072, d1j2qF_, 0.9199, 1.84, 0.411, 237, 231, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1073, d1j2qD_, 0.9199, 1.84, 0.411, 237, 231, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1074, p5mpac_, 0.9198, 1.78, 0.359, 244, 231, 26S PROTEASOME IN PRESENCE OF ATP (S2)
1075, d1j2qG_, 0.9198, 1.84, 0.411, 237, 231, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1076, d1rypB_, 0.9197, 1.57, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1077, d1j2qE_, 0.9196, 1.85, 0.411, 237, 231, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1078, d1j2qA_, 0.9196, 1.84, 0.411, 237, 231, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1079, d3mg7O_, 0.9195, 1.57, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1080, d1j2qC_, 0.9195, 1.85, 0.411, 237, 231, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1081, d1g65O_, 0.9194, 1.57, 0.330, 250, 227, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1082, d3oeuO_, 0.9193, 1.57, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1083, p5mpaC_, 0.9192, 1.81, 0.359, 244, 231, 26S PROTEASOME IN PRESENCE OF ATP (S2)
1084, d3sdkO_, 0.9192, 1.57, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1085, d3mg8O_, 0.9192, 1.57, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1086, d1jd2A_, 0.9192, 1.57, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1087, d4intO_, 0.9191, 1.57, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1088, d3e47O_, 0.9191, 1.58, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1089, d2gplO_, 0.9191, 1.58, 0.330, 250, 227, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1090, d2fnyO_, 0.9191, 1.58, 0.330, 250, 227,  
1091, d1g65A_, 0.9191, 1.58, 0.330, 250, 227, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1092, p5vfok_, 0.9190, 1.56, 0.608, 228, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1093, d4qv5O_, 0.9190, 1.58, 0.330, 250, 227, YCP BETA5-M45I MUTANT
1094, d4qv5A_, 0.9190, 1.58, 0.330, 250, 227, YCP BETA5-M45I MUTANT
1095, d3mg4O_, 0.9190, 1.58, 0.330, 250, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1096, d3e47A_, 0.9190, 1.58, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1097, d2gplA_, 0.9190, 1.58, 0.330, 250, 227, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1098, d2fnyA_, 0.9190, 1.58, 0.330, 250, 227,  
1099, d3mg0O_, 0.9189, 1.58, 0.330, 250, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1100, p3jcoLA_, 0.9189, 1.84, 0.359, 244, 231, 
1101, p3jcoL_, 0.9189, 1.84, 0.359, 244, 231, 
1102, p5vfpCA_, 0.9188, 1.49, 0.606, 228, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1103, d3wxrP_, 0.9188, 1.58, 0.330, 249, 227, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1104, d4inuO_, 0.9187, 1.58, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1105, d4intA_, 0.9187, 1.58, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1106, d4inrO_, 0.9187, 1.58, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1107, d2f16O_, 0.9187, 1.58, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1108, d5l5rO_, 0.9186, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1109, d5l5rA_, 0.9186, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1110, d4qv3O_, 0.9186, 1.59, 0.330, 250, 227, YCP BETA5-M45V MUTANT
1111, d4jsqO_, 0.9186, 1.58, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1112, d4jsqA_, 0.9186, 1.58, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1113, d4fzcO_, 0.9186, 1.58, 0.330, 250, 227, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1114, d4fzcA_, 0.9186, 1.58, 0.330, 250, 227, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1115, d3oevO_, 0.9186, 1.58, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1116, d2fakO_, 0.9186, 1.59, 0.330, 250, 227, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1117, d2f16A_, 0.9186, 1.59, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1118, d5l5bO_, 0.9185, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1119, d5l5bA_, 0.9185, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1120, d4qv4O_, 0.9185, 1.59, 0.330, 250, 227, YCP BETA5-M45T MUTANT
1121, d4qv3A_, 0.9185, 1.59, 0.330, 250, 227, YCP BETA5-M45V MUTANT
1122, d4inuA_, 0.9185, 1.58, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1123, d4hnpO_, 0.9185, 1.59, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1124, p3un4O_, 0.9185, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1125, d3sdiA_, 0.9185, 1.58, 0.330, 246, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1126, d3mg6A_, 0.9185, 1.58, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1127, d2fakA_, 0.9185, 1.59, 0.330, 250, 227, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1128, p5vfrk_, 0.9184, 1.49, 0.606, 228, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1129, d4qv4A_, 0.9184, 1.59, 0.330, 250, 227, YCP BETA5-M45T MUTANT
1130, d4ltcO_, 0.9184, 1.59, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1131, d4inrA_, 0.9184, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1132, d3un8O_, 0.9184, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1133, d3mg7A_, 0.9184, 1.58, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1134, d3mg6O_, 0.9184, 1.58, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1135, p5t0gK_, 0.9183, 1.55, 0.612, 228, 227, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1136, d5l6aO_, 0.9183, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1137, d5l6aA_, 0.9183, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1138, d5d0wO_, 0.9183, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1139, d5d0wA_, 0.9183, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1140, d5ahjO_, 0.9183, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1141, d5ahjA_, 0.9183, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1142, d4qv1O_, 0.9183, 1.59, 0.330, 250, 227, YCP BETA5-M45A MUTANT
1143, d4qv1A_, 0.9183, 1.59, 0.330, 250, 227, YCP BETA5-M45A MUTANT
1144, d4no1O_, 0.9183, 1.59, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1145, d4no1A_, 0.9183, 1.59, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1146, d3okjO_, 0.9183, 1.59, 0.330, 250, 227, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1147, p1fntC_, 0.9183, 1.75, 0.361, 241, 230, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1148, p6gopO_, 0.9182, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1149, d5l5uO_, 0.9182, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1150, d5l5uA_, 0.9182, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1151, d5l55O_, 0.9182, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1152, d5fggO_, 0.9182, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1153, d5fggA_, 0.9182, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1154, d4qv9O_, 0.9182, 1.59, 0.330, 250, 227, YCP BETA5-C63F MUTANT
1155, d4qv9A_, 0.9182, 1.59, 0.330, 250, 227, YCP BETA5-C63F MUTANT
1156, d4qv0O_, 0.9182, 1.59, 0.330, 250, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1157, d4qv0A_, 0.9182, 1.59, 0.330, 250, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1158, d4quyO_, 0.9182, 1.59, 0.330, 250, 227, YCP BETA5-A49S-MUTANT
1159, d4quyA_, 0.9182, 1.59, 0.330, 250, 227, YCP BETA5-A49S-MUTANT
1160, d4jsuO_, 0.9182, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1161, d4jsuA_, 0.9182, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1162, d3wxrB_, 0.9182, 1.60, 0.330, 249, 227, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1163, d3sdkA_, 0.9182, 1.58, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1164, d3okjA_, 0.9182, 1.59, 0.330, 250, 227, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1165, d3mg8A_, 0.9182, 1.58, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1166, p1fntQ_, 0.9182, 1.75, 0.361, 241, 230, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1167, d5l5dO_, 0.9181, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1168, d5l5dA_, 0.9181, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1169, d5l55A_, 0.9181, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1170, d5bxnO_, 0.9181, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1171, d5bxnA_, 0.9181, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1172, p4zzgB_, 0.9181, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1173, d4ya4O_, 0.9181, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1174, d4ya4A_, 0.9181, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1175, p4y8sO_, 0.9181, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1176, d4qv7O_, 0.9181, 1.60, 0.330, 250, 227, YCP BETA5-A50V MUTANT
1177, d4no8O_, 0.9181, 1.59, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1178, d4no8A_, 0.9181, 1.59, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1179, d4fzgO_, 0.9181, 1.59, 0.330, 250, 227, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1180, d3shjO_, 0.9181, 1.60, 0.330, 250, 227, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1181, d3shjA_, 0.9181, 1.60, 0.330, 250, 227, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1182, d3oevA_, 0.9181, 1.58, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1183, d3oeuA_, 0.9181, 1.58, 0.330, 250, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1184, d3hyeO_, 0.9181, 1.59, 0.330, 250, 227, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1185, d5l5hO_, 0.9180, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1186, d5l5hA_, 0.9180, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1187, d5czaO_, 0.9180, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1188, d5czaA_, 0.9180, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1189, p5cggO_, 0.9180, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1190, d5bxlO_, 0.9180, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1191, d5bxlA_, 0.9180, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1192, p4ya9O_, 0.9180, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1193, d4r02O_, 0.9180, 1.59, 0.330, 250, 227, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1194, d4qz7O_, 0.9180, 1.59, 0.330, 250, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1195, d4qz7A_, 0.9180, 1.59, 0.330, 250, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1196, d4qz4O_, 0.9180, 1.59, 0.330, 250, 227, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1197, d4qz4A_, 0.9180, 1.60, 0.330, 250, 227, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1198, d4qvnO_, 0.9180, 1.60, 0.330, 250, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1199, d4qv8O_, 0.9180, 1.60, 0.330, 250, 227, YCP BETA5-C52F MUTANT
1200, d4qv8A_, 0.9180, 1.60, 0.330, 250, 227, YCP BETA5-C52F MUTANT
1201, d4qv7A_, 0.9180, 1.60, 0.330, 250, 227, YCP BETA5-A50V MUTANT
1202, d4qv6O_, 0.9180, 1.60, 0.330, 250, 227, YCP BETA5-A49V MUTANT
1203, d4qv6A_, 0.9180, 1.60, 0.330, 250, 227, YCP BETA5-A49V MUTANT
1204, d4no6O_, 0.9180, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1205, d4jt0O_, 0.9180, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1206, d4jt0A_, 0.9180, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1207, d4g4sB_, 0.9180, 1.58, 0.330, 246, 227, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
1208, d4fzgA_, 0.9180, 1.59, 0.330, 250, 227, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1209, d3un8A_, 0.9180, 1.59, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1210, d3tddO_, 0.9180, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1211, d3mg4A_, 0.9180, 1.59, 0.330, 250, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1212, d3hyeA_, 0.9180, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1213, d5l63O_, 0.9179, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1214, d5l5wO_, 0.9179, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1215, d5l5wA_, 0.9179, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1216, p4zzgP_, 0.9179, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1217, d4ya1O_, 0.9179, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1218, d4ya1A_, 0.9179, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1219, d4y8rO_, 0.9179, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1220, d4qwuO_, 0.9179, 1.60, 0.330, 250, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1221, d4qvnA_, 0.9179, 1.60, 0.330, 250, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1222, d4qlsO_, 0.9179, 1.59, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1223, d4qlsA_, 0.9179, 1.59, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1224, d4no6A_, 0.9179, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1225, d4nnnO_, 0.9179, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH MG132
1226, d4nnnA_, 0.9179, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH MG132
1227, d4ltcA_, 0.9179, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1228, d3tddA_, 0.9179, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1229, d3nzxO_, 0.9179, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1230, d3nzxA_, 0.9179, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1231, d3nzwO_, 0.9179, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1232, d3gptO_, 0.9179, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1233, d2zcyO_, 0.9179, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1234, p5vfqC_, 0.9178, 1.84, 0.342, 248, 234, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1235, p5vfoI_, 0.9178, 1.85, 0.342, 248, 234, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1236, p5nifP_, 0.9178, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1237, p5nifB_, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1238, d5m2bO_, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1239, d5m2bA_, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1240, d5l6bO_, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1241, d5l6bA_, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1242, d5l63A_, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1243, d5l61O_, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1244, d5jhrO_, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1245, d5jhrA_, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1246, p4ya2O_, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1247, d4y9yO_, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1248, d4y9yA_, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1249, p4y8tO_, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1250, d4y8rA_, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1251, p4y8pO_, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1252, p4y75O_, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1253, d4qz0O_, 0.9178, 1.60, 0.330, 250, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1254, d4qz0A_, 0.9178, 1.60, 0.330, 250, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1255, d4qwuA_, 0.9178, 1.60, 0.330, 250, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1256, d4qluO_, 0.9178, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1257, d4qluA_, 0.9178, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1258, d4g4sC_, 0.9178, 1.74, 0.358, 237, 229, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
1259, d3nzwA_, 0.9178, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1260, d3gptA_, 0.9178, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1261, d2zcyA_, 0.9178, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1262, p5vfrI_, 0.9177, 1.84, 0.342, 248, 234, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1263, d5l65O_, 0.9177, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1264, d5l61A_, 0.9177, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1265, d5l5sO_, 0.9177, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1266, d5l5sA_, 0.9177, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1267, d5l5pO_, 0.9177, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1268, d5l5pA_, 0.9177, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1269, d5l5oO_, 0.9177, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1270, d5l5oA_, 0.9177, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1271, p5cghO_, 0.9177, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1272, p4ya7O_, 0.9177, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1273, p4x6zP_, 0.9177, 1.60, 0.330, 249, 227, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1274, d4qzzO_, 0.9177, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH OMURALIDE
1275, d4qzzA_, 0.9177, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH OMURALIDE
1276, d4nnwO_, 0.9177, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1277, d4nnwA_, 0.9177, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1278, d4lqiO_, 0.9177, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1279, p4gk7O_, 0.9177, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1280, d3dy3O_, 0.9177, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1281, d3dy3A_, 0.9177, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1282, d5l69O_, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1283, d5l69A_, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1284, d5l66O_, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1285, d5l65A_, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1286, d5l64O_, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1287, d5l64A_, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1288, d5l62O_, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1289, d5l5tO_, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1290, d5l5tA_, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1291, d5l5qO_, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1292, d5l5qA_, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1293, d5l5aO_, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1294, d5l5aA_, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1295, d5l52O_, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1296, d5l52A_, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1297, p4y9zO_, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1298, p4y8gO_, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1299, d4qz6O_, 0.9176, 1.60, 0.330, 250, 227, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1300, d4qz6A_, 0.9176, 1.60, 0.330, 250, 227, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1301, d4qwxO_, 0.9176, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1302, d4qwlO_, 0.9176, 1.60, 0.330, 250, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1303, d4qwlA_, 0.9176, 1.60, 0.330, 250, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1304, d4qvlO_, 0.9176, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH BORTEZOMIB
1305, d4qvlA_, 0.9176, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH BORTEZOMIB
1306, d4qltO_, 0.9176, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1307, d4no9O_, 0.9176, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1308, d4lqiA_, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1309, d4hrcO_, 0.9176, 1.59, 0.330, 249, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1310, d3nzjO_, 0.9176, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1311, d3nzjA_, 0.9176, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1312, d3gpwO_, 0.9176, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1313, d3gpwA_, 0.9176, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1314, d3gpjO_, 0.9176, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1315, d3bdmO_, 0.9176, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1316, p5vfqDA_, 0.9175, 1.30, 0.609, 228, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1317, d5l6cO_, 0.9175, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1318, d5l6cA_, 0.9175, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1319, d5l67O_, 0.9175, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1320, d5l67A_, 0.9175, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1321, d5l66A_, 0.9175, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1322, d5l62A_, 0.9175, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1323, d5l5xO_, 0.9175, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1324, d5l5jO_, 0.9175, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1325, d5l5jA_, 0.9175, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1326, d5fgaO_, 0.9175, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1327, d5fgaA_, 0.9175, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1328, d5d0vO_, 0.9175, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1329, d5cz6O_, 0.9175, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1330, d5cz6A_, 0.9175, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1331, p4y8hO_, 0.9175, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1332, d4r17O_, 0.9175, 1.60, 0.330, 249, 227, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1333, d4qwxA_, 0.9175, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1334, d4qw6O_, 0.9175, 1.60, 0.330, 250, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1335, d4qw6A_, 0.9175, 1.60, 0.330, 250, 227, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1336, d4qw1O_, 0.9175, 1.60, 0.330, 250, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1337, d4qw1A_, 0.9175, 1.60, 0.330, 250, 227, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1338, d4qltA_, 0.9175, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1339, d4no9A_, 0.9175, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1340, d3mg0A_, 0.9175, 1.60, 0.330, 250, 227, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1341, d3gpjA_, 0.9175, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1342, d3bdmA_, 0.9175, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1343, d5lttO_, 0.9174, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1344, d5lttA_, 0.9174, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1345, d5l68O_, 0.9174, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1346, d5l5xA_, 0.9174, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1347, d5l5iO_, 0.9174, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1348, d5l5iA_, 0.9174, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1349, d5fg7O_, 0.9174, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1350, d5fg7A_, 0.9174, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1351, d5d0vA_, 0.9174, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1352, d5d0sO_, 0.9174, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1353, d5d0sA_, 0.9174, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1354, p4y8kO_, 0.9174, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1355, p4y77O_, 0.9174, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1356, d4r18O_, 0.9174, 1.60, 0.330, 250, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1357, d4r18A_, 0.9174, 1.60, 0.330, 250, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1358, d4r17A_, 0.9174, 1.60, 0.330, 249, 227, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1359, d4qz3O_, 0.9174, 1.60, 0.330, 250, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1360, d4qz3A_, 0.9174, 1.60, 0.330, 250, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1361, d4qlqO_, 0.9174, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1362, d4qlqA_, 0.9174, 1.60, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1363, d4q1sO_, 0.9174, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1364, d3d29O_, 0.9174, 1.60, 0.330, 250, 227, PROTEASOME INHIBITION BY FELLUTAMIDE B
1365, d5l68A_, 0.9173, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1366, d5l5fO_, 0.9173, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1367, d5cgfO_, 0.9173, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1368, d5cgfA_, 0.9173, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1369, d4r00O_, 0.9173, 1.60, 0.330, 250, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1370, d4r00A_, 0.9173, 1.60, 0.330, 250, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1371, d4qwfO_, 0.9173, 1.60, 0.330, 250, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1372, d4qwfA_, 0.9173, 1.60, 0.330, 250, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1373, d4qvyO_, 0.9173, 1.61, 0.330, 250, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1374, d4qvyA_, 0.9173, 1.61, 0.330, 250, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1375, d4quxO_, 0.9173, 1.61, 0.330, 250, 227, YCP BETA5-A49T-MUTANT
1376, d4quxA_, 0.9173, 1.61, 0.330, 250, 227, YCP BETA5-A49T-MUTANT
1377, d3dy4O_, 0.9173, 1.61, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1378, d3dy4A_, 0.9173, 1.61, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1379, d3d29A_, 0.9173, 1.60, 0.330, 250, 227, PROTEASOME INHIBITION BY FELLUTAMIDE B
1380, d5l5zO_, 0.9172, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1381, d5l5zA_, 0.9172, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1382, d5l5vO_, 0.9172, 1.61, 0.330, 250, 227,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1383, d5l5vA_, 0.9172, 1.61, 0.330, 250, 227,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1384, d5l5fA_, 0.9172, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1385, d5fg9O_, 0.9172, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1386, d5fg9A_, 0.9172, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1387, d5d0zO_, 0.9172, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1388, d5d0zA_, 0.9172, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1389, d5cz9O_, 0.9172, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1390, d5cz9A_, 0.9172, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1391, p5cgiO_, 0.9172, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1392, d4y8mO_, 0.9172, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1393, d4y8mA_, 0.9172, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1394, d4qzwO_, 0.9172, 1.61, 0.330, 250, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1395, d4qzwA_, 0.9172, 1.61, 0.330, 250, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1396, d4qz2O_, 0.9172, 1.61, 0.330, 250, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1397, d4qz2A_, 0.9172, 1.61, 0.330, 250, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1398, d4qw7O_, 0.9172, 1.61, 0.330, 250, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1399, d4qw7A_, 0.9172, 1.61, 0.330, 250, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1400, d4qw5O_, 0.9172, 1.61, 0.330, 250, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1401, d4qw5A_, 0.9172, 1.61, 0.330, 250, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1402, d4qvwO_, 0.9172, 1.61, 0.330, 250, 227, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1403, d4qvwA_, 0.9172, 1.61, 0.330, 250, 227, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1404, p4qbyO_, 0.9172, 1.61, 0.330, 250, 227, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1405, d5l60O_, 0.9171, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1406, d5l60A_, 0.9171, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1407, d5l5yO_, 0.9171, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1408, d5l5yA_, 0.9171, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1409, d5l5eO_, 0.9171, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1410, d5l54O_, 0.9171, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1411, d5l54A_, 0.9171, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1412, d4qz5O_, 0.9171, 1.61, 0.330, 250, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1413, d4qz5A_, 0.9171, 1.61, 0.330, 250, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1414, d4qvpO_, 0.9171, 1.61, 0.330, 250, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1415, d4q1sA_, 0.9171, 1.60, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1416, d4hnpA_, 0.9171, 1.61, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1417, d5lajA_, 0.9170, 1.61, 0.330, 250, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1418, d5l5eA_, 0.9170, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1419, d5jhsO_, 0.9170, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1420, d5cz7O_, 0.9170, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1421, d5cz7A_, 0.9170, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1422, p4y74O_, 0.9170, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1423, d4qvpA_, 0.9170, 1.61, 0.330, 250, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1424, d4hrdO_, 0.9170, 1.60, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1425, d5lajO_, 0.9169, 1.61, 0.330, 250, 227, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1426, d5jhsA_, 0.9169, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1427, d5fgfO_, 0.9169, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1428, d5fgfA_, 0.9169, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1429, d5bouO_, 0.9169, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1430, d5bouA_, 0.9169, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1431, d4z1lO_, 0.9169, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1432, d4z1lA_, 0.9169, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1433, p4y84O_, 0.9169, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1434, p5mpbQ_, 0.9168, 1.83, 0.359, 244, 231, 
1435, p4y70O_, 0.9168, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1436, p4y6vO_, 0.9168, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1437, d4qvqO_, 0.9168, 1.61, 0.330, 250, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1438, d4qvqA_, 0.9168, 1.61, 0.330, 250, 227, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1439, d5fgeO_, 0.9167, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1440, d5dkjO_, 0.9167, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1441, d5dkjA_, 0.9167, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1442, p4y8lO_, 0.9167, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1443, p4y8jO_, 0.9167, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1444, p4y82O_, 0.9167, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1445, d4rurO_, 0.9167, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1446, d4rurA_, 0.9167, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1447, d4r02A_, 0.9167, 1.61, 0.330, 250, 227, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1448, d4qwrO_, 0.9167, 1.61, 0.330, 250, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1449, d4qwrA_, 0.9167, 1.61, 0.330, 250, 227, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1450, p5ln3E_, 0.9166, 1.29, 0.602, 232, 226, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
1451, d5fgeA_, 0.9166, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1452, d5cz8O_, 0.9166, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1453, p4y7wO_, 0.9166, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1454, d4qw4O_, 0.9166, 1.62, 0.330, 250, 227, YCP IN COMPLEX WITH CARFILZOMIB
1455, d4qw4A_, 0.9166, 1.62, 0.330, 250, 227, YCP IN COMPLEX WITH CARFILZOMIB
1456, d4qlvO_, 0.9166, 1.61, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1457, d4qlvA_, 0.9166, 1.61, 0.330, 250, 227, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1458, d1z7qP1, 0.9166, 1.46, 0.330, 249, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1459, d5cz8A_, 0.9165, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1460, p4y8uO_, 0.9165, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1461, p4y8qO_, 0.9165, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1462, p4y6aO_, 0.9165, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1463, p4y69O_, 0.9165, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1464, d1z7qB1, 0.9165, 1.46, 0.330, 249, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1465, d5fhsO_, 0.9164, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1466, d5fhsA_, 0.9164, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1467, d5fgiO_, 0.9164, 1.62, 0.330, 249, 227, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1468, d5fgiA_, 0.9164, 1.62, 0.330, 249, 227, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1469, p4y8nO_, 0.9164, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1470, p4y8iO_, 0.9164, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1471, p4y80O_, 0.9164, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1472, p4y7xO_, 0.9164, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1473, p4y6zO_, 0.9164, 1.61, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1474, d4qzxO_, 0.9164, 1.61, 0.330, 250, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1475, d4qz1O_, 0.9164, 1.62, 0.330, 250, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1476, d4qz1A_, 0.9164, 1.62, 0.330, 250, 227, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1477, d5d0tO_, 0.9163, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1478, d5d0tA_, 0.9163, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1479, p4y8oO_, 0.9163, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1480, p4y81O_, 0.9163, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1481, p4y7yO_, 0.9163, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1482, d4qzxA_, 0.9163, 1.62, 0.330, 250, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1483, d4qxjO_, 0.9163, 1.62, 0.330, 250, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1484, d4qw0O_, 0.9163, 1.62, 0.330, 250, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1485, d4qw0A_, 0.9163, 1.62, 0.330, 250, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1486, d4hrdA_, 0.9163, 1.61, 0.330, 250, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1487, p5vfpC_, 0.9162, 1.86, 0.342, 248, 234, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1488, d5laiO_, 0.9162, 1.62, 0.330, 250, 227, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1489, d5laiA_, 0.9162, 1.62, 0.330, 250, 227, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1490, d5fgdO_, 0.9162, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1491, d5fgdA_, 0.9162, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1492, d4qxjA_, 0.9162, 1.62, 0.330, 250, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1493, d4qwiO_, 0.9162, 1.62, 0.330, 250, 227, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1494, d4qwiA_, 0.9162, 1.62, 0.330, 250, 227, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1495, d5d0xO_, 0.9161, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1496, d5d0xA_, 0.9161, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1497, p4ya5O_, 0.9161, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1498, d4qvmO_, 0.9161, 1.62, 0.330, 250, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1499, d4qvmA_, 0.9161, 1.62, 0.330, 250, 227, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1500, d4j70O_, 0.9161, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1501, d4j70A_, 0.9161, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1502, p6epfC_, 0.9160, 1.88, 0.339, 249, 233, GROUND STATE 26S PROTEASOME (GS1)
1503, p5fghO_, 0.9160, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1504, d5cz5O_, 0.9160, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1505, d5cz5A_, 0.9160, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1506, d3mg7P_, 0.9160, 1.66, 0.361, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1507, d4eu2P_, 0.9159, 1.57, 0.327, 249, 226, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1508, p4y78O_, 0.9158, 1.62, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1509, d4qwkO_, 0.9158, 1.62, 0.330, 250, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1510, d4qwkA_, 0.9158, 1.62, 0.330, 250, 227, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1511, p3jcpKA_, 0.9158, 1.61, 0.330, 250, 227, 
1512, p3jcpK_, 0.9158, 1.61, 0.330, 250, 227, 
1513, d4hrcA_, 0.9157, 1.62, 0.330, 249, 227, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1514, d5dkiO_, 0.9156, 1.63, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1515, d5dkiA_, 0.9156, 1.63, 0.330, 250, 227, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1516, d3oeuP_, 0.9156, 1.67, 0.361, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1517, d3sdiP_, 0.9155, 1.65, 0.361, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1518, d3oevP_, 0.9155, 1.67, 0.361, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1519, d5cz4O_, 0.9154, 1.63, 0.330, 250, 227, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1520, d5cz4A_, 0.9154, 1.63, 0.330, 250, 227, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1521, d4qwjO_, 0.9154, 1.63, 0.330, 250, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1522, d4qwjA_, 0.9154, 1.63, 0.330, 250, 227, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1523, d3mg6P_, 0.9154, 1.67, 0.361, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1524, d4qvvO_, 0.9153, 1.63, 0.330, 250, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1525, d4qvvA_, 0.9153, 1.63, 0.330, 250, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1526, d3mg8P_, 0.9153, 1.67, 0.361, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1527, p4ya3O_, 0.9152, 1.63, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1528, d4qwsO_, 0.9152, 1.63, 0.330, 250, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1529, d4qwsA_, 0.9152, 1.63, 0.330, 250, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1530, d1g0uP_, 0.9152, 1.65, 0.361, 235, 227, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1531, p4ya0O_, 0.9151, 1.63, 0.330, 250, 227, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1532, d4qw3O_, 0.9151, 1.64, 0.330, 250, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1533, d4qw3A_, 0.9151, 1.64, 0.330, 250, 227, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1534, d4qwgO_, 0.9147, 1.64, 0.330, 250, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1535, d4qwgA_, 0.9147, 1.64, 0.330, 250, 227, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1536, d3sdkP_, 0.9146, 1.68, 0.361, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1537, p5vfsC_, 0.9145, 1.92, 0.338, 250, 234, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1538, p5mp9B_, 0.9145, 1.62, 0.330, 250, 227, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1539, p3unbe_, 0.9144, 1.79, 0.346, 239, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1540, p5t0hK_, 0.9142, 1.53, 0.612, 228, 227, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1541, d1g0uB_, 0.9141, 1.67, 0.361, 235, 227, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1542, p3unhQ_, 0.9140, 1.80, 0.351, 238, 231, MOUSE 20S IMMUNOPROTEASOME
1543, p3unhC_, 0.9140, 1.80, 0.351, 238, 231, MOUSE 20S IMMUNOPROTEASOME
1544, d3unfQ_, 0.9139, 1.80, 0.351, 238, 231, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1545, d3unfC_, 0.9139, 1.80, 0.351, 238, 231, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1546, d5lf3O_, 0.9133, 1.55, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1547, d3mg8B_, 0.9132, 1.68, 0.361, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1548, p5lf0O_, 0.9131, 1.56, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1549, p5lezO_, 0.9131, 1.56, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1550, p5leyO_, 0.9131, 1.56, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1551, p5t0cU_, 0.9130, 2.01, 0.336, 250, 235, 
1552, p5t0cAB_, 0.9130, 2.01, 0.336, 250, 235, 
1553, p5mpbC_, 0.9130, 1.86, 0.351, 244, 231, 
1554, d4eu2B_, 0.9130, 1.60, 0.327, 249, 226, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1555, d1g0uC_, 0.9130, 1.81, 0.338, 238, 231, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1556, d5lf1O_, 0.9129, 1.56, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1557, p5lezA_, 0.9129, 1.56, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1558, d5lexO_, 0.9129, 1.56, 0.311, 230, 225, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1559, d4q1sC_, 0.9129, 1.82, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1560, p3unbQ_, 0.9129, 1.81, 0.346, 239, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1561, p3unbC_, 0.9129, 1.82, 0.346, 239, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1562, p3jcoKA_, 0.9129, 1.63, 0.330, 250, 227, 
1563, p3jcoK_, 0.9129, 1.63, 0.330, 250, 227, 
1564, p5lf6O_, 0.9128, 1.56, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1565, d3mg6B_, 0.9128, 1.69, 0.361, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1566, d5lf7O_, 0.9127, 1.56, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1567, d3sdiC_, 0.9127, 1.83, 0.338, 238, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1568, p5lf0A_, 0.9126, 1.56, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1569, d5lexA_, 0.9126, 1.56, 0.311, 230, 225, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1570, p5vfpE_, 0.9125, 1.60, 0.606, 228, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1571, p4x6zB_, 0.9125, 1.62, 0.327, 248, 226, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1572, d5lf4O_, 0.9124, 1.56, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1573, p3unbs_, 0.9124, 1.82, 0.346, 239, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1574, p5gjqD_, 0.9123, 1.76, 0.336, 240, 229, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1575, p3uneQ_, 0.9123, 1.81, 0.351, 239, 231, MOUSE CONSTITUTIVE 20S PROTEASOME
1576, p5vfrK_, 0.9122, 1.67, 0.608, 228, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1577, d3sdkB_, 0.9122, 1.69, 0.361, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1578, d3sdiB_, 0.9122, 1.69, 0.361, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1579, d5lf7C_, 0.9121, 1.72, 0.354, 236, 229, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1580, d5lf3A_, 0.9121, 1.57, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1581, p5leyA_, 0.9121, 1.57, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1582, d5le5O_, 0.9121, 1.57, 0.311, 230, 225, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1583, d3oevB_, 0.9121, 1.70, 0.361, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1584, d3oeuC_, 0.9121, 1.86, 0.338, 241, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1585, d5lf1A_, 0.9120, 1.57, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1586, p5gjqm_, 0.9120, 1.68, 0.316, 238, 228, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1587, p5lf6A_, 0.9119, 1.57, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1588, d5lf4A_, 0.9119, 1.57, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1589, d5le5C_, 0.9119, 1.72, 0.354, 236, 229, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1590, p3uneq_, 0.9119, 1.68, 0.310, 233, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
1591, d3sdkC_, 0.9119, 1.86, 0.338, 241, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
1592, d5lf3C_, 0.9118, 1.72, 0.354, 236, 229, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
1593, d3oeuB_, 0.9118, 1.69, 0.361, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1594, d3dy4C_, 0.9118, 1.82, 0.338, 241, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1595, d2zcyC_, 0.9118, 1.82, 0.338, 241, 231, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1596, d1g0uQ_, 0.9118, 1.82, 0.338, 238, 231, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1597, p5vfqE_, 0.9117, 1.41, 0.609, 228, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1598, p5vfoK_, 0.9117, 1.60, 0.606, 228, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1599, p5gjrX_, 0.9117, 1.65, 0.316, 238, 228, 
1600, p3uneO_, 0.9117, 1.69, 0.310, 233, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
1601, d3mg7B_, 0.9117, 1.70, 0.361, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1602, d3dy4Q_, 0.9117, 1.82, 0.338, 241, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1603, d2zcyQ_, 0.9117, 1.82, 0.338, 241, 231, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1604, d5lf7A_, 0.9116, 1.57, 0.311, 230, 225, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
1605, d5le5A_, 0.9116, 1.57, 0.311, 230, 225, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
1606, d4r3oP_, 0.9116, 1.70, 0.310, 233, 226, HUMAN CONSTITUTIVE 20S PROTEASOME
1607, d4r3oB_, 0.9116, 1.70, 0.310, 233, 226, HUMAN CONSTITUTIVE 20S PROTEASOME
1608, d4eu2D_, 0.9116, 1.83, 0.338, 241, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1609, p6avoP_, 0.9115, 1.59, 0.311, 230, 225, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1610, p6avob_, 0.9115, 1.59, 0.311, 230, 225, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1611, p5mp9b_, 0.9115, 1.67, 0.330, 250, 227, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1612, d4r67r_, 0.9115, 1.70, 0.310, 233, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1613, d4r67P_, 0.9115, 1.70, 0.310, 233, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1614, d5lf4C_, 0.9114, 1.73, 0.354, 236, 229, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
1615, d4r67d_, 0.9114, 1.70, 0.310, 233, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1616, p5leyC_, 0.9113, 1.73, 0.354, 236, 229, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
1617, p5gjqG_, 0.9113, 1.66, 0.316, 238, 228, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1618, p4r67s_, 0.9113, 1.79, 0.341, 240, 229, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1619, d4r67B_, 0.9113, 1.71, 0.310, 233, 226, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1620, p3uneC_, 0.9113, 1.82, 0.351, 239, 231, MOUSE CONSTITUTIVE 20S PROTEASOME
1621, d3dy3Q_, 0.9113, 1.83, 0.338, 241, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1622, d3dy3C_, 0.9113, 1.83, 0.338, 241, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1623, p5vfuT_, 0.9111, 2.05, 0.336, 250, 235, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1624, p5vftI_, 0.9111, 2.05, 0.336, 250, 235, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1625, d1rypD_, 0.9111, 1.83, 0.338, 241, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1626, p5mpab_, 0.9110, 1.67, 0.330, 250, 227, 26S PROTEASOME IN PRESENCE OF ATP (S2)
1627, p5lf0C_, 0.9110, 1.73, 0.354, 236, 229, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1628, p5lezC_, 0.9110, 1.74, 0.354, 236, 229, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
1629, d1g65C_, 0.9110, 1.83, 0.338, 241, 231, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1630, p1fntP_, 0.9110, 1.61, 0.330, 247, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1631, p4zzgD_, 0.9109, 1.85, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1632, d3un8Q_, 0.9109, 1.84, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1633, d3mg6C_, 0.9109, 1.87, 0.338, 241, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1634, d3bdmC_, 0.9109, 1.83, 0.338, 241, 231, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1635, d1iruP_, 0.9109, 1.72, 0.310, 233, 226, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1636, p1fntB_, 0.9109, 1.61, 0.330, 247, 227, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1637, d5lf1C_, 0.9108, 1.74, 0.354, 236, 229, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
1638, p5gjrLA_, 0.9108, 1.69, 0.316, 238, 228, 
1639, d3un8C_, 0.9108, 1.85, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1640, d3mg8C_, 0.9108, 1.88, 0.338, 241, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1641, d3gpjQ_, 0.9108, 1.83, 0.338, 241, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1642, d3gpjC_, 0.9108, 1.83, 0.338, 241, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1643, d3bdmQ_, 0.9108, 1.83, 0.338, 241, 231, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1644, p6avoZ_, 0.9106, 1.77, 0.341, 240, 229, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1645, p6avoO_, 0.9106, 1.77, 0.341, 240, 229, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
1646, d4inrC_, 0.9106, 1.85, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1647, d3shjC_, 0.9106, 1.84, 0.338, 241, 231, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1648, d1rypR_, 0.9106, 1.83, 0.338, 241, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1649, p5nifD_, 0.9105, 1.86, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1650, p5lf6C_, 0.9105, 1.74, 0.354, 236, 229, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
1651, d4q1sQ_, 0.9105, 1.84, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1652, d3shjQ_, 0.9105, 1.84, 0.338, 241, 231, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1653, d5lexC_, 0.9104, 1.74, 0.354, 236, 229, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
1654, p5l4gP_, 0.9104, 1.68, 0.310, 233, 226, 
1655, d4lqiC_, 0.9104, 1.84, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1656, d4lqiQ_, 0.9103, 1.84, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1657, d4hnpC_, 0.9103, 1.86, 0.338, 241, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1658, d4eu2R_, 0.9103, 1.85, 0.338, 241, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1659, d3nzwC_, 0.9103, 1.84, 0.338, 241, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1660, p5wvkY_, 0.9102, 1.83, 0.342, 241, 231, 
1661, d4inuC_, 0.9102, 1.85, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1662, d4inrQ_, 0.9102, 1.85, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1663, p3unec_, 0.9102, 1.69, 0.310, 233, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
1664, p3uneA_, 0.9102, 1.70, 0.310, 233, 226, MOUSE CONSTITUTIVE 20S PROTEASOME
1665, d3nzwQ_, 0.9102, 1.85, 0.338, 241, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1666, d3gptC_, 0.9102, 1.84, 0.338, 241, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1667, p4v7oMA_, 0.9101, 1.04, 1.000, 227, 220, 
1668, p4v7oE_, 0.9101, 1.04, 1.000, 227, 220, 
1669, p4v7oAB_, 0.9101, 1.04, 1.000, 227, 220, 
1670, d4intC_, 0.9101, 1.85, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1671, p4gk7Q_, 0.9101, 1.85, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1672, p4gk7C_, 0.9101, 1.85, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1673, d4fzcC_, 0.9101, 1.85, 0.342, 241, 231, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1674, p3un4Q_, 0.9101, 1.85, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1675, p3un4C_, 0.9101, 1.85, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1676, d3tddC_, 0.9101, 1.84, 0.338, 241, 231, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1677, d3nzxC_, 0.9101, 1.84, 0.338, 241, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1678, d3hyeC_, 0.9101, 1.85, 0.338, 241, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1679, d3gpwC_, 0.9101, 1.84, 0.338, 241, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1680, d3gptQ_, 0.9101, 1.84, 0.338, 241, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1681, p4v7oS_, 0.9100, 1.05, 1.000, 227, 220, 
1682, d4jsuQ_, 0.9100, 1.85, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1683, d4jsuC_, 0.9100, 1.85, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1684, d4jsqQ_, 0.9100, 1.86, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1685, d4jsqC_, 0.9100, 1.86, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1686, d4fzcQ_, 0.9100, 1.85, 0.342, 241, 231, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1687, d3tddQ_, 0.9100, 1.84, 0.338, 241, 231, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1688, d3okjC_, 0.9100, 1.84, 0.338, 241, 231, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1689, d3nzxQ_, 0.9100, 1.84, 0.338, 241, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1690, d3gpwQ_, 0.9100, 1.85, 0.338, 241, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1691, p4x6zD_, 0.9099, 1.85, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1692, d4inuQ_, 0.9099, 1.85, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1693, d4intQ_, 0.9099, 1.85, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1694, d3okjQ_, 0.9099, 1.85, 0.338, 241, 231, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1695, d3hyeQ_, 0.9099, 1.85, 0.338, 241, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1696, d2fnyC_, 0.9099, 1.85, 0.338, 241, 231,  
1697, d1g65Q_, 0.9099, 1.84, 0.338, 241, 231, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1698, p4zzgR_, 0.9098, 1.87, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1699, d4jt0Q_, 0.9098, 1.86, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1700, d4jt0C_, 0.9098, 1.86, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1701, p3unes_, 0.9098, 1.83, 0.351, 239, 231, MOUSE CONSTITUTIVE 20S PROTEASOME
1702, d3unbq_, 0.9098, 1.55, 0.312, 231, 224, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1703, d3e47C_, 0.9098, 1.85, 0.338, 241, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1704, d2fnyQ_, 0.9098, 1.85, 0.338, 241, 231,  
1705, d4hrcC_, 0.9097, 1.86, 0.338, 241, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1706, d3nzjQ_, 0.9097, 1.85, 0.338, 241, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1707, d3nzjC_, 0.9097, 1.85, 0.338, 241, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1708, d3mg7C_, 0.9097, 1.90, 0.338, 241, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1709, d3e47Q_, 0.9097, 1.85, 0.338, 241, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1710, p5nifR_, 0.9096, 1.88, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1711, p5vfqB_, 0.9095, 1.52, 0.310, 230, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1712, p5m32P_, 0.9095, 2.05, 0.339, 244, 233, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
1713, d4j70C_, 0.9095, 1.86, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1714, d2fakC_, 0.9095, 1.86, 0.338, 241, 231, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1715, d2f16C_, 0.9095, 1.85, 0.338, 241, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1716, d3wxrD_, 0.9094, 1.88, 0.338, 241, 231, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1717, d2fakQ_, 0.9094, 1.86, 0.338, 241, 231, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1718, d1z7qR1, 0.9094, 1.92, 0.345, 241, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1719, d1z7qD1, 0.9094, 1.92, 0.345, 241, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1720, d4fzgQ_, 0.9093, 1.85, 0.338, 241, 231, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1721, d4fzgC_, 0.9093, 1.85, 0.338, 241, 231, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1722, d3mg0C_, 0.9093, 1.87, 0.338, 241, 231, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1723, d2f16Q_, 0.9093, 1.86, 0.338, 241, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1724, p5l4gT_, 0.9092, 1.68, 0.316, 238, 228, 
1725, d4j70Q_, 0.9092, 1.86, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1726, d3unbc_, 0.9092, 1.57, 0.312, 231, 224, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1727, d3sdiQ_, 0.9092, 1.86, 0.338, 238, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1728, d3oevC_, 0.9092, 1.90, 0.338, 241, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1729, d3mg0Q_, 0.9092, 1.87, 0.342, 241, 231, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1730, p5gjqC_, 0.9091, 1.75, 0.310, 233, 226, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1731, d4ltcC_, 0.9091, 1.87, 0.338, 241, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1732, d4hrdC_, 0.9091, 1.87, 0.338, 241, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1733, p3unee_, 0.9091, 1.85, 0.351, 239, 231, MOUSE CONSTITUTIVE 20S PROTEASOME
1734, d4hnpQ_, 0.9090, 1.87, 0.338, 241, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1735, d3unbO_, 0.9090, 1.56, 0.312, 231, 224, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1736, d3unbA_, 0.9090, 1.57, 0.312, 231, 224, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1737, p5gjqj_, 0.9089, 1.81, 0.341, 240, 229, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1738, d1iruR_, 0.9089, 1.85, 0.346, 243, 231, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1739, d1iruD_, 0.9089, 1.85, 0.346, 243, 231, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1740, p5l4gC_, 0.9087, 1.79, 0.341, 240, 229, 
1741, p5l4gB_, 0.9087, 1.82, 0.310, 233, 226, 
1742, d1j2pF_, 0.9087, 2.06, 0.405, 243, 232, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1743, d2gplC_, 0.9086, 1.86, 0.338, 241, 231, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1744, d1j2pG_, 0.9086, 2.06, 0.405, 243, 232, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1745, d1j2pA_, 0.9086, 2.07, 0.405, 243, 232, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1746, p5l4gF_, 0.9085, 1.73, 0.316, 238, 228, 
1747, d4ltcQ_, 0.9085, 1.87, 0.338, 241, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1748, d2gplQ_, 0.9085, 1.86, 0.338, 241, 231, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1749, d1j2pE_, 0.9085, 2.07, 0.405, 243, 232, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1750, d1j2pC_, 0.9085, 2.07, 0.405, 243, 232, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1751, d1iruT_, 0.9085, 1.86, 0.314, 238, 229, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1752, p5l4gQ_, 0.9084, 1.80, 0.341, 240, 229, 
1753, d1j2pD_, 0.9084, 2.07, 0.405, 243, 232, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1754, d1j2pB_, 0.9084, 2.07, 0.405, 243, 232, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1755, d4r3oF_, 0.9083, 1.69, 0.316, 238, 228, HUMAN CONSTITUTIVE 20S PROTEASOME
1756, p5wvkW_, 0.9082, 1.70, 0.330, 250, 227, 
1757, p5t0gI_, 0.9082, 1.96, 0.338, 250, 234, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1758, d4r67T_, 0.9082, 1.86, 0.314, 238, 229, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1759, p6gopC_, 0.9080, 1.83, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1760, p4x6zR_, 0.9080, 1.89, 0.338, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1761, d3mg4C_, 0.9080, 1.89, 0.338, 241, 231, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1762, p6gopQ_, 0.9079, 1.83, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1763, p5gjrHA_, 0.9079, 1.57, 0.312, 231, 224, 
1764, d4hrcQ_, 0.9079, 1.88, 0.338, 241, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1765, p5gjrT_, 0.9078, 1.57, 0.312, 231, 224, 
1766, p3unhS_, 0.9078, 1.77, 0.316, 238, 228, MOUSE 20S IMMUNOPROTEASOME
1767, d1iruB_, 0.9078, 1.79, 0.310, 233, 226, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1768, p1fntD_, 0.9078, 1.95, 0.345, 239, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1769, p4r67h_, 0.9077, 1.72, 0.316, 238, 228, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1770, p3unhE_, 0.9077, 1.77, 0.316, 238, 228, MOUSE 20S IMMUNOPROTEASOME
1771, p1fntR_, 0.9077, 1.95, 0.345, 239, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1772, p5vfoH_, 0.9076, 1.56, 0.310, 230, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1773, d4r67F_, 0.9076, 1.73, 0.316, 238, 228, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1774, d3unfS_, 0.9076, 1.77, 0.316, 238, 228, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1775, d3unfE_, 0.9076, 1.77, 0.316, 238, 228, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1776, d1jd2C_, 0.9076, 1.87, 0.338, 241, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1777, p5wvkP_, 0.9075, 1.69, 0.330, 250, 227, 
1778, p5mpcC_, 0.9075, 1.97, 0.355, 244, 231, 
1779, d4r3oT_, 0.9075, 1.73, 0.316, 238, 228, HUMAN CONSTITUTIVE 20S PROTEASOME
1780, d4qv9Q_, 0.9075, 1.83, 0.343, 240, 230, YCP BETA5-C63F MUTANT
1781, d4qv9C_, 0.9075, 1.83, 0.343, 240, 230, YCP BETA5-C63F MUTANT
1782, d4qv6Q_, 0.9075, 1.84, 0.343, 240, 230, YCP BETA5-A49V MUTANT
1783, d4qv6C_, 0.9075, 1.84, 0.343, 240, 230, YCP BETA5-A49V MUTANT
1784, d4qv0Q_, 0.9075, 1.83, 0.343, 240, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1785, d4qv0C_, 0.9075, 1.83, 0.343, 240, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1786, d5d0tC_, 0.9074, 1.83, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1787, p4r67e_, 0.9074, 1.79, 0.342, 239, 228, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
1788, d3unbS_, 0.9074, 1.73, 0.316, 238, 228, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1789, p5vfrH_, 0.9073, 1.56, 0.310, 230, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1790, d5d0tQ_, 0.9073, 1.83, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1791, d5cz8Q_, 0.9073, 1.83, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1792, d5cz8C_, 0.9073, 1.83, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1793, d4qz5Q_, 0.9073, 1.84, 0.343, 240, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1794, d4qz5C_, 0.9073, 1.84, 0.343, 240, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1795, d4qw1C_, 0.9073, 1.83, 0.343, 240, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1796, d4qv7Q_, 0.9073, 1.83, 0.343, 240, 230, YCP BETA5-A50V MUTANT
1797, d4qv7C_, 0.9073, 1.83, 0.343, 240, 230, YCP BETA5-A50V MUTANT
1798, p4cr4C_, 0.9073, 2.03, 0.353, 245, 232, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
1799, d4qzzQ_, 0.9072, 1.84, 0.343, 240, 230, YCP IN COMPLEX WITH OMURALIDE
1800, d4qzzC_, 0.9072, 1.84, 0.343, 240, 230, YCP IN COMPLEX WITH OMURALIDE
1801, d4qz3Q_, 0.9072, 1.84, 0.343, 240, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1802, d4qz3C_, 0.9072, 1.84, 0.343, 240, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1803, d4qwlQ_, 0.9072, 1.84, 0.343, 240, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1804, d4qwlC_, 0.9072, 1.84, 0.343, 240, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1805, d4qw1Q_, 0.9072, 1.84, 0.343, 240, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1806, d4qvvQ_, 0.9072, 1.83, 0.343, 240, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1807, d4qv3Q_, 0.9072, 1.84, 0.343, 240, 230, YCP BETA5-M45V MUTANT
1808, d4qv3C_, 0.9072, 1.84, 0.343, 240, 230, YCP BETA5-M45V MUTANT
1809, d5l54C_, 0.9071, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1810, d5fgaQ_, 0.9071, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1811, d5fgaC_, 0.9071, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1812, d5dkjC_, 0.9071, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1813, d5cgfQ_, 0.9071, 1.83, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1814, d5cgfC_, 0.9071, 1.83, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1815, p4ya2Q_, 0.9071, 1.83, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1816, p4ya2C_, 0.9071, 1.83, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1817, p4y8sQ_, 0.9071, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1818, p4y8sC_, 0.9071, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1819, d4r00Q_, 0.9071, 1.84, 0.343, 240, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1820, d4r00C_, 0.9071, 1.84, 0.343, 240, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1821, d4qz6Q_, 0.9071, 1.84, 0.343, 240, 230, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1822, d4qz6C_, 0.9071, 1.84, 0.343, 240, 230, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1823, d4qwuC_, 0.9071, 1.84, 0.343, 240, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1824, d4qwjQ_, 0.9071, 1.84, 0.343, 240, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1825, d4qwjC_, 0.9071, 1.84, 0.343, 240, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1826, d4qvvC_, 0.9071, 1.83, 0.343, 240, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1827, d4qvpQ_, 0.9071, 1.84, 0.343, 240, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1828, d4qvpC_, 0.9071, 1.84, 0.343, 240, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1829, d4qv8Q_, 0.9071, 1.84, 0.343, 240, 230, YCP BETA5-C52F MUTANT
1830, d4qv8C_, 0.9071, 1.84, 0.343, 240, 230, YCP BETA5-C52F MUTANT
1831, d1jd2X_, 0.9071, 1.87, 0.338, 241, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1832, d5l54Q_, 0.9070, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1833, d5fg7Q_, 0.9070, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1834, d5fg7C_, 0.9070, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1835, d5dkjQ_, 0.9070, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1836, d5d0sQ_, 0.9070, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1837, d5d0sC_, 0.9070, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1838, d4qwuQ_, 0.9070, 1.84, 0.343, 240, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1839, d4quyQ_, 0.9070, 1.84, 0.343, 240, 230, YCP BETA5-A49S-MUTANT
1840, d4quyC_, 0.9070, 1.84, 0.343, 240, 230, YCP BETA5-A49S-MUTANT
1841, d4hrdQ_, 0.9070, 1.89, 0.338, 241, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1842, d1iruO_, 0.9070, 1.82, 0.265, 244, 230, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1843, d1iruA_, 0.9070, 1.83, 0.265, 244, 230, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1844, d5dkiC_, 0.9069, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1845, d5d0zC_, 0.9069, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1846, d5d0xC_, 0.9069, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1847, d5d0wC_, 0.9069, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1848, d4z1lC_, 0.9069, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1849, d4y8rQ_, 0.9069, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1850, d4y8rC_, 0.9069, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1851, d4qzwQ_, 0.9069, 1.84, 0.343, 240, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1852, d4qzwC_, 0.9069, 1.84, 0.343, 240, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1853, d4qz7Q_, 0.9069, 1.84, 0.343, 240, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1854, d4qz7C_, 0.9069, 1.84, 0.343, 240, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1855, d4qw7Q_, 0.9069, 1.84, 0.343, 240, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1856, d4qw7C_, 0.9069, 1.84, 0.343, 240, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1857, d4qvlQ_, 0.9069, 1.84, 0.343, 240, 230, YCP IN COMPLEX WITH BORTEZOMIB
1858, d4qvlC_, 0.9069, 1.84, 0.343, 240, 230, YCP IN COMPLEX WITH BORTEZOMIB
1859, d4qv1Q_, 0.9069, 1.84, 0.343, 240, 230, YCP BETA5-M45A MUTANT
1860, d4qv1C_, 0.9069, 1.84, 0.343, 240, 230, YCP BETA5-M45A MUTANT
1861, p3unbu_, 0.9069, 1.74, 0.316, 238, 228, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1862, d3mg8Q_, 0.9069, 1.92, 0.338, 241, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1863, d5lajQ_, 0.9068, 1.84, 0.343, 240, 230, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1864, d5lajC_, 0.9068, 1.84, 0.343, 240, 230, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1865, d5l52C_, 0.9068, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1866, d5jhsQ_, 0.9068, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1867, d5jhsC_, 0.9068, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1868, d5fhsQ_, 0.9068, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1869, d5fhsC_, 0.9068, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1870, d5dkiQ_, 0.9068, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1871, d5d0zQ_, 0.9068, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1872, d5d0xQ_, 0.9068, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1873, d5d0wQ_, 0.9068, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1874, d4z1lQ_, 0.9068, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1875, d4y9yC_, 0.9068, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1876, p4y7yQ_, 0.9068, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1877, p4y7yC_, 0.9068, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1878, d4qwkC_, 0.9068, 1.84, 0.343, 240, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1879, d4qw6Q_, 0.9068, 1.84, 0.343, 240, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1880, d4qw6C_, 0.9068, 1.84, 0.343, 240, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1881, d4qv5C_, 0.9068, 1.84, 0.343, 240, 230, YCP BETA5-M45I MUTANT
1882, d4qv4Q_, 0.9068, 1.84, 0.343, 240, 230, YCP BETA5-M45T MUTANT
1883, d4qv4C_, 0.9068, 1.84, 0.343, 240, 230, YCP BETA5-M45T MUTANT
1884, d4qltQ_, 0.9068, 1.84, 0.343, 240, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1885, d4qltC_, 0.9068, 1.84, 0.343, 240, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1886, p3uneG_, 0.9068, 1.80, 0.265, 244, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
1887, d5l55Q_, 0.9067, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1888, d5l55C_, 0.9067, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1889, d5l52Q_, 0.9067, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1890, d5fggQ_, 0.9067, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1891, d5fggC_, 0.9067, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1892, d5czaQ_, 0.9067, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1893, d5czaC_, 0.9067, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1894, d5cz5Q_, 0.9067, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1895, d5cz5C_, 0.9067, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1896, d5bxnQ_, 0.9067, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1897, d5bxnC_, 0.9067, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1898, d4y9yQ_, 0.9067, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1899, p4y8lC_, 0.9067, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1900, p4y8jQ_, 0.9067, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1901, p4y8jC_, 0.9067, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1902, d4qzxC_, 0.9067, 1.84, 0.343, 240, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1903, d4qxjQ_, 0.9067, 1.84, 0.343, 240, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1904, d4qxjC_, 0.9067, 1.84, 0.343, 240, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1905, d4qwkQ_, 0.9067, 1.84, 0.343, 240, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1906, d4qwiQ_, 0.9067, 1.84, 0.343, 240, 230, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1907, d4qwiC_, 0.9067, 1.84, 0.343, 240, 230, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1908, d4qw5Q_, 0.9067, 1.84, 0.343, 240, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1909, d4qw5C_, 0.9067, 1.84, 0.343, 240, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1910, d4qw0Q_, 0.9067, 1.84, 0.343, 240, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1911, d4qw0C_, 0.9067, 1.84, 0.343, 240, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1912, d4qvqQ_, 0.9067, 1.84, 0.343, 240, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1913, d4qvqC_, 0.9067, 1.84, 0.343, 240, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1914, d4qv5Q_, 0.9067, 1.84, 0.343, 240, 230, YCP BETA5-M45I MUTANT
1915, p3uneS_, 0.9067, 1.81, 0.316, 238, 228, MOUSE CONSTITUTIVE 20S PROTEASOME
1916, p5lf0S_, 0.9066, 1.55, 0.319, 237, 226, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
1917, d5fg9Q_, 0.9066, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1918, d5fg9C_, 0.9066, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1919, d5cz9C_, 0.9066, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1920, p5cgiQ_, 0.9066, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1921, p5cgiC_, 0.9066, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1922, p5cggQ_, 0.9066, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1923, p5cggC_, 0.9066, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1924, p4y9zQ_, 0.9066, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1925, p4y9zC_, 0.9066, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1926, p4y8lQ_, 0.9066, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1927, d4r3oO_, 0.9066, 1.82, 0.265, 244, 230, HUMAN CONSTITUTIVE 20S PROTEASOME
1928, d4qzxQ_, 0.9066, 1.84, 0.343, 240, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1929, d4qw4C_, 0.9066, 1.85, 0.343, 240, 230, YCP IN COMPLEX WITH CARFILZOMIB
1930, d4qvyQ_, 0.9066, 1.84, 0.343, 240, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1931, d4qvyC_, 0.9066, 1.84, 0.343, 240, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1932, d4qvwQ_, 0.9066, 1.84, 0.343, 240, 230, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1933, d4qvwC_, 0.9066, 1.84, 0.343, 240, 230, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1934, p5vfpB_, 0.9065, 1.57, 0.310, 230, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1935, d5fgiQ_, 0.9065, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1936, d5fgiC_, 0.9065, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1937, p5fghC_, 0.9065, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1938, d5cz9Q_, 0.9065, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1939, p4ya7Q_, 0.9065, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1940, p4ya7C_, 0.9065, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1941, d4ya4Q_, 0.9065, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1942, d4ya4C_, 0.9065, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1943, p4y8iQ_, 0.9065, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1944, p4y8iC_, 0.9065, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1945, p4y7wC_, 0.9065, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1946, p4y70C_, 0.9065, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1947, d4qz4C_, 0.9065, 1.85, 0.343, 240, 230, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1948, d4qz2Q_, 0.9065, 1.84, 0.343, 240, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1949, d4qz2C_, 0.9065, 1.84, 0.343, 240, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1950, d4qwrQ_, 0.9065, 1.85, 0.343, 240, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1951, d4qwrC_, 0.9065, 1.85, 0.343, 240, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1952, d4qw4Q_, 0.9065, 1.85, 0.343, 240, 230, YCP IN COMPLEX WITH CARFILZOMIB
1953, d4qvnC_, 0.9065, 1.85, 0.343, 240, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1954, d4nnnQ_, 0.9065, 1.85, 0.343, 240, 230, YCP IN COMPLEX WITH MG132
1955, d4nnnC_, 0.9065, 1.85, 0.343, 240, 230, YCP IN COMPLEX WITH MG132
1956, p5fghQ_, 0.9064, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1957, d5d0vQ_, 0.9064, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1958, d5d0vC_, 0.9064, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1959, d5bxlQ_, 0.9064, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1960, d5bxlC_, 0.9064, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1961, d4ya1C_, 0.9064, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1962, p4y7wQ_, 0.9064, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1963, p4y78C_, 0.9064, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1964, p4y70Q_, 0.9064, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1965, d4r02C_, 0.9064, 1.85, 0.343, 240, 230, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1966, d4qz4Q_, 0.9064, 1.85, 0.343, 240, 230, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1967, d4qwfQ_, 0.9064, 1.85, 0.343, 240, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1968, d4qwfC_, 0.9064, 1.85, 0.343, 240, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1969, d4qvnQ_, 0.9064, 1.85, 0.343, 240, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1970, d4qlsQ_, 0.9064, 1.84, 0.343, 240, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1971, d4qlsC_, 0.9064, 1.84, 0.343, 240, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1972, d4no8Q_, 0.9064, 1.84, 0.343, 240, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1973, d4no8C_, 0.9064, 1.84, 0.343, 240, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1974, p5m32O_, 0.9063, 1.63, 0.311, 230, 225, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
1975, p5m32A_, 0.9063, 1.63, 0.311, 230, 225, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
1976, d5jhrQ_, 0.9063, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1977, d5jhrC_, 0.9063, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1978, d5fgdC_, 0.9063, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1979, d4ya1Q_, 0.9063, 1.84, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1980, p4y8qQ_, 0.9063, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1981, p4y8qC_, 0.9063, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1982, p4y8hQ_, 0.9063, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1983, p4y8hC_, 0.9063, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1984, p4y80C_, 0.9063, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1985, p4y78Q_, 0.9063, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1986, d4r3oA_, 0.9063, 1.83, 0.265, 244, 230, HUMAN CONSTITUTIVE 20S PROTEASOME
1987, d4r18Q_, 0.9063, 1.85, 0.343, 240, 230, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1988, d4r18C_, 0.9063, 1.84, 0.343, 240, 230, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1989, d4qz0C_, 0.9063, 1.85, 0.343, 240, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1990, d4quxQ_, 0.9063, 1.84, 0.343, 240, 230, YCP BETA5-A49T-MUTANT
1991, d4quxC_, 0.9063, 1.84, 0.343, 240, 230, YCP BETA5-A49T-MUTANT
1992, d4no1Q_, 0.9063, 1.85, 0.343, 240, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1993, d4no1C_, 0.9063, 1.85, 0.343, 240, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1994, d5fgfQ_, 0.9062, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1995, d5fgfC_, 0.9062, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1996, d5fgdQ_, 0.9062, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1997, d5ahjQ_, 0.9062, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1998, d5ahjC_, 0.9062, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1999, p4y8uQ_, 0.9062, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2000, p4y8uC_, 0.9062, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2001, p4y80Q_, 0.9062, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
2002, d4qz0Q_, 0.9062, 1.85, 0.343, 240, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2003, d4qvmQ_, 0.9062, 1.85, 0.343, 240, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2004, d4qvmC_, 0.9062, 1.85, 0.343, 240, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2005, d5fgeQ_, 0.9061, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2006, d5fgeC_, 0.9061, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2007, d5cz7Q_, 0.9061, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2008, d5cz7C_, 0.9061, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2009, d5cz6Q_, 0.9061, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2010, d5cz6C_, 0.9061, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2011, p4ya9C_, 0.9061, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2012, p4ya0C_, 0.9061, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2013, p4y8pC_, 0.9061, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2014, d4y8mQ_, 0.9061, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2015, d4y8mC_, 0.9061, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2016, p4y84Q_, 0.9061, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2017, d4qlqQ_, 0.9061, 1.85, 0.343, 240, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2018, d4qlqC_, 0.9061, 1.85, 0.343, 240, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2019, d4no6C_, 0.9061, 1.85, 0.343, 240, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2020, p5cghQ_, 0.9060, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2021, p5cghC_, 0.9060, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2022, p4ya9Q_, 0.9060, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2023, p4ya0Q_, 0.9060, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2024, p4y8pQ_, 0.9060, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2025, p4y84C_, 0.9060, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2026, p4y77Q_, 0.9060, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2027, p4y77C_, 0.9060, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2028, p4r67q_, 0.9060, 1.82, 0.265, 244, 230, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2029, d4r67O_, 0.9060, 1.82, 0.265, 244, 230, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2030, p4r67c_, 0.9060, 1.82, 0.265, 244, 230, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2031, d4r67A_, 0.9060, 1.82, 0.265, 244, 230, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2032, d4qwxQ_, 0.9060, 1.85, 0.343, 240, 230, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2033, d4qwxC_, 0.9060, 1.85, 0.343, 240, 230, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2034, d4no6Q_, 0.9060, 1.85, 0.343, 240, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2035, d3mg6Q_, 0.9060, 1.93, 0.338, 241, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2036, d1iruF_, 0.9060, 1.64, 0.317, 238, 227, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2037, d5lf7S_, 0.9059, 1.56, 0.314, 237, 226, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2038, d5lf4S_, 0.9059, 1.56, 0.314, 237, 226, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2039, p5gjqi_, 0.9059, 1.59, 0.312, 231, 224, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2040, p4ya3Q_, 0.9059, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2041, p4ya3C_, 0.9059, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2042, p4y8gQ_, 0.9059, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2043, p4y8gC_, 0.9059, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2044, p4y82C_, 0.9059, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2045, p4y7xC_, 0.9059, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2046, p4y69Q_, 0.9059, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2047, p4y69C_, 0.9059, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2048, d4qwsC_, 0.9059, 1.85, 0.343, 240, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2049, d5lexS_, 0.9058, 1.56, 0.314, 235, 226, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2050, d5cz4Q_, 0.9058, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2051, d5cz4C_, 0.9058, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2052, p4ya5C_, 0.9058, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2053, p4y82Q_, 0.9058, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2054, p4y7xQ_, 0.9058, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2055, p4y75Q_, 0.9058, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2056, p4y75C_, 0.9058, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2057, p4y74C_, 0.9058, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2058, d4qwsQ_, 0.9058, 1.85, 0.343, 240, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2059, d4no9Q_, 0.9058, 1.85, 0.343, 240, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2060, d4no9C_, 0.9058, 1.85, 0.343, 240, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2061, d4cr2C_, 0.9058, 2.03, 0.353, 245, 232, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2062, p5lf6S_, 0.9057, 1.56, 0.319, 237, 226, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2063, p4ya5Q_, 0.9057, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2064, p4y8oC_, 0.9057, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2065, p4y74Q_, 0.9057, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2066, p4y6vQ_, 0.9057, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2067, p4y6vC_, 0.9057, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2068, d4qw3Q_, 0.9057, 1.85, 0.343, 240, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2069, d4qw3C_, 0.9057, 1.85, 0.343, 240, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2070, d3oevQ_, 0.9057, 1.93, 0.338, 241, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2071, d3mg4Q_, 0.9057, 1.91, 0.338, 241, 231, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2072, p6epdC_, 0.9056, 2.08, 0.340, 249, 235, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
2073, p4y8tQ_, 0.9056, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2074, p4y8tC_, 0.9056, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2075, p4y8oQ_, 0.9056, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2076, p4y8nQ_, 0.9056, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2077, p4y8nC_, 0.9056, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2078, p4y81C_, 0.9056, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2079, d4rurQ_, 0.9056, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2080, d4rurC_, 0.9056, 1.85, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2081, d4qlvC_, 0.9056, 1.86, 0.343, 240, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2082, d3unfO_, 0.9056, 1.55, 0.314, 230, 223, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2083, d3unfA_, 0.9056, 1.55, 0.314, 230, 223, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2084, d5lf3S_, 0.9055, 1.56, 0.314, 237, 226, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2085, d5lf1S_, 0.9055, 1.56, 0.319, 237, 226, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2086, d5bouQ_, 0.9055, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2087, d5bouC_, 0.9055, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2088, p4y8kQ_, 0.9055, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2089, p4y8kC_, 0.9055, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2090, p4y81Q_, 0.9055, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2091, p4y6aQ_, 0.9055, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2092, p4y6aC_, 0.9055, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2093, d4qlvQ_, 0.9055, 1.86, 0.343, 240, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2094, p3uneU_, 0.9055, 1.82, 0.265, 244, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
2095, d3sdkQ_, 0.9055, 1.93, 0.338, 241, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2096, p5mp9d_, 0.9054, 1.85, 0.343, 240, 230, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2097, p5leyS_, 0.9054, 1.56, 0.319, 235, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2098, p5gjqX_, 0.9054, 2.25, 0.349, 243, 232, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2099, d4qz1Q_, 0.9054, 1.86, 0.343, 240, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2100, d4qz1C_, 0.9054, 1.86, 0.343, 240, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2101, p3unhO_, 0.9054, 1.55, 0.314, 230, 223, MOUSE 20S IMMUNOPROTEASOME
2102, p3unhA_, 0.9054, 1.55, 0.314, 230, 223, MOUSE 20S IMMUNOPROTEASOME
2103, p3uneu_, 0.9054, 1.66, 0.317, 238, 227, MOUSE CONSTITUTIVE 20S PROTEASOME
2104, p5gjqn_, 0.9053, 2.20, 0.349, 243, 232, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2105, p4qbyC_, 0.9053, 1.86, 0.343, 240, 230, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2106, p3uneg_, 0.9053, 1.82, 0.316, 238, 228, MOUSE CONSTITUTIVE 20S PROTEASOME
2107, d3unbG_, 0.9053, 1.77, 0.262, 243, 229, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2108, p3jcpMA_, 0.9053, 1.91, 0.338, 241, 231, 
2109, p3jcpM_, 0.9053, 1.91, 0.338, 241, 231, 
2110, p5lezS_, 0.9052, 1.57, 0.319, 237, 226, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2111, p4y6zC_, 0.9052, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2112, d4r17Q_, 0.9052, 1.86, 0.343, 240, 230, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2113, d4r17C_, 0.9052, 1.85, 0.343, 240, 230, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2114, p4qbyQ_, 0.9052, 1.86, 0.343, 240, 230, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2115, d4nnwQ_, 0.9052, 1.86, 0.343, 240, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2116, d4nnwC_, 0.9052, 1.86, 0.343, 240, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2117, p3uneE_, 0.9052, 1.66, 0.317, 238, 227, MOUSE CONSTITUTIVE 20S PROTEASOME
2118, p5vfsAA_, 0.9051, 1.74, 0.310, 232, 226, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2119, d5l5wQ_, 0.9051, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2120, d5l5wC_, 0.9051, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2121, p4y6zQ_, 0.9051, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2122, p5t0iI_, 0.9050, 2.06, 0.340, 250, 235, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2123, d4qluQ_, 0.9050, 1.86, 0.343, 240, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2124, d4qluC_, 0.9050, 1.86, 0.343, 240, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2125, p3unbi_, 0.9050, 1.78, 0.262, 243, 229, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2126, d5laiQ_, 0.9049, 1.86, 0.343, 240, 230, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2127, d5laiC_, 0.9049, 1.86, 0.343, 240, 230, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2128, d5l5zQ_, 0.9049, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2129, d5l5zC_, 0.9048, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2130, d5l5xQ_, 0.9048, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2131, d5l5xC_, 0.9048, 1.86, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2132, p3unew_, 0.9048, 1.83, 0.261, 244, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
2133, p3unbg_, 0.9048, 1.78, 0.316, 238, 228, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2134, p5vfsB_, 0.9047, 1.76, 0.310, 232, 226, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2135, p5vfoL_, 0.9047, 1.74, 0.316, 238, 228, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2136, d5lttQ_, 0.9047, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2137, d5lttC_, 0.9047, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2138, d5l60Q_, 0.9047, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2139, d5l60C_, 0.9047, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2140, d5l5uQ_, 0.9047, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2141, d5l5uC_, 0.9047, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2142, p5l4gG_, 0.9047, 2.20, 0.349, 242, 232, 
2143, d4qwgQ_, 0.9047, 1.87, 0.343, 240, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2144, d4qwgC_, 0.9047, 1.87, 0.343, 240, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2145, d3unbE_, 0.9047, 1.84, 0.316, 238, 228, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2146, d5le5S_, 0.9046, 1.62, 0.319, 237, 226, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2147, d5l64Q_, 0.9046, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2148, d5l64C_, 0.9046, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2149, d5l5yQ_, 0.9046, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2150, d5l5yC_, 0.9046, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2151, d4r02Q_, 0.9046, 1.87, 0.343, 240, 230, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2152, d5l62Q_, 0.9045, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2153, d5l62C_, 0.9045, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2154, d5l5fQ_, 0.9045, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2155, d5l5fC_, 0.9045, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2156, d5l5eQ_, 0.9045, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2157, d5l5eC_, 0.9045, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2158, d5l65Q_, 0.9044, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2159, d5l65C_, 0.9044, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2160, d5l61Q_, 0.9044, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2161, d5l61C_, 0.9044, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2162, d5l5sQ_, 0.9044, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2163, d5l5sC_, 0.9044, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2164, p5mp9D_, 0.9043, 1.86, 0.343, 240, 230, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2165, d5l63Q_, 0.9043, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2166, d5l63C_, 0.9043, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2167, d5l5bQ_, 0.9043, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2168, d5l5aQ_, 0.9043, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2169, d5l5aC_, 0.9043, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2170, p5gjrMA_, 0.9043, 2.21, 0.349, 243, 232, 
2171, p5vfrl_, 0.9042, 1.77, 0.316, 238, 228, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2172, d5l6bQ_, 0.9042, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2173, d5l6bC_, 0.9042, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2174, d5l5bC_, 0.9042, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2175, p5a0qQ_, 0.9042, 1.73, 0.344, 237, 227, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
2176, p5a0qC_, 0.9042, 1.73, 0.344, 237, 227, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
2177, p5vfol_, 0.9041, 1.78, 0.316, 238, 228, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2178, d5l67Q_, 0.9041, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2179, d5l67C_, 0.9041, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2180, d5l66Q_, 0.9041, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2181, d5l66C_, 0.9041, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2182, d5l5vQ_, 0.9041, 1.87, 0.343, 240, 230,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2183, d5l5vC_, 0.9041, 1.87, 0.343, 240, 230,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2184, d5l5rQ_, 0.9041, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2185, d5l5rC_, 0.9041, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2186, d5l5hQ_, 0.9041, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2187, d5l5hC_, 0.9041, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2188, p5gjrY_, 0.9041, 2.21, 0.349, 243, 232, 
2189, d3mg7Q_, 0.9041, 1.96, 0.342, 241, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2190, p5vfqAA_, 0.9040, 1.75, 0.310, 232, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2191, p5mpaB_, 0.9040, 1.77, 0.330, 250, 227, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2192, d5l5qQ_, 0.9040, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2193, d5l5qC_, 0.9040, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2194, d5l5pQ_, 0.9040, 1.88, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2195, d5l5pC_, 0.9040, 1.88, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2196, d5l5iQ_, 0.9040, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2197, d5l5iC_, 0.9040, 1.87, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2198, p3unei_, 0.9040, 1.85, 0.265, 244, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
2199, p5vfuS_, 0.9039, 1.73, 0.310, 232, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2200, p5vftH_, 0.9039, 1.73, 0.310, 232, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2201, d5l6cQ_, 0.9039, 1.88, 0.343, 240, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2202, d5l6cC_, 0.9039, 1.88, 0.343, 240, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2203, d5l6aQ_, 0.9039, 1.88, 0.343, 240, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2204, d5l6aC_, 0.9039, 1.88, 0.343, 240, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2205, d5l5tQ_, 0.9039, 1.88, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2206, d5l5tC_, 0.9039, 1.88, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2207, p6avoG_, 0.9038, 1.51, 0.320, 234, 225, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2208, p5t0jI_, 0.9038, 2.07, 0.336, 250, 235, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2209, d5l5oQ_, 0.9038, 1.88, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2210, p3unbw_, 0.9038, 1.80, 0.262, 243, 229, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2211, d3oeuQ_, 0.9038, 1.96, 0.338, 241, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2212, p5vfsF_, 0.9037, 1.84, 0.316, 238, 228, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2213, p5mpbE_, 0.9037, 1.17, 1.000, 228, 221, 
2214, d5l5oC_, 0.9037, 1.88, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2215, d5l5jC_, 0.9037, 1.88, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2216, d5l5dQ_, 0.9037, 1.88, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2217, d5l5dC_, 0.9037, 1.88, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2218, p6avoL_, 0.9036, 1.51, 0.320, 234, 225, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2219, p5vfqEA_, 0.9036, 1.78, 0.316, 238, 228, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2220, p5vfoh_, 0.9036, 1.75, 0.310, 232, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2221, d5m2bQ_, 0.9036, 1.88, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2222, d5l5jQ_, 0.9036, 1.88, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2223, d3unbU_, 0.9036, 1.80, 0.262, 243, 229, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2224, d5m2bC_, 0.9035, 1.88, 0.343, 240, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2225, d5l68Q_, 0.9035, 1.88, 0.343, 240, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2226, d5l68C_, 0.9035, 1.88, 0.343, 240, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2227, p5l4gU_, 0.9035, 2.23, 0.349, 241, 232, 
2228, p5vfuGA_, 0.9034, 1.73, 0.310, 232, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2229, p5vfth_, 0.9034, 1.73, 0.310, 232, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2230, p5vfrL_, 0.9034, 1.77, 0.316, 238, 228, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2231, p5vfrh_, 0.9034, 1.75, 0.310, 232, 226, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2232, p5vfpZ_, 0.9034, 1.76, 0.310, 232, 226, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2233, p5t0hI_, 0.9034, 2.02, 0.338, 250, 234, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2234, d5l69Q_, 0.9034, 1.88, 0.343, 240, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2235, d5l69C_, 0.9034, 1.88, 0.343, 240, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2236, p5vfpDA_, 0.9031, 1.78, 0.316, 238, 228, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2237, p3jcoMA_, 0.9031, 1.93, 0.338, 241, 231, 
2238, p3jcoM_, 0.9031, 1.93, 0.338, 241, 231, 
2239, p6avoQ_, 0.9030, 2.16, 0.346, 239, 231, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2240, p6avoJ_, 0.9030, 2.16, 0.346, 239, 231, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2241, p5vftL_, 0.9030, 1.85, 0.316, 238, 228, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2242, p5vfsEA_, 0.9030, 1.84, 0.316, 238, 228, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2243, d4r3oG_, 0.9030, 2.25, 0.349, 245, 232, HUMAN CONSTITUTIVE 20S PROTEASOME
2244, p5t0cZA_, 0.9029, 1.76, 0.310, 232, 226, 
2245, p5t0cT_, 0.9029, 1.76, 0.310, 232, 226, 
2246, p5mpad_, 0.9029, 1.88, 0.343, 240, 230, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2247, p5vfuW_, 0.9028, 1.85, 0.316, 238, 228, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2248, p5vfpF_, 0.9028, 1.78, 0.316, 238, 228, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2249, d4r3oU_, 0.9027, 2.25, 0.349, 245, 232, HUMAN CONSTITUTIVE 20S PROTEASOME
2250, d3wxrR_, 0.9027, 1.97, 0.338, 241, 231, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2251, p3unbv_, 0.9027, 2.17, 0.351, 244, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2252, p5vfqF_, 0.9026, 1.79, 0.316, 238, 228, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2253, d3unbT_, 0.9025, 2.17, 0.351, 244, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2254, d5lf4E_, 0.9021, 1.47, 0.317, 233, 224, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2255, p3unbh_, 0.9021, 2.18, 0.351, 244, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2256, p5mpcQ_, 0.9020, 1.98, 0.351, 244, 231, 
2257, p5lf0E_, 0.9020, 1.47, 0.317, 233, 224, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2258, d4r67U_, 0.9020, 2.25, 0.349, 245, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2259, d4r67G_, 0.9020, 2.25, 0.349, 245, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2260, p5lf6E_, 0.9019, 1.47, 0.317, 233, 224, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2261, p4r67w_, 0.9019, 2.25, 0.349, 245, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2262, p4r67i_, 0.9019, 2.25, 0.349, 245, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2263, d5lexT_, 0.9018, 2.31, 0.345, 240, 232, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2264, d5lf7E_, 0.9017, 1.48, 0.317, 233, 224, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2265, p5leyE_, 0.9017, 1.48, 0.317, 233, 224, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2266, d5lf1E_, 0.9016, 1.48, 0.317, 233, 224, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2267, p5lezT_, 0.9015, 2.31, 0.345, 240, 232, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2268, d3unfU_, 0.9015, 1.83, 0.266, 243, 229, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2269, d3unfG_, 0.9015, 1.83, 0.266, 243, 229, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2270, d5lf3E_, 0.9014, 1.48, 0.317, 233, 224, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2271, d5le5E_, 0.9014, 1.49, 0.317, 233, 224, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2272, d5lexE_, 0.9013, 1.48, 0.317, 233, 224, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2273, d5lexF_, 0.9011, 2.18, 0.346, 239, 231, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2274, d5l63T_, 0.9011, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2275, d5l63F_, 0.9011, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2276, p3uneF_, 0.9011, 2.07, 0.352, 244, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
2277, p5vfuKA_, 0.9010, 1.71, 0.317, 238, 227, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2278, p5t0cX_, 0.9010, 1.82, 0.316, 238, 228, 
2279, p5t0cDB_, 0.9010, 1.82, 0.316, 238, 228, 
2280, p5vftl_, 0.9009, 1.71, 0.317, 238, 227, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2281, d5m2bT_, 0.9009, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2282, d5m2bF_, 0.9009, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2283, d5l6aT_, 0.9009, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2284, d5l6aF_, 0.9009, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2285, d5l64T_, 0.9009, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2286, d5l64F_, 0.9009, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2287, d5l61T_, 0.9009, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2288, d5l61F_, 0.9009, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2289, d5l5wT_, 0.9009, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2290, d5l5wF_, 0.9009, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2291, d5l5dT_, 0.9009, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2292, d5l5dF_, 0.9009, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2293, d4r18T_, 0.9009, 2.10, 0.330, 243, 230, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2294, d4r18F_, 0.9009, 2.10, 0.330, 243, 230, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2295, d4r02F_, 0.9009, 2.09, 0.326, 243, 230, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2296, d3unbF_, 0.9009, 2.11, 0.352, 244, 230, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2297, d3sdiT_, 0.9009, 2.09, 0.330, 242, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2298, d5l69T_, 0.9008, 2.09, 0.330, 243, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2299, d5l69F_, 0.9008, 2.09, 0.330, 243, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2300, d5l66T_, 0.9008, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2301, d5l62T_, 0.9008, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2302, d5l62F_, 0.9008, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2303, d5l5yT_, 0.9008, 2.09, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2304, d5l5pT_, 0.9008, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2305, d5l5pF_, 0.9008, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2306, d5l5hT_, 0.9008, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2307, d5l5hF_, 0.9008, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2308, p5lezF_, 0.9007, 2.19, 0.346, 239, 231, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2309, d5l6cT_, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2310, d5l6cF_, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2311, d5l66F_, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2312, d5l65T_, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2313, d5l65F_, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2314, d5l60T_, 0.9007, 2.09, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2315, d5l60F_, 0.9007, 2.09, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2316, d5l5zT_, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2317, d5l5zF_, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2318, d5l5yF_, 0.9007, 2.09, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2319, d5l5uT_, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2320, d5l5uF_, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2321, d5l5tT_, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2322, d5l5tF_, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2323, d5l5sT_, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2324, d5l5sF_, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2325, d5l5rT_, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2326, d5l5rF_, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2327, d5l5qT_, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2328, d5l5qF_, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2329, d5l5oT_, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2330, d5l5oF_, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2331, d5l5jT_, 0.9007, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2332, d4qvnT_, 0.9007, 2.10, 0.330, 243, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2333, d4qvnF_, 0.9007, 2.10, 0.330, 243, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2334, p3unev_, 0.9007, 2.13, 0.352, 244, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
2335, p5t0gH_, 0.9006, 1.80, 0.310, 233, 226, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2336, d5lf3F_, 0.9006, 2.31, 0.345, 239, 232, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2337, p5lezE_, 0.9006, 1.49, 0.317, 233, 224, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2338, d5le5T_, 0.9006, 2.32, 0.345, 240, 232, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2339, d5l6bT_, 0.9006, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2340, d5l6bF_, 0.9006, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2341, d5l67T_, 0.9006, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2342, d5l5jF_, 0.9006, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2343, d5l5iT_, 0.9006, 2.09, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2344, d5l5iF_, 0.9006, 2.09, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2345, p4zzgG_, 0.9006, 2.08, 0.326, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2346, d4eu2G_, 0.9006, 2.09, 0.330, 244, 230, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2347, d5lf1T_, 0.9005, 2.33, 0.345, 240, 232, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2348, d5lajT_, 0.9005, 2.10, 0.330, 243, 230, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2349, d5lajF_, 0.9005, 2.10, 0.330, 243, 230, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2350, d5l68T_, 0.9005, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2351, d5l68F_, 0.9005, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2352, d5l67F_, 0.9005, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2353, d5l5xT_, 0.9005, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2354, d5l5xF_, 0.9005, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2355, d5l5vT_, 0.9005, 2.10, 0.330, 243, 230,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2356, d5l5vF_, 0.9005, 2.10, 0.330, 243, 230,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2357, d5l5fT_, 0.9005, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2358, d5l5fF_, 0.9005, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2359, d4r02T_, 0.9005, 2.11, 0.326, 243, 230, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2360, d5l5eT_, 0.9004, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2361, d5l5eF_, 0.9004, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2362, d5l5bT_, 0.9004, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2363, d5l5bF_, 0.9004, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2364, d5fggT_, 0.9004, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2365, d5fggF_, 0.9004, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2366, p5cghT_, 0.9004, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2367, p5cghF_, 0.9004, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2368, d5bxnT_, 0.9004, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2369, d5bxnF_, 0.9004, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2370, d5ahjT_, 0.9004, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2371, d5ahjF_, 0.9004, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2372, p4zzgU_, 0.9004, 2.08, 0.326, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2373, d4qvwT_, 0.9004, 2.10, 0.330, 243, 230, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2374, d4qv6T_, 0.9004, 2.10, 0.330, 243, 230, YCP BETA5-A49V MUTANT
2375, d4qv6F_, 0.9004, 2.10, 0.330, 243, 230, YCP BETA5-A49V MUTANT
2376, p5nifG_, 0.9003, 2.09, 0.326, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2377, d5lttT_, 0.9003, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2378, d5lttF_, 0.9003, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2379, d5lf7T_, 0.9003, 2.33, 0.345, 240, 232, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2380, d5l5aT_, 0.9003, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2381, d5l5aF_, 0.9003, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2382, p4ya9T_, 0.9003, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2383, p4ya9F_, 0.9003, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2384, d4qz7T_, 0.9003, 2.11, 0.330, 243, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2385, d4qz7F_, 0.9003, 2.11, 0.330, 243, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2386, d4qw1T_, 0.9003, 2.10, 0.330, 243, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2387, d4qw1F_, 0.9003, 2.10, 0.330, 243, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2388, d4qvyT_, 0.9003, 2.10, 0.330, 243, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2389, d4qvyF_, 0.9003, 2.10, 0.330, 243, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2390, d4qvwF_, 0.9003, 2.10, 0.330, 243, 230, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2391, d3sdiF_, 0.9003, 2.08, 0.330, 242, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2392, d5lf1Q_, 0.9002, 1.93, 0.348, 238, 230, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2393, d5cz9T_, 0.9002, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2394, d5bxlT_, 0.9002, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2395, d5bxlF_, 0.9002, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2396, d5bouT_, 0.9002, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2397, d5bouF_, 0.9002, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2398, d4ya4T_, 0.9002, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2399, d4ya4F_, 0.9002, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2400, p4y8tT_, 0.9002, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2401, p4y8tF_, 0.9002, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2402, p4y8pT_, 0.9002, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2403, p4y8pF_, 0.9002, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2404, p4y8gT_, 0.9002, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2405, p4y8gF_, 0.9002, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2406, p4y75T_, 0.9002, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2407, p4y75F_, 0.9002, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2408, d4qzzT_, 0.9002, 2.11, 0.330, 243, 230, YCP IN COMPLEX WITH OMURALIDE
2409, d4qzzF_, 0.9002, 2.11, 0.330, 243, 230, YCP IN COMPLEX WITH OMURALIDE
2410, d4qz4T_, 0.9002, 2.10, 0.330, 243, 230, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2411, d4qz4F_, 0.9002, 2.10, 0.330, 243, 230, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2412, d4qwfT_, 0.9002, 2.11, 0.330, 243, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2413, d4qwfF_, 0.9002, 2.11, 0.330, 243, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2414, d4qw6T_, 0.9002, 2.11, 0.330, 243, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2415, d4qw6F_, 0.9002, 2.11, 0.330, 243, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2416, d4qvqT_, 0.9002, 2.10, 0.330, 243, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2417, d4qvqF_, 0.9002, 2.10, 0.330, 243, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2418, d4qvpT_, 0.9002, 2.10, 0.330, 243, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2419, d4qvpF_, 0.9002, 2.10, 0.330, 243, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2420, d4qvlT_, 0.9002, 2.10, 0.330, 243, 230, YCP IN COMPLEX WITH BORTEZOMIB
2421, d4qvlF_, 0.9002, 2.10, 0.330, 243, 230, YCP IN COMPLEX WITH BORTEZOMIB
2422, d4hnpF_, 0.9002, 2.14, 0.335, 244, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2423, p6gopT_, 0.9001, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2424, p6gopF_, 0.9001, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2425, p5nifU_, 0.9001, 2.09, 0.326, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2426, p5lf6Q_, 0.9001, 1.93, 0.348, 238, 230, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2427, d5fgiT_, 0.9001, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2428, d5d0vT_, 0.9001, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2429, d5d0vF_, 0.9001, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2430, d5cz9F_, 0.9001, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2431, d5cz7T_, 0.9001, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2432, d5cz7F_, 0.9001, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2433, d5cz6T_, 0.9001, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2434, d5cz6F_, 0.9001, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2435, p5cggT_, 0.9001, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2436, p5cggF_, 0.9001, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2437, d4qz6T_, 0.9001, 2.11, 0.330, 243, 230, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2438, d4qz0T_, 0.9001, 2.11, 0.330, 243, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2439, d4qz0F_, 0.9001, 2.11, 0.330, 243, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2440, d4qwxT_, 0.9001, 2.10, 0.330, 243, 230, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2441, d4qwxF_, 0.9001, 2.10, 0.330, 243, 230, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2442, d4qwlT_, 0.9001, 2.11, 0.330, 243, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2443, d4qw7T_, 0.9001, 2.11, 0.330, 243, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2444, d4qw7F_, 0.9001, 2.11, 0.330, 243, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2445, d4qw5T_, 0.9001, 2.11, 0.330, 243, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2446, d4qw5F_, 0.9001, 2.11, 0.330, 243, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2447, d4qv1T_, 0.9001, 2.11, 0.330, 243, 230, YCP BETA5-M45A MUTANT
2448, d4qv1F_, 0.9001, 2.11, 0.330, 243, 230, YCP BETA5-M45A MUTANT
2449, d4qv0F_, 0.9001, 2.11, 0.330, 243, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2450, d4quxT_, 0.9001, 2.10, 0.330, 243, 230, YCP BETA5-A49T-MUTANT
2451, d4quxF_, 0.9001, 2.10, 0.330, 243, 230, YCP BETA5-A49T-MUTANT
2452, d4qlsT_, 0.9001, 2.12, 0.330, 243, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2453, d4qlsF_, 0.9001, 2.12, 0.330, 243, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2454, d5fgiF_, 0.9000, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2455, d5fgeT_, 0.9000, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2456, d5fgeF_, 0.9000, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2457, d5d0zT_, 0.9000, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2458, d5d0wT_, 0.9000, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2459, d5d0wF_, 0.9000, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2460, d5d0sT_, 0.9000, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2461, d5d0sF_, 0.9000, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2462, d5czaT_, 0.9000, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2463, d5czaF_, 0.9000, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2464, d4y9yT_, 0.9000, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2465, p4y8kT_, 0.9000, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2466, p4y77T_, 0.9000, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2467, p4y77F_, 0.9000, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2468, p4y6aT_, 0.9000, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2469, p4y6aF_, 0.9000, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2470, d4rurT_, 0.9000, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2471, d4rurF_, 0.9000, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2472, d4qz6F_, 0.9000, 2.11, 0.330, 243, 230, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2473, d4qwuT_, 0.9000, 2.11, 0.330, 243, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2474, d4qwuF_, 0.9000, 2.11, 0.330, 243, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2475, d4qwlF_, 0.9000, 2.11, 0.330, 243, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2476, d4qw4T_, 0.9000, 2.10, 0.330, 243, 230, YCP IN COMPLEX WITH CARFILZOMIB
2477, d4qw4F_, 0.9000, 2.10, 0.330, 243, 230, YCP IN COMPLEX WITH CARFILZOMIB
2478, d4qvmT_, 0.9000, 2.10, 0.330, 243, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2479, d4qvmF_, 0.9000, 2.10, 0.330, 243, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2480, d4qv5T_, 0.9000, 2.12, 0.330, 243, 230, YCP BETA5-M45I MUTANT
2481, d4qv5F_, 0.9000, 2.12, 0.330, 243, 230, YCP BETA5-M45I MUTANT
2482, d4qv4T_, 0.9000, 2.11, 0.330, 243, 230, YCP BETA5-M45T MUTANT
2483, d4qv4F_, 0.9000, 2.11, 0.330, 243, 230, YCP BETA5-M45T MUTANT
2484, d4qv0T_, 0.9000, 2.11, 0.330, 243, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2485, d4quyT_, 0.9000, 2.11, 0.330, 243, 230, YCP BETA5-A49S-MUTANT
2486, d4quyF_, 0.9000, 2.11, 0.330, 243, 230, YCP BETA5-A49S-MUTANT
2487, d4hrcF_, 0.9000, 2.08, 0.330, 244, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2488, p4cr4B_, 0.9000, 1.83, 0.330, 250, 227, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2489, p6gopA_, 0.8999, 1.57, 0.333, 230, 222, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2490, p6epcC_, 0.8999, 2.20, 0.340, 249, 235, GROUND STATE 26S PROTEASOME (GS2)
2491, p5lf6T_, 0.8999, 2.34, 0.345, 240, 232, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2492, d5l55T_, 0.8999, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2493, d5l55F_, 0.8999, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2494, d5jhsT_, 0.8999, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2495, d5jhsF_, 0.8999, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2496, d5jhrT_, 0.8999, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2497, d5jhrF_, 0.8999, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2498, d5fgaF_, 0.8999, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2499, d5d0zF_, 0.8999, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2500, d4ya1T_, 0.8999, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2501, d4ya1F_, 0.8999, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2502, d4y9yF_, 0.8999, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2503, p4y8uT_, 0.8999, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2504, p4y8uF_, 0.8999, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2505, p4y8sT_, 0.8999, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2506, p4y8sF_, 0.8999, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2507, d4y8mT_, 0.8999, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2508, d4y8mF_, 0.8999, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2509, p4y8kF_, 0.8999, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2510, p4y84T_, 0.8999, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2511, p4y84F_, 0.8999, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2512, p4y6vT_, 0.8999, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2513, p4y6vF_, 0.8999, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2514, p4y69T_, 0.8999, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2515, p4y69F_, 0.8999, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2516, d4qz3T_, 0.8999, 2.11, 0.330, 243, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2517, d4qz3F_, 0.8999, 2.11, 0.330, 243, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2518, d4qv8T_, 0.8999, 2.11, 0.330, 243, 230, YCP BETA5-C52F MUTANT
2519, d4qv8F_, 0.8999, 2.11, 0.330, 243, 230, YCP BETA5-C52F MUTANT
2520, d4qv7F_, 0.8999, 2.11, 0.330, 243, 230, YCP BETA5-A50V MUTANT
2521, d4qlvT_, 0.8999, 2.10, 0.330, 243, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2522, p3uneh_, 0.8999, 2.14, 0.352, 244, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
2523, d5lf4Q_, 0.8998, 1.94, 0.348, 238, 230, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2524, p5lf0T_, 0.8998, 2.34, 0.345, 240, 232, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2525, p5leyT_, 0.8998, 2.35, 0.345, 240, 232, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2526, d5fgfT_, 0.8998, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2527, d5fgfF_, 0.8998, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2528, d5fgaT_, 0.8998, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2529, d5fg9T_, 0.8998, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2530, d5fg9F_, 0.8998, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2531, p4ya7T_, 0.8998, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2532, p4ya7F_, 0.8998, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2533, p4ya5T_, 0.8998, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2534, d4y8rT_, 0.8998, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2535, d4y8rF_, 0.8998, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2536, p4y8nT_, 0.8998, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2537, p4y8nF_, 0.8998, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2538, p4y8hT_, 0.8998, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2539, p4y81T_, 0.8998, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2540, p4y81F_, 0.8998, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2541, p4y7xT_, 0.8998, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2542, d4r17T_, 0.8998, 2.11, 0.330, 243, 230, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2543, d4r17F_, 0.8998, 2.11, 0.330, 243, 230, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2544, d4qz2T_, 0.8998, 2.11, 0.330, 243, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2545, d4qz2F_, 0.8998, 2.11, 0.330, 243, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2546, d4qwkT_, 0.8998, 2.11, 0.330, 243, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2547, d4qw0T_, 0.8998, 2.10, 0.330, 243, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2548, d4qw0F_, 0.8998, 2.10, 0.330, 243, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2549, d4qv7T_, 0.8998, 2.11, 0.330, 243, 230, YCP BETA5-A50V MUTANT
2550, d4qlvF_, 0.8998, 2.10, 0.330, 243, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2551, d4nnwT_, 0.8998, 2.12, 0.330, 243, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2552, d4nnwF_, 0.8998, 2.12, 0.330, 243, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2553, d4hrdF_, 0.8998, 2.09, 0.330, 244, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2554, d5lf7F_, 0.8997, 2.20, 0.346, 239, 231, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2555, d5lf3T_, 0.8997, 2.34, 0.345, 240, 232, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2556, p5lf0F_, 0.8997, 2.21, 0.346, 239, 231, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2557, p5fghT_, 0.8997, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2558, p5fghF_, 0.8997, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2559, d5fgdT_, 0.8997, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2560, d5fgdF_, 0.8997, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2561, d5fg7T_, 0.8997, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2562, d5fg7F_, 0.8997, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2563, d5dkjT_, 0.8997, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2564, d5dkjF_, 0.8997, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2565, d5d0tT_, 0.8997, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2566, d5d0tF_, 0.8997, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2567, p4ya5F_, 0.8997, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2568, p4ya2T_, 0.8997, 2.13, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2569, p4ya2F_, 0.8997, 2.13, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2570, p4y9zT_, 0.8997, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2571, p4y8oT_, 0.8997, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2572, p4y8oF_, 0.8997, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2573, p4y8hF_, 0.8997, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2574, p4y82T_, 0.8997, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2575, p4y82F_, 0.8997, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2576, p4y7xF_, 0.8997, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2577, p4y74T_, 0.8997, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2578, p4y74F_, 0.8997, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2579, p4y6zT_, 0.8997, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2580, p4y6zF_, 0.8997, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2581, p4x6zU_, 0.8997, 2.10, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2582, d4qzwT_, 0.8997, 2.11, 0.330, 243, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2583, d4qzwF_, 0.8997, 2.11, 0.330, 243, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2584, d4qz1T_, 0.8997, 2.11, 0.330, 243, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2585, d4qz1F_, 0.8997, 2.11, 0.330, 243, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2586, d4qwkF_, 0.8997, 2.11, 0.330, 243, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2587, d5lf4T_, 0.8996, 2.34, 0.345, 240, 232, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2588, d5laiT_, 0.8996, 2.11, 0.330, 243, 230, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2589, d5laiF_, 0.8996, 2.11, 0.330, 243, 230, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2590, d5l52T_, 0.8996, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2591, d5l52F_, 0.8996, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2592, d5d0xT_, 0.8996, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2593, d5d0xF_, 0.8996, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2594, p5cgiT_, 0.8996, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2595, p5cgiF_, 0.8996, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2596, d5cgfT_, 0.8996, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2597, p4y9zF_, 0.8996, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2598, d4r00T_, 0.8996, 2.11, 0.330, 243, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2599, d4r00F_, 0.8996, 2.11, 0.330, 243, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2600, d4qz5T_, 0.8996, 2.11, 0.330, 243, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
2601, d4qz5F_, 0.8996, 2.11, 0.330, 243, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
2602, d4qwrT_, 0.8996, 2.11, 0.330, 243, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2603, d4qwrF_, 0.8996, 2.11, 0.330, 243, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2604, d4qwiT_, 0.8996, 2.11, 0.330, 243, 230, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2605, d4qwiF_, 0.8996, 2.11, 0.330, 243, 230, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2606, d4qv9F_, 0.8996, 2.12, 0.330, 243, 230, YCP BETA5-C63F MUTANT
2607, d4no9T_, 0.8996, 2.12, 0.330, 243, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2608, d4no9F_, 0.8996, 2.12, 0.330, 243, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2609, p3unhT_, 0.8996, 2.00, 0.354, 244, 229, MOUSE 20S IMMUNOPROTEASOME
2610, p3unhF_, 0.8996, 2.00, 0.354, 244, 229, MOUSE 20S IMMUNOPROTEASOME
2611, d3unfT_, 0.8996, 2.00, 0.354, 244, 229, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2612, d3unfF_, 0.8996, 2.00, 0.354, 244, 229, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2613, d5fhsT_, 0.8995, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2614, d5fhsF_, 0.8995, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2615, d5cgfF_, 0.8995, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2616, p4y8qT_, 0.8995, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2617, p4y8qF_, 0.8995, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2618, p4y8lT_, 0.8995, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2619, p4y8lF_, 0.8995, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2620, p4y8iT_, 0.8995, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2621, p4y8iF_, 0.8995, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2622, p4x6zG_, 0.8995, 2.10, 0.326, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2623, d4qw3T_, 0.8995, 2.10, 0.330, 243, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2624, d4qw3F_, 0.8995, 2.10, 0.330, 243, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2625, d4qv9T_, 0.8995, 2.12, 0.330, 243, 230, YCP BETA5-C63F MUTANT
2626, d4qv3T_, 0.8995, 2.12, 0.330, 243, 230, YCP BETA5-M45V MUTANT
2627, d4qv3F_, 0.8995, 2.12, 0.330, 243, 230, YCP BETA5-M45V MUTANT
2628, d4no1T_, 0.8995, 2.12, 0.330, 243, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2629, d4no1F_, 0.8995, 2.12, 0.330, 243, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2630, d4nnnT_, 0.8995, 2.11, 0.330, 243, 230, YCP IN COMPLEX WITH MG132
2631, d4nnnF_, 0.8995, 2.11, 0.330, 243, 230, YCP IN COMPLEX WITH MG132
2632, p5t0gL_, 0.8994, 1.81, 0.316, 238, 228, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2633, d5lf1F_, 0.8994, 2.21, 0.346, 239, 231, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2634, d5cz5T_, 0.8994, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2635, d5cz5F_, 0.8994, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2636, d4z1lT_, 0.8994, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2637, d4z1lF_, 0.8994, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2638, d4qwsT_, 0.8994, 2.11, 0.330, 243, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2639, d4qwsF_, 0.8994, 2.11, 0.330, 243, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2640, d4qluT_, 0.8994, 2.13, 0.330, 243, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2641, d4qluF_, 0.8994, 2.13, 0.330, 243, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2642, d4qltT_, 0.8994, 2.12, 0.330, 243, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2643, d4qltF_, 0.8994, 2.12, 0.330, 243, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2644, d4q1sF_, 0.8994, 2.11, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2645, p3uneT_, 0.8994, 2.17, 0.352, 244, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
2646, p5leyF_, 0.8993, 2.21, 0.346, 239, 231, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2647, d5le5F_, 0.8993, 2.20, 0.346, 239, 231, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2648, p4y8jT_, 0.8993, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
2649, p4y8jF_, 0.8993, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
2650, p4y80T_, 0.8993, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
2651, p4y80F_, 0.8993, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
2652, d4qxjT_, 0.8993, 2.11, 0.330, 243, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2653, d4qxjF_, 0.8993, 2.11, 0.330, 243, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2654, d4qlqT_, 0.8993, 2.12, 0.330, 243, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2655, d4qlqF_, 0.8993, 2.12, 0.330, 243, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2656, d4no6T_, 0.8993, 2.11, 0.330, 243, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2657, d4no6F_, 0.8993, 2.11, 0.330, 243, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2658, d3un8F_, 0.8993, 2.17, 0.335, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2659, d5lf7Q_, 0.8992, 1.95, 0.348, 238, 230, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2660, d5lf3Q_, 0.8992, 1.95, 0.348, 238, 230, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2661, p5leyQ_, 0.8992, 1.95, 0.348, 239, 230, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2662, d5l54T_, 0.8992, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2663, d5l54F_, 0.8992, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2664, d5dkiT_, 0.8992, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2665, d5dkiF_, 0.8992, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2666, d5cz8T_, 0.8992, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2667, d5cz8F_, 0.8992, 2.12, 0.330, 243, 230, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2668, d5cz4T_, 0.8992, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2669, d5cz4F_, 0.8992, 2.10, 0.330, 243, 230, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2670, p4y7wT_, 0.8992, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2671, p4y7wF_, 0.8992, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2672, p4y70T_, 0.8992, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2673, p4y70F_, 0.8992, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2674, d4qzxT_, 0.8992, 2.12, 0.330, 243, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2675, d4qzxF_, 0.8992, 2.12, 0.330, 243, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2676, d4qwjT_, 0.8992, 2.11, 0.330, 243, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2677, d4qwjF_, 0.8992, 2.11, 0.330, 243, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2678, d4qwgT_, 0.8992, 2.11, 0.330, 243, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2679, d4qwgF_, 0.8992, 2.11, 0.330, 243, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2680, d4qvvT_, 0.8992, 2.10, 0.330, 243, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2681, d4qvvF_, 0.8992, 2.10, 0.330, 243, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2682, d4no8T_, 0.8992, 2.12, 0.330, 243, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2683, d4no8F_, 0.8992, 2.12, 0.330, 243, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2684, d4ltcT_, 0.8992, 2.11, 0.330, 244, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2685, d4ltcF_, 0.8992, 2.11, 0.330, 244, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2686, p5lf6F_, 0.8991, 2.21, 0.346, 239, 231, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2687, p4ya3T_, 0.8991, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2688, p4ya3F_, 0.8991, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2689, p4qbyT_, 0.8991, 2.13, 0.326, 243, 230, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2690, p4qbyF_, 0.8991, 2.13, 0.326, 243, 230, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2691, d3un8T_, 0.8991, 2.18, 0.335, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2692, d5lf4F_, 0.8990, 2.21, 0.346, 239, 231, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2693, p4ya0T_, 0.8990, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2694, p4ya0F_, 0.8990, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2695, p4y7yT_, 0.8990, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2696, p4y78T_, 0.8990, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2697, p4y78F_, 0.8990, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2698, p6epfE_, 0.8989, 1.64, 0.608, 233, 227, GROUND STATE 26S PROTEASOME (GS1)
2699, p4y7yF_, 0.8989, 2.11, 0.330, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2700, d4hnpT_, 0.8989, 2.12, 0.330, 244, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2701, p5lf0Q_, 0.8988, 1.96, 0.348, 238, 230, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2702, d4j70F_, 0.8988, 2.12, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2703, d4intT_, 0.8988, 2.18, 0.335, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2704, d4inrT_, 0.8988, 2.18, 0.335, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2705, d4inrF_, 0.8988, 2.18, 0.335, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2706, d4hrcT_, 0.8988, 2.12, 0.330, 244, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2707, d3nzjT_, 0.8988, 2.12, 0.330, 244, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2708, d3nzjF_, 0.8988, 2.12, 0.330, 244, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2709, d4q1sT_, 0.8987, 2.14, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2710, d4intF_, 0.8987, 2.18, 0.335, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2711, p5vfsD_, 0.8986, 2.00, 0.342, 239, 231, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2712, d3mg4F_, 0.8986, 2.12, 0.330, 244, 230, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2713, d3mg0T_, 0.8986, 2.13, 0.330, 244, 230, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2714, p5mp9G_, 0.8985, 2.11, 0.330, 243, 230, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2715, d4j70T_, 0.8985, 2.12, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2716, d4inuF_, 0.8985, 2.19, 0.335, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2717, d4hrdT_, 0.8985, 2.12, 0.330, 244, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2718, d3gptT_, 0.8985, 2.12, 0.330, 244, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2719, d3gptF_, 0.8985, 2.12, 0.330, 244, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2720, p5mpaD_, 0.8984, 1.94, 0.343, 240, 230, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2721, d4inuT_, 0.8984, 2.19, 0.335, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2722, d3nzwT_, 0.8984, 2.12, 0.330, 244, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2723, d3nzwF_, 0.8984, 2.12, 0.330, 244, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2724, d3hyeT_, 0.8984, 2.12, 0.330, 244, 230, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2725, d3hyeF_, 0.8984, 2.12, 0.330, 244, 230, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2726, d1rypG_, 0.8984, 2.17, 0.335, 244, 230, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2727, p5mp9g_, 0.8983, 2.16, 0.335, 243, 230, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2728, d4lqiT_, 0.8983, 2.13, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2729, d4lqiF_, 0.8983, 2.13, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2730, d1iruG_, 0.8983, 2.28, 0.349, 245, 232, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2731, d3mg7U_, 0.8982, 1.91, 0.239, 243, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2732, d1rypU_, 0.8982, 2.17, 0.335, 244, 230, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2733, d1jd2F_, 0.8982, 2.18, 0.335, 244, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2734, d1iruU_, 0.8982, 2.28, 0.349, 245, 232, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2735, d4jsqT_, 0.8981, 2.12, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2736, d4jsqF_, 0.8981, 2.12, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2737, d4fzgF_, 0.8981, 2.12, 0.330, 244, 230, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2738, d4fzgT_, 0.8980, 2.12, 0.330, 244, 230, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2739, d3tddT_, 0.8980, 2.13, 0.330, 244, 230, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2740, d3tddF_, 0.8980, 2.13, 0.330, 244, 230, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2741, d3nzxT_, 0.8980, 2.12, 0.330, 244, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2742, d3nzxF_, 0.8980, 2.12, 0.330, 244, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2743, d3mg4T_, 0.8980, 2.13, 0.330, 244, 230, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2744, d3gpwT_, 0.8980, 2.13, 0.330, 244, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2745, d3gpwF_, 0.8980, 2.13, 0.330, 244, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2746, d3d29T_, 0.8980, 2.13, 0.330, 244, 230, PROTEASOME INHIBITION BY FELLUTAMIDE B
2747, d2fnyT_, 0.8980, 2.13, 0.330, 244, 230,  
2748, d2fnyF_, 0.8980, 2.13, 0.330, 244, 230,  
2749, d2fakT_, 0.8980, 2.12, 0.330, 244, 230, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2750, p4gk7T_, 0.8979, 2.13, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2751, p4gk7F_, 0.8979, 2.13, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2752, d4eu2U_, 0.8979, 2.20, 0.335, 244, 230, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2753, d3e47T_, 0.8979, 2.13, 0.330, 244, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2754, d3e47F_, 0.8979, 2.13, 0.330, 244, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2755, d3d29F_, 0.8979, 2.13, 0.330, 244, 230, PROTEASOME INHIBITION BY FELLUTAMIDE B
2756, d2fakF_, 0.8979, 2.12, 0.330, 244, 230, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2757, d1jd21_, 0.8979, 2.18, 0.335, 244, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2758, d1g0uF_, 0.8979, 2.17, 0.335, 242, 230, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2759, d4jt0T_, 0.8978, 2.13, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2760, d4jt0F_, 0.8978, 2.13, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2761, d4jsuT_, 0.8978, 2.13, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2762, d4jsuF_, 0.8978, 2.13, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2763, d3mg6U_, 0.8978, 1.91, 0.239, 243, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2764, d3mg0F_, 0.8978, 2.13, 0.330, 244, 230, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2765, d2gplT_, 0.8978, 2.12, 0.330, 244, 230, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2766, d2gplF_, 0.8978, 2.12, 0.330, 244, 230, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2767, d1z7qG1, 0.8978, 2.09, 0.330, 243, 230, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2768, p4v7oU_, 0.8977, 2.15, 0.326, 244, 230, 
2769, p4v7oG_, 0.8977, 2.15, 0.326, 244, 230, 
2770, d3okjT_, 0.8977, 2.12, 0.330, 244, 230, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2771, d3okjF_, 0.8977, 2.12, 0.330, 244, 230, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2772, d3mg8U_, 0.8977, 1.92, 0.239, 243, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2773, d3l5qX_, 0.8977, 2.15, 0.326, 244, 230,  
2774, d3l5qL_, 0.8977, 2.15, 0.326, 244, 230,  
2775, d1z7qU1, 0.8977, 2.09, 0.330, 243, 230, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2776, d3sdkU_, 0.8976, 1.92, 0.239, 243, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2777, p5mpbB_, 0.8975, 1.75, 0.332, 250, 226, 
2778, p4v7oOA_, 0.8975, 2.15, 0.326, 244, 230, 
2779, p4v7oCB_, 0.8975, 2.15, 0.326, 244, 230, 
2780, d3dy3T_, 0.8975, 2.14, 0.330, 244, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2781, d3dy3F_, 0.8975, 2.14, 0.330, 244, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2782, d1vsyU_, 0.8975, 2.15, 0.326, 244, 230,  
2783, d1vsyG_, 0.8975, 2.15, 0.326, 244, 230,  
2784, d1g0uT_, 0.8975, 2.17, 0.335, 242, 230, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2785, p3un4T_, 0.8974, 2.14, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2786, p3un4F_, 0.8974, 2.13, 0.330, 244, 230, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2787, d3oeuU_, 0.8974, 1.92, 0.239, 243, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2788, d1g65T_, 0.8974, 2.17, 0.335, 244, 230, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2789, d3gpjT_, 0.8973, 2.14, 0.330, 244, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2790, d3bdmT_, 0.8973, 2.20, 0.335, 244, 230, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2791, d3bdmF_, 0.8973, 2.20, 0.335, 244, 230, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2792, d2f16T_, 0.8973, 2.13, 0.330, 244, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2793, d2f16F_, 0.8973, 2.13, 0.330, 244, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2794, d3gpjF_, 0.8972, 2.14, 0.330, 244, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2795, d1g65F_, 0.8972, 2.17, 0.335, 244, 230, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2796, d4fzcT_, 0.8971, 2.19, 0.335, 244, 230, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2797, d4fzcF_, 0.8971, 2.19, 0.335, 244, 230, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2798, d4cr2B_, 0.8971, 1.81, 0.330, 250, 227, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2799, d3shjT_, 0.8971, 2.13, 0.330, 244, 230, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2800, d3shjF_, 0.8971, 2.13, 0.330, 244, 230, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2801, d3dy4T_, 0.8971, 2.14, 0.330, 244, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2802, p5mpcP_, 0.8970, 1.73, 0.339, 250, 227, 
2803, d3mg4U_, 0.8970, 1.92, 0.239, 243, 230, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2804, d3dy4F_, 0.8970, 2.14, 0.330, 244, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2805, d2zcyT_, 0.8970, 2.14, 0.330, 244, 230, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2806, d2zcyF_, 0.8970, 2.14, 0.330, 244, 230, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2807, d1rypO_, 0.8969, 1.94, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2808, d3un8U_, 0.8968, 1.93, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2809, d3oevU_, 0.8968, 1.93, 0.239, 243, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2810, p4v7oQ_, 0.8966, 1.80, 0.344, 232, 224, 
2811, d3l5qT_, 0.8966, 1.80, 0.344, 232, 224,  
2812, p4v7oKA_, 0.8965, 1.80, 0.344, 232, 224, 
2813, p4v7oC_, 0.8965, 1.80, 0.344, 232, 224, 
2814, d3l5qH_, 0.8965, 1.80, 0.344, 232, 224,  
2815, d1vsyQ_, 0.8965, 1.80, 0.344, 232, 224,  
2816, d1vsyC_, 0.8965, 1.80, 0.344, 232, 224,  
2817, d3wxrO_, 0.8963, 1.93, 0.239, 243, 230, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2818, d1rypA_, 0.8961, 1.96, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2819, p5vfuU_, 0.8960, 2.02, 0.342, 239, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2820, p5vftJ_, 0.8960, 2.02, 0.342, 239, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2821, p5dsvF_, 0.8960, 2.40, 0.349, 244, 232, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2822, d3h4pA_, 0.8960, 2.08, 0.434, 232, 228, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2823, p5wviDA_, 0.8958, 1.86, 0.326, 250, 227, 
2824, p5dsvL_, 0.8958, 2.40, 0.349, 245, 232, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2825, d4q1sU_, 0.8958, 1.94, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2826, d4ltcU_, 0.8958, 1.94, 0.239, 243, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2827, d4g4sG_, 0.8958, 2.03, 0.338, 246, 228, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2828, d3mg7G_, 0.8958, 1.95, 0.239, 243, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2829, p5dsvN_, 0.8957, 2.40, 0.349, 244, 232, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2830, p4y8sA_, 0.8957, 1.57, 0.335, 229, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2831, d4j70U_, 0.8957, 1.95, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2832, d3h4pE_, 0.8957, 2.11, 0.434, 232, 228, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2833, d3h4pD_, 0.8957, 2.09, 0.434, 232, 228, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2834, d1g65U_, 0.8957, 1.96, 0.239, 243, 230, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2835, p5mpcB_, 0.8956, 1.72, 0.330, 250, 227, 
2836, p5dsvB_, 0.8956, 2.40, 0.349, 245, 232, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2837, d3un8G_, 0.8956, 1.95, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2838, d3mg6G_, 0.8956, 1.95, 0.239, 243, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2839, p5dsvA_, 0.8955, 2.40, 0.349, 244, 232, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2840, p5cggA_, 0.8955, 1.57, 0.335, 229, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2841, d4hnpU_, 0.8955, 1.94, 0.239, 243, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2842, p3h4pH_, 0.8955, 2.09, 0.434, 232, 228, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2843, p4ya9A_, 0.8954, 1.58, 0.335, 229, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2844, p4y8tA_, 0.8954, 1.57, 0.335, 229, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2845, p3h4pN_, 0.8954, 2.09, 0.434, 232, 228, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2846, p5wvkR_, 0.8953, 2.06, 0.342, 241, 231, 
2847, p5wvkBA_, 0.8953, 2.09, 0.330, 244, 230, 
2848, p5wviOA_, 0.8953, 1.87, 0.330, 250, 227, 
2849, p5cghA_, 0.8953, 1.58, 0.335, 229, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2850, p4ya2A_, 0.8953, 1.58, 0.335, 229, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2851, p4y75A_, 0.8953, 1.58, 0.335, 229, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2852, d3mg0U_, 0.8953, 1.95, 0.239, 243, 230, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2853, p3jcpPA_, 0.8953, 2.12, 0.326, 244, 230, 
2854, p3h4pL_, 0.8953, 2.09, 0.434, 232, 228, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2855, p4ya7A_, 0.8952, 1.58, 0.335, 229, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2856, p4y8gA_, 0.8952, 1.58, 0.335, 229, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2857, d4jsuU_, 0.8952, 1.96, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2858, d4jsuG_, 0.8952, 1.96, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2859, d3oevG_, 0.8952, 1.96, 0.239, 243, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2860, d3h4pC_, 0.8952, 2.10, 0.434, 232, 228, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2861, p5vfsCA_, 0.8951, 2.03, 0.342, 239, 231, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2862, p5dsvD_, 0.8951, 2.41, 0.349, 244, 232, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2863, p4y8hA_, 0.8951, 1.58, 0.335, 229, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2864, d4jsqU_, 0.8951, 1.95, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2865, d4jsqG_, 0.8951, 1.96, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2866, d4j70G_, 0.8951, 1.97, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2867, d4hrcU_, 0.8951, 1.94, 0.239, 243, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2868, d3wxrA_, 0.8951, 1.96, 0.239, 243, 230, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2869, d3tddU_, 0.8951, 1.96, 0.239, 243, 230, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2870, d3tddG_, 0.8951, 1.96, 0.239, 243, 230, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2871, d3sdkG_, 0.8951, 1.96, 0.239, 243, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2872, p3jcpP_, 0.8951, 2.12, 0.326, 244, 230, 
2873, p5dsvE_, 0.8950, 2.41, 0.349, 245, 232, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2874, p4y9zA_, 0.8950, 1.58, 0.335, 229, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2875, d4inrU_, 0.8950, 1.96, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2876, d3oeuG_, 0.8950, 1.96, 0.239, 243, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2877, p5mpbP_, 0.8949, 1.88, 0.330, 250, 227, 
2878, p4y77A_, 0.8949, 1.58, 0.335, 229, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2879, p3un4U_, 0.8949, 1.96, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2880, d3nzjU_, 0.8949, 1.96, 0.239, 243, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2881, p5a5bD_, 0.8948, 2.07, 0.338, 242, 231, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
2882, p4qbyA_, 0.8948, 1.58, 0.335, 229, 221, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2883, d4intU_, 0.8948, 1.95, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2884, d4hrdU_, 0.8948, 1.95, 0.239, 243, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2885, p4cr3D_, 0.8948, 2.07, 0.338, 242, 231, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2886, p3un4G_, 0.8948, 1.96, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2887, d3nzxU_, 0.8948, 1.97, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2888, d1jd22_, 0.8948, 1.97, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2889, p5cgiA_, 0.8947, 1.58, 0.335, 229, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2890, p4v7oO_, 0.8947, 1.96, 0.239, 243, 230, 
2891, p4v7oIA_, 0.8947, 1.96, 0.239, 243, 230, 
2892, p4v7oA_, 0.8947, 1.96, 0.239, 243, 230, 
2893, d3nzjG_, 0.8947, 1.96, 0.239, 243, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2894, d3l5qC_, 0.8947, 1.96, 0.239, 243, 230,  
2895, d3l5qA_, 0.8947, 1.96, 0.239, 243, 230,  
2896, p3h4pJ_, 0.8947, 2.11, 0.434, 232, 228, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2897, d1vsyA_, 0.8947, 1.96, 0.239, 243, 230,  
2898, p4v7oWA_, 0.8946, 1.96, 0.239, 243, 230, 
2899, d4lqiU_, 0.8946, 1.97, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2900, d4jt0U_, 0.8946, 1.96, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2901, d4jt0G_, 0.8946, 1.96, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2902, d4inrG_, 0.8946, 1.97, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2903, d3shjU_, 0.8946, 1.96, 0.239, 243, 230, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2904, d3nzxG_, 0.8946, 1.97, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2905, d3hyeU_, 0.8946, 1.97, 0.239, 243, 230, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2906, d3h4pF_, 0.8946, 2.11, 0.434, 232, 228, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2907, d3gpwU_, 0.8946, 1.97, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2908, d1vsyO_, 0.8946, 1.96, 0.239, 243, 230,  
2909, p4y84A_, 0.8945, 1.59, 0.335, 229, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2910, d4lqiG_, 0.8945, 1.97, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2911, d3shjG_, 0.8945, 1.97, 0.239, 243, 230, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2912, d3hyeG_, 0.8945, 1.97, 0.239, 243, 230, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2913, d3gpwG_, 0.8945, 1.98, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2914, d3gpjU_, 0.8945, 1.98, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2915, d3gpjG_, 0.8945, 1.98, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2916, d2fakU_, 0.8945, 1.97, 0.239, 243, 230, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2917, p4y6vA_, 0.8944, 1.59, 0.335, 229, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2918, d3mg8G_, 0.8944, 1.97, 0.239, 243, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2919, d3gptU_, 0.8944, 1.98, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2920, d2fakG_, 0.8944, 1.98, 0.239, 243, 230, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2921, p5dsvG_, 0.8943, 2.43, 0.349, 242, 232, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2922, p4y70A_, 0.8943, 1.59, 0.335, 229, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2923, d3gptG_, 0.8943, 1.98, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2924, d3bdmU_, 0.8943, 1.98, 0.239, 243, 230, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2925, d3bdmG_, 0.8943, 1.98, 0.239, 243, 230, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2926, p1fntG_, 0.8943, 2.21, 0.335, 240, 230, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2927, p4y8lA_, 0.8942, 1.59, 0.335, 229, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2928, p4y8jA_, 0.8942, 1.59, 0.335, 229, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
2929, d4inuU_, 0.8942, 1.97, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2930, d3nzwU_, 0.8942, 1.98, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2931, p1fntU_, 0.8942, 2.22, 0.335, 240, 230, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2932, p5dsvK_, 0.8941, 2.36, 0.346, 244, 231, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2933, p4y8uA_, 0.8941, 1.59, 0.335, 229, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2934, p4y7wA_, 0.8941, 1.59, 0.335, 229, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2935, p4y69A_, 0.8941, 1.59, 0.335, 229, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2936, d4ltcG_, 0.8941, 1.97, 0.239, 243, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2937, d4fzcU_, 0.8941, 1.97, 0.239, 243, 230, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2938, d3nzwG_, 0.8941, 1.98, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2939, d3e47U_, 0.8941, 1.97, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2940, p4y8nA_, 0.8940, 1.59, 0.335, 229, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2941, p4y8iA_, 0.8940, 1.60, 0.335, 229, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2942, d4fzcG_, 0.8940, 1.97, 0.239, 243, 230, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2943, d3sdiU_, 0.8940, 1.99, 0.248, 240, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2944, d3mg4G_, 0.8940, 1.98, 0.239, 243, 230, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2945, p3jcpJA_, 0.8940, 1.98, 0.239, 243, 230, 
2946, p3jcpJ_, 0.8940, 1.98, 0.239, 243, 230, 
2947, d3e47G_, 0.8940, 1.97, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2948, d2gplU_, 0.8940, 1.98, 0.239, 243, 230, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2949, d2fnyU_, 0.8940, 1.97, 0.239, 243, 230,  
2950, d2f16U_, 0.8940, 1.98, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2951, d1g65G_, 0.8940, 1.99, 0.239, 243, 230, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2952, p5mpag_, 0.8939, 2.23, 0.335, 243, 230, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2953, p5dsvI_, 0.8939, 2.36, 0.346, 244, 231, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2954, p4y8oA_, 0.8939, 1.60, 0.335, 229, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2955, d3okjU_, 0.8939, 1.97, 0.239, 243, 230, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2956, d2gplG_, 0.8939, 1.98, 0.239, 243, 230, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2957, d2f16G_, 0.8939, 1.98, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2958, p4ya5A_, 0.8938, 1.60, 0.335, 229, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2959, p4y7yA_, 0.8938, 1.60, 0.335, 229, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2960, d4intG_, 0.8938, 1.97, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2961, d4fzgU_, 0.8938, 1.97, 0.239, 243, 230, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2962, d3okjG_, 0.8938, 1.98, 0.239, 243, 230, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2963, d3h4pG_, 0.8938, 2.12, 0.434, 232, 228, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2964, d3h4pB_, 0.8938, 2.13, 0.434, 232, 228, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2965, d2fnyG_, 0.8938, 1.97, 0.239, 243, 230,  
2966, d4inuG_, 0.8937, 1.98, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2967, d4fzgG_, 0.8937, 1.97, 0.239, 243, 230, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2968, p3h4pI_, 0.8937, 1.87, 0.434, 232, 226, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2969, p5nifA_, 0.8936, 1.92, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2970, p5m32Q_, 0.8936, 1.94, 0.346, 235, 228, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2971, p5fghA_, 0.8936, 1.60, 0.335, 229, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2972, p3h4pK_, 0.8934, 2.13, 0.434, 232, 228, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
2973, d1g0uU_, 0.8934, 2.00, 0.248, 240, 230, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2974, p4zzgA_, 0.8933, 1.93, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2975, p4gk7U_, 0.8933, 1.97, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2976, d3dy3U_, 0.8933, 2.00, 0.239, 243, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2977, p5t0iH_, 0.8932, 1.76, 0.311, 233, 225, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2978, d3dy3G_, 0.8932, 2.00, 0.239, 243, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2979, d2zcyU_, 0.8932, 2.00, 0.239, 243, 230, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2980, d2zcyG_, 0.8932, 2.00, 0.239, 243, 230, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2981, p4gk7G_, 0.8931, 1.98, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2982, d3dy4U_, 0.8931, 2.00, 0.239, 243, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2983, d3dy4G_, 0.8931, 2.00, 0.239, 243, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2984, d4q1sG_, 0.8930, 2.00, 0.239, 243, 230, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2985, p4ya3A_, 0.8929, 1.61, 0.335, 229, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2986, p4x6zA_, 0.8929, 1.99, 0.239, 242, 230, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2987, p5m32C_, 0.8927, 1.93, 0.348, 234, 227, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2988, p4ya0A_, 0.8927, 1.61, 0.335, 229, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2989, d1g0uG_, 0.8927, 2.01, 0.248, 240, 230, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2990, d3d29G2, 0.8926, 2.01, 0.239, 241, 230, PROTEASOME INHIBITION BY FELLUTAMIDE B
2991, d4qv9U_, 0.8925, 1.94, 0.240, 241, 229, YCP BETA5-C63F MUTANT
2992, d4qv9G_, 0.8925, 1.94, 0.240, 241, 229, YCP BETA5-C63F MUTANT
2993, d3d29U2, 0.8925, 2.01, 0.239, 241, 230, PROTEASOME INHIBITION BY FELLUTAMIDE B
2994, p5t0cV_, 0.8924, 2.03, 0.342, 239, 231, 
2995, p5t0cBB_, 0.8924, 2.03, 0.342, 239, 231, 
2996, d5l5bU_, 0.8924, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2997, d5l5bG_, 0.8924, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2998, d5d0wU_, 0.8924, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2999, d5d0wG_, 0.8923, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3000, d4ya4U_, 0.8923, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3001, d4ya4G_, 0.8923, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3002, d5fggU_, 0.8922, 1.94, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3003, d5fggG_, 0.8922, 1.94, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3004, d5czaU_, 0.8922, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3005, d5czaG_, 0.8922, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3006, p3h4pM_, 0.8922, 1.88, 0.434, 232, 226, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
3007, d4y8rU_, 0.8921, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3008, d4y8rG_, 0.8921, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3009, d4qv3U_, 0.8921, 1.95, 0.240, 241, 229, YCP BETA5-M45V MUTANT
3010, d4qv3G_, 0.8921, 1.95, 0.240, 241, 229, YCP BETA5-M45V MUTANT
3011, d4hrdG_, 0.8920, 2.00, 0.239, 243, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3012, d4hnpG_, 0.8920, 2.00, 0.239, 243, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3013, p3un4A_, 0.8920, 1.57, 0.336, 228, 220, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3014, d5fg7U_, 0.8919, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3015, d5fg7G_, 0.8919, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3016, d5cgfU_, 0.8919, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3017, d5cgfG_, 0.8919, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3018, d5ahjU_, 0.8919, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3019, d1jd2G_, 0.8919, 2.00, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3020, p5vfom_, 0.8918, 2.32, 0.333, 240, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3021, p5m32E_, 0.8918, 1.73, 0.316, 234, 225, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3022, d5l55U_, 0.8918, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3023, d5l55G_, 0.8918, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3024, p5cggU_, 0.8918, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3025, d5ahjG_, 0.8918, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3026, d4ya1U_, 0.8918, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3027, d4ya1G_, 0.8918, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3028, d4quyU_, 0.8918, 1.95, 0.240, 241, 229, YCP BETA5-A49S-MUTANT
3029, d4quyG_, 0.8918, 1.95, 0.240, 241, 229, YCP BETA5-A49S-MUTANT
3030, d4no8U_, 0.8918, 1.95, 0.240, 241, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3031, d4no8G_, 0.8918, 1.95, 0.240, 241, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3032, p5vftM_, 0.8917, 2.32, 0.333, 240, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3033, d5l5rU_, 0.8917, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3034, d5l5rG_, 0.8917, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3035, d5fgaU_, 0.8917, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3036, p5cggG_, 0.8917, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3037, d4qv7U_, 0.8917, 1.96, 0.240, 241, 229, YCP BETA5-A50V MUTANT
3038, d4qv7G_, 0.8917, 1.96, 0.240, 241, 229, YCP BETA5-A50V MUTANT
3039, p5vfuX_, 0.8916, 2.32, 0.333, 240, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3040, d5l5uU_, 0.8916, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3041, d5fgaG_, 0.8916, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3042, d5d0sU_, 0.8916, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3043, d5d0sG_, 0.8916, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3044, d5bxlU_, 0.8916, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3045, d4qwlU_, 0.8916, 1.95, 0.240, 241, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3046, d4qwlG_, 0.8916, 1.95, 0.240, 241, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3047, d4no1U_, 0.8916, 1.95, 0.240, 241, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3048, d4no1G_, 0.8916, 1.95, 0.240, 241, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3049, d4nnnU_, 0.8916, 1.95, 0.240, 241, 229, YCP IN COMPLEX WITH MG132
3050, d5l5uG_, 0.8915, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3051, d5jhrU_, 0.8915, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3052, d5bxlG_, 0.8915, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3053, p4y8hU_, 0.8915, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3054, p4y8hG_, 0.8915, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3055, d4nnnG_, 0.8915, 1.95, 0.240, 241, 229, YCP IN COMPLEX WITH MG132
3056, d3mg0G_, 0.8915, 2.01, 0.239, 243, 230, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3057, p5wvkV_, 0.8914, 2.02, 0.235, 243, 230, 
3058, p5vfqG_, 0.8914, 2.34, 0.333, 240, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3059, d5jhrG_, 0.8914, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3060, d5bxnU_, 0.8914, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3061, d4qv5U_, 0.8914, 1.96, 0.240, 241, 229, YCP BETA5-M45I MUTANT
3062, d4qv5G_, 0.8914, 1.96, 0.240, 241, 229, YCP BETA5-M45I MUTANT
3063, d4qv1U_, 0.8914, 1.96, 0.240, 241, 229, YCP BETA5-M45A MUTANT
3064, d4qv1G_, 0.8914, 1.96, 0.240, 241, 229, YCP BETA5-M45A MUTANT
3065, d4no9U_, 0.8914, 1.95, 0.240, 241, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3066, d4no9G_, 0.8914, 1.95, 0.240, 241, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3067, d4hrcG_, 0.8914, 2.00, 0.239, 243, 230, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3068, d5l6aU_, 0.8913, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3069, d5l6aG_, 0.8913, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3070, d5l52U_, 0.8913, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3071, d5l52G_, 0.8913, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3072, p4y8tU_, 0.8913, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3073, p4y8tG_, 0.8913, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3074, p4y8pA_, 0.8913, 1.58, 0.336, 228, 220, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3075, d4qwuU_, 0.8913, 1.96, 0.240, 241, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3076, d4qwuG_, 0.8913, 1.96, 0.240, 241, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3077, d3sdiG_, 0.8913, 2.03, 0.248, 240, 230, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3078, d5fgfU_, 0.8912, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3079, d5fgfG_, 0.8912, 1.95, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3080, d5bxnG_, 0.8912, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3081, d4z1lU_, 0.8912, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3082, d4z1lG_, 0.8912, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3083, p4ya2U_, 0.8912, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3084, p4ya2G_, 0.8912, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3085, d4qv4U_, 0.8912, 1.96, 0.240, 241, 229, YCP BETA5-M45T MUTANT
3086, d4qv4G_, 0.8912, 1.96, 0.240, 241, 229, YCP BETA5-M45T MUTANT
3087, p4gk7A_, 0.8912, 1.58, 0.336, 228, 220, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3088, p5t0hL_, 0.8911, 1.92, 0.316, 238, 228, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3089, d4qz6U_, 0.8911, 1.95, 0.240, 241, 229, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3090, d4qv8U_, 0.8911, 1.96, 0.240, 241, 229, YCP BETA5-C52F MUTANT
3091, d4qv8G_, 0.8911, 1.96, 0.240, 241, 229, YCP BETA5-C52F MUTANT
3092, d4qv0U_, 0.8911, 1.96, 0.240, 241, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3093, p6gopU_, 0.8910, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3094, p5wviCA_, 0.8910, 2.17, 0.353, 245, 232, 
3095, p4ya7U_, 0.8910, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3096, p4ya7G_, 0.8910, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3097, d4y9yU_, 0.8910, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3098, d4y9yG_, 0.8910, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3099, d4y8mU_, 0.8910, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3100, d4y8mG_, 0.8910, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3101, d4qzzU_, 0.8910, 1.96, 0.240, 241, 229, YCP IN COMPLEX WITH OMURALIDE
3102, d4qzzG_, 0.8910, 1.96, 0.240, 241, 229, YCP IN COMPLEX WITH OMURALIDE
3103, d4qz6G_, 0.8910, 1.96, 0.240, 241, 229, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3104, d4qvnU_, 0.8910, 1.96, 0.240, 241, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3105, d4qvnG_, 0.8910, 1.96, 0.240, 241, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3106, d4qv0G_, 0.8910, 1.96, 0.240, 241, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3107, d3mg8T_, 0.8910, 2.09, 0.335, 237, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3108, p3jcoJA_, 0.8910, 2.02, 0.239, 243, 230, 
3109, p6gopG_, 0.8909, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3110, d5fg9U_, 0.8909, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3111, d5fg9G_, 0.8909, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3112, p5dsvH_, 0.8909, 2.09, 0.351, 239, 228, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
3113, d5d0zU_, 0.8909, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3114, d5d0zG_, 0.8909, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3115, p4y8sU_, 0.8909, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3116, p4y8pU_, 0.8909, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3117, p4y8pG_, 0.8909, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3118, p4y8kA_, 0.8909, 1.58, 0.336, 228, 220, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3119, d4r17U_, 0.8909, 1.97, 0.240, 241, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3120, d4r17G_, 0.8909, 1.97, 0.240, 241, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3121, d4r00U_, 0.8909, 1.96, 0.240, 241, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3122, d4r00G_, 0.8909, 1.96, 0.240, 241, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3123, d4qz0U_, 0.8909, 1.96, 0.240, 241, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3124, d4qluU_, 0.8909, 1.96, 0.240, 241, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3125, d4qluG_, 0.8909, 1.96, 0.240, 241, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3126, d4cr2D_, 0.8909, 2.11, 0.342, 242, 231, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3127, p3jcoJ_, 0.8909, 2.02, 0.239, 243, 230, 
3128, p5vfpEA_, 0.8908, 2.33, 0.333, 240, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3129, d5lttU_, 0.8908, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3130, d5lttG_, 0.8908, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3131, d5cz9U_, 0.8908, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3132, d5cz9G_, 0.8908, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3133, p4y8sG_, 0.8908, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3134, p4y8kU_, 0.8908, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3135, p4y8kG_, 0.8908, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3136, p4y8gU_, 0.8908, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3137, d4qz0G_, 0.8908, 1.96, 0.240, 241, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3138, d4qv6U_, 0.8908, 1.96, 0.240, 241, 229, YCP BETA5-A49V MUTANT
3139, p5vfqFA_, 0.8907, 2.34, 0.333, 240, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3140, p5vfoM_, 0.8907, 2.25, 0.335, 240, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3141, p5nifO_, 0.8907, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3142, d5l5hU_, 0.8907, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3143, d5fhsU_, 0.8907, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3144, d5fhsG_, 0.8907, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3145, p4y8gG_, 0.8907, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3146, d4r02U_, 0.8907, 1.96, 0.240, 241, 229, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3147, d4qv6G_, 0.8907, 1.96, 0.240, 241, 229, YCP BETA5-A49V MUTANT
3148, d4g4sA_, 0.8907, 2.08, 0.239, 241, 230, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
3149, p5vfsG_, 0.8906, 2.45, 0.332, 240, 232, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3150, p5t0jL_, 0.8906, 1.93, 0.316, 238, 228, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3151, d5l6bU_, 0.8906, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3152, d5l6bG_, 0.8906, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3153, d5l5hG_, 0.8906, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3154, d5l5aU_, 0.8906, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3155, d5l5aG_, 0.8906, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3156, p4zzgO_, 0.8906, 1.98, 0.240, 242, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3157, p4y9zU_, 0.8906, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3158, p4y9zG_, 0.8906, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3159, d4qltU_, 0.8906, 1.97, 0.240, 241, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3160, d3oeuT_, 0.8906, 2.10, 0.335, 237, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3161, d3mg6T_, 0.8906, 2.09, 0.335, 237, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3162, d5l67U_, 0.8905, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3163, d5l67G_, 0.8905, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3164, d5d0vU_, 0.8905, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3165, d5d0vG_, 0.8905, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3166, d5cz8U_, 0.8905, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3167, d5cz8G_, 0.8905, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3168, d5cz7U_, 0.8905, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3169, d5cz7G_, 0.8905, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3170, p5cghU_, 0.8905, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3171, p4y74A_, 0.8905, 1.59, 0.336, 228, 220, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3172, d4qz3U_, 0.8905, 1.96, 0.240, 241, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3173, d4qw7U_, 0.8905, 1.96, 0.240, 241, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3174, d4qvpU_, 0.8905, 1.97, 0.240, 241, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3175, d4qvlU_, 0.8905, 1.97, 0.240, 241, 229, YCP IN COMPLEX WITH BORTEZOMIB
3176, d4qvlG_, 0.8905, 1.97, 0.240, 241, 229, YCP IN COMPLEX WITH BORTEZOMIB
3177, d4qltG_, 0.8905, 1.97, 0.240, 241, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3178, d4no6U_, 0.8905, 1.97, 0.240, 241, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3179, d3oevT_, 0.8905, 2.09, 0.335, 237, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3180, d3mg7T_, 0.8905, 2.10, 0.335, 237, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3181, d5jhsU_, 0.8904, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3182, d5jhsG_, 0.8904, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3183, p5cghG_, 0.8904, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3184, d4qz5U_, 0.8904, 1.96, 0.240, 241, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3185, d4qz3G_, 0.8904, 1.96, 0.240, 241, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3186, d4qw7G_, 0.8904, 1.96, 0.240, 241, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3187, d4qw6U_, 0.8904, 1.96, 0.240, 241, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3188, d4qw5U_, 0.8904, 1.96, 0.240, 241, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3189, d4qw5G_, 0.8904, 1.96, 0.240, 241, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3190, d4qw1U_, 0.8904, 1.97, 0.240, 241, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3191, d4qw1G_, 0.8904, 1.97, 0.240, 241, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3192, d4qvyU_, 0.8904, 1.97, 0.240, 241, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3193, d4qvpG_, 0.8904, 1.97, 0.240, 241, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3194, d4qlsU_, 0.8904, 1.97, 0.240, 241, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3195, d4qlsG_, 0.8904, 1.97, 0.240, 241, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3196, d4no6G_, 0.8904, 1.97, 0.240, 241, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3197, d5l64U_, 0.8903, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3198, d5l63U_, 0.8903, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3199, d5l63G_, 0.8903, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3200, d5l61U_, 0.8903, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3201, d5l5pU_, 0.8903, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3202, d5l5pG_, 0.8903, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3203, d5l5oU_, 0.8903, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3204, d5l5oG_, 0.8903, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3205, d5fgeU_, 0.8903, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3206, d5fgeG_, 0.8903, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3207, d5cz6U_, 0.8903, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3208, d5cz6G_, 0.8903, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3209, p4ya9U_, 0.8903, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3210, p4ya9G_, 0.8903, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3211, p4y8lU_, 0.8903, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3212, p4y8lG_, 0.8903, 1.96, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3213, p4y82A_, 0.8903, 1.59, 0.336, 228, 220, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3214, p4y75U_, 0.8903, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3215, p4y75G_, 0.8903, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3216, p4x6zO_, 0.8903, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3217, d4r18U_, 0.8903, 1.98, 0.240, 241, 229, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3218, d4qz5G_, 0.8903, 1.96, 0.240, 241, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3219, d4qw6G_, 0.8903, 1.96, 0.240, 241, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3220, d4qvyG_, 0.8903, 1.97, 0.240, 241, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3221, d4quxU_, 0.8903, 1.97, 0.240, 241, 229, YCP BETA5-A49T-MUTANT
3222, d4eu2O_, 0.8903, 1.90, 0.241, 241, 228, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3223, p5vfpG_, 0.8902, 2.24, 0.335, 240, 230, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3224, d5l6cU_, 0.8902, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3225, d5l6cG_, 0.8902, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3226, d5l64G_, 0.8902, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3227, d5l61G_, 0.8902, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3228, d5l5fU_, 0.8902, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3229, d5l5fG_, 0.8902, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3230, d5l5dU_, 0.8902, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3231, d5l54U_, 0.8902, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3232, p4y8uU_, 0.8902, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3233, p4y8uG_, 0.8902, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3234, p4y6aA_, 0.8902, 1.59, 0.336, 228, 220, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3235, d4r18G_, 0.8902, 1.98, 0.240, 241, 229, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3236, d4quxG_, 0.8902, 1.97, 0.240, 241, 229, YCP BETA5-A49T-MUTANT
3237, d4nnwU_, 0.8902, 1.97, 0.240, 241, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3238, d4nnwG_, 0.8902, 1.98, 0.240, 241, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3239, d5lajU_, 0.8901, 1.98, 0.240, 241, 229, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3240, d5lajG_, 0.8901, 1.98, 0.240, 241, 229, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3241, d5l66U_, 0.8901, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3242, d5l65U_, 0.8901, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3243, d5l65G_, 0.8901, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3244, d5l62U_, 0.8901, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3245, d5l62G_, 0.8901, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3246, d5l5wU_, 0.8901, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3247, d5l5dG_, 0.8901, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3248, d5l54G_, 0.8901, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3249, p5cgiU_, 0.8901, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3250, p4y8qA_, 0.8901, 1.59, 0.336, 228, 220, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3251, p4y77U_, 0.8901, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3252, p4y77G_, 0.8901, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3253, d4qz7U_, 0.8901, 1.98, 0.240, 241, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3254, d4qz7G_, 0.8901, 1.98, 0.240, 241, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3255, d4qz4U_, 0.8901, 1.97, 0.240, 241, 229, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3256, p5t0cY_, 0.8900, 2.29, 0.346, 240, 231, 
3257, p5t0cEB_, 0.8900, 2.29, 0.346, 240, 231, 
3258, d5l66G_, 0.8900, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3259, d5l5wG_, 0.8900, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3260, p5cgiG_, 0.8900, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3261, p4y81A_, 0.8900, 1.60, 0.336, 228, 220, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3262, p4y80A_, 0.8900, 1.59, 0.336, 228, 220, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3263, p4y7xA_, 0.8900, 1.59, 0.336, 228, 220, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3264, p4y70U_, 0.8900, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3265, p4y70G_, 0.8900, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3266, d4qzxU_, 0.8900, 1.97, 0.240, 241, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3267, d4qzwU_, 0.8900, 1.97, 0.240, 241, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3268, d4qzwG_, 0.8900, 1.97, 0.240, 241, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3269, d4qz4G_, 0.8900, 1.97, 0.240, 241, 229, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3270, d4qwrU_, 0.8900, 1.97, 0.240, 241, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3271, p4qbyU_, 0.8900, 1.98, 0.240, 241, 229, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3272, p4qbyG_, 0.8900, 1.98, 0.240, 241, 229, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3273, d5l5xU_, 0.8899, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3274, d5l5qU_, 0.8899, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3275, d5l5qG_, 0.8899, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3276, d5l5eU_, 0.8899, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3277, d5l5eG_, 0.8899, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3278, d5d0tU_, 0.8899, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3279, d5d0tG_, 0.8899, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3280, p4y8qU_, 0.8899, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3281, p4y7yU_, 0.8899, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3282, p4y7yG_, 0.8899, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3283, p4y7wU_, 0.8899, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3284, p4y7wG_, 0.8899, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3285, p4y6zA_, 0.8899, 1.59, 0.336, 228, 220, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3286, d4qzxG_, 0.8899, 1.97, 0.240, 241, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3287, d4qwrG_, 0.8899, 1.97, 0.240, 241, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3288, d4qvwU_, 0.8899, 1.98, 0.240, 241, 229, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3289, d5m2bU_, 0.8898, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3290, d5m2bG_, 0.8898, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3291, d5l5xG_, 0.8898, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3292, d5l5vU_, 0.8898, 1.98, 0.240, 241, 229,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3293, d5l5vG_, 0.8898, 1.98, 0.240, 241, 229,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3294, d5l5sU_, 0.8898, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3295, d5l5sG_, 0.8898, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3296, p4y8qG_, 0.8898, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3297, p4y6aU_, 0.8898, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3298, p4y6aG_, 0.8898, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3299, d4qwjU_, 0.8898, 1.97, 0.240, 241, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3300, d4qwjG_, 0.8898, 1.97, 0.240, 241, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3301, d4qvwG_, 0.8898, 1.98, 0.240, 241, 229, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3302, d3oevF_, 0.8898, 2.08, 0.335, 237, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3303, d3mg7F_, 0.8898, 2.08, 0.335, 237, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3304, p5mpaG_, 0.8897, 2.16, 0.332, 243, 229, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3305, d5l5tU_, 0.8897, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3306, d5cz5U_, 0.8897, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3307, p4y8jU_, 0.8897, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3308, p4y8jG_, 0.8897, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3309, p4y84U_, 0.8897, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3310, p4y84G_, 0.8897, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3311, p4y82U_, 0.8897, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3312, p4y82G_, 0.8897, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3313, p4y6vU_, 0.8897, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3314, p4y6vG_, 0.8897, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3315, d4qz2U_, 0.8897, 1.97, 0.240, 241, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3316, d4qz2G_, 0.8897, 1.97, 0.240, 241, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3317, p5vfrM_, 0.8896, 2.25, 0.335, 240, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3318, d5l5zU_, 0.8896, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3319, d5l5tG_, 0.8896, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3320, d5fgiU_, 0.8896, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3321, d5fgiG_, 0.8896, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3322, d5fgdU_, 0.8896, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3323, d5fgdG_, 0.8896, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3324, d5cz5G_, 0.8896, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3325, p4y80U_, 0.8896, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3326, p4y7xU_, 0.8896, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3327, p4y7xG_, 0.8896, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3328, p4y74U_, 0.8896, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3329, p4y69U_, 0.8896, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3330, p4y69G_, 0.8896, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3331, d4qwxU_, 0.8896, 1.97, 0.240, 241, 229, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3332, d4qwxG_, 0.8896, 1.97, 0.240, 241, 229, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3333, d4qvqU_, 0.8896, 1.98, 0.240, 241, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3334, d4qvqG_, 0.8896, 1.98, 0.240, 241, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3335, d4qlvU_, 0.8896, 1.98, 0.240, 241, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3336, d4qlvG_, 0.8896, 1.98, 0.240, 241, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3337, d4qlqU_, 0.8896, 1.99, 0.240, 241, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3338, d4qlqG_, 0.8896, 1.99, 0.240, 241, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3339, d3oeuF_, 0.8896, 2.08, 0.335, 237, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3340, p6epfB_, 0.8895, 1.80, 0.311, 234, 225, GROUND STATE 26S PROTEASOME (GS1)
3341, d5l5zG_, 0.8895, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3342, p4y80G_, 0.8895, 1.97, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3343, p4y74G_, 0.8895, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3344, d4qwiU_, 0.8895, 1.97, 0.240, 241, 229, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3345, d4qwiG_, 0.8895, 1.97, 0.240, 241, 229, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3346, d4cr2G_, 0.8895, 2.14, 0.332, 245, 229, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3347, d5l5iU_, 0.8894, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3348, d5dkjU_, 0.8894, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3349, d5bouU_, 0.8894, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3350, d5bouG_, 0.8894, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3351, p4y8nU_, 0.8894, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3352, p4y8nG_, 0.8894, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3353, p4y78A_, 0.8894, 1.60, 0.336, 228, 220, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3354, d4qwfU_, 0.8894, 1.98, 0.240, 241, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3355, d3mg8F_, 0.8894, 2.09, 0.335, 237, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3356, p5m32T_, 0.8893, 2.34, 0.343, 240, 230, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3357, d5l5jU_, 0.8893, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3358, d5l5iG_, 0.8893, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3359, d5dkjG_, 0.8893, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3360, d4rurU_, 0.8893, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3361, d4rurG_, 0.8893, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3362, d4qwfG_, 0.8893, 1.98, 0.240, 241, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3363, p4cr4D_, 0.8893, 2.19, 0.341, 242, 232, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3364, d5l68U_, 0.8892, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3365, d5l68G_, 0.8892, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3366, d5l5jG_, 0.8892, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3367, p4ya5U_, 0.8892, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3368, p4ya5G_, 0.8892, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3369, d4qwkU_, 0.8892, 1.98, 0.240, 241, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3370, d4qw0U_, 0.8892, 1.99, 0.240, 241, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3371, p5a0qS_, 0.8891, 0.99, 0.609, 215, 215, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
3372, p5a0qE_, 0.8891, 0.99, 0.609, 215, 215, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
3373, d4qwkG_, 0.8891, 1.98, 0.240, 241, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3374, d4qw0G_, 0.8891, 1.99, 0.240, 241, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3375, d3mg6F_, 0.8891, 2.10, 0.335, 237, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3376, d5l60U_, 0.8890, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3377, d5l60G_, 0.8890, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3378, d5l5yU_, 0.8890, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3379, d5d0xU_, 0.8890, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3380, p4y8iU_, 0.8890, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3381, p4y8iG_, 0.8890, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3382, p4y6zU_, 0.8890, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3383, d4qxjU_, 0.8890, 1.98, 0.240, 241, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3384, d4qvvU_, 0.8890, 1.98, 0.240, 241, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3385, d4qvvG_, 0.8890, 1.98, 0.240, 241, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3386, d5l5yG_, 0.8889, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3387, d5d0xG_, 0.8889, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3388, p4y78U_, 0.8889, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3389, p4y78G_, 0.8889, 1.98, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3390, p4y6zG_, 0.8889, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3391, d4qxjG_, 0.8889, 1.98, 0.240, 241, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3392, d4intE_, 0.8889, 1.48, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3393, d4g4sF_, 0.8889, 1.49, 0.344, 234, 221, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
3394, p5vfsBA_, 0.8888, 1.95, 0.333, 240, 228, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3395, p4ya3U_, 0.8888, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3396, d4qw4U_, 0.8888, 1.98, 0.240, 241, 229, YCP IN COMPLEX WITH CARFILZOMIB
3397, d4qw4G_, 0.8888, 1.98, 0.240, 241, 229, YCP IN COMPLEX WITH CARFILZOMIB
3398, p5vfsFA_, 0.8887, 2.47, 0.332, 240, 232, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3399, d5laiU_, 0.8887, 2.00, 0.240, 241, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3400, d5laiG_, 0.8887, 2.00, 0.240, 241, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3401, p4ya3G_, 0.8887, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3402, d4intS_, 0.8887, 1.48, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3403, d3un8S_, 0.8887, 1.49, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3404, d5l69U_, 0.8886, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3405, d5l69G_, 0.8886, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3406, d5cz4U_, 0.8886, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3407, d4r02G_, 0.8886, 2.01, 0.240, 241, 229, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3408, d3un8E_, 0.8886, 1.49, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
3409, d5cz4G_, 0.8885, 2.00, 0.240, 241, 229, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3410, d4qvmU_, 0.8885, 1.99, 0.240, 241, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3411, d4qvmG_, 0.8885, 1.99, 0.240, 241, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3412, p4y81U_, 0.8884, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3413, p5t0gM_, 0.8883, 2.31, 0.346, 240, 231, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3414, p5mpbD_, 0.8883, 1.95, 0.351, 240, 228, 
3415, p4y81G_, 0.8883, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3416, d4qz1U_, 0.8883, 1.99, 0.240, 241, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3417, d4qz1G_, 0.8883, 1.99, 0.240, 241, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3418, d4hnpE_, 0.8883, 1.49, 0.344, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3419, p6avoN_, 0.8882, 1.82, 0.356, 232, 225, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3420, p5fghU_, 0.8882, 2.00, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3421, p5fghG_, 0.8882, 2.00, 0.240, 241, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3422, p4ya0U_, 0.8882, 2.00, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3423, p4ya0G_, 0.8882, 2.00, 0.240, 241, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3424, p4r67t_, 0.8882, 1.83, 0.356, 232, 225, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3425, p4r67f_, 0.8882, 1.83, 0.356, 232, 225, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3426, p4r67D_, 0.8882, 1.83, 0.356, 232, 225, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3427, d4qwsU_, 0.8882, 1.99, 0.240, 241, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3428, d4hrdE_, 0.8882, 1.49, 0.344, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3429, d3sdkE_, 0.8882, 1.49, 0.344, 233, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3430, p4r67R_, 0.8881, 1.83, 0.356, 232, 225, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3431, d4qwsG_, 0.8881, 1.99, 0.240, 241, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3432, d4jsqS_, 0.8881, 1.49, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3433, d4jsqE_, 0.8881, 1.49, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3434, p5vfrm_, 0.8880, 2.37, 0.333, 240, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3435, p4y8oU_, 0.8880, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3436, p4y8oG_, 0.8880, 1.99, 0.240, 241, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3437, d4inrS_, 0.8880, 1.49, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3438, d4inrE_, 0.8880, 1.49, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3439, p3jcoPA_, 0.8880, 2.20, 0.326, 244, 230, 
3440, p5dsvJ_, 0.8879, 2.16, 0.355, 239, 228, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
3441, d4eu2A_, 0.8879, 1.96, 0.241, 241, 228, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3442, d3sdkS_, 0.8879, 1.49, 0.344, 233, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3443, p3jcoP_, 0.8879, 2.20, 0.326, 244, 230, 
3444, d3dy3S_, 0.8879, 1.49, 0.344, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3445, d3dy3E_, 0.8879, 1.49, 0.344, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3446, p6epcE_, 0.8878, 1.78, 0.608, 233, 227, GROUND STATE 26S PROTEASOME (GS2)
3447, p6avoI_, 0.8878, 1.82, 0.356, 232, 225, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3448, p5mpbU_, 0.8878, 2.18, 0.326, 243, 230, 
3449, d3sdkT_, 0.8878, 2.07, 0.336, 236, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3450, d3d29Q2, 0.8878, 1.79, 0.348, 234, 224, PROTEASOME INHIBITION BY FELLUTAMIDE B
3451, d3d29C2, 0.8878, 1.79, 0.348, 234, 224, PROTEASOME INHIBITION BY FELLUTAMIDE B
3452, d3bdmS_, 0.8878, 1.50, 0.344, 233, 221, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3453, d3bdmE_, 0.8878, 1.50, 0.344, 233, 221, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3454, d4ltcS_, 0.8877, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3455, d4ltcE_, 0.8877, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3456, d4hrdS_, 0.8877, 1.49, 0.344, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3457, d4hnpS_, 0.8877, 1.50, 0.344, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3458, d4eu2F_, 0.8877, 1.51, 0.344, 232, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3459, d3nzjS_, 0.8877, 1.50, 0.344, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3460, d3nzjE_, 0.8877, 1.50, 0.344, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3461, d3mg6S_, 0.8877, 1.49, 0.344, 233, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3462, d1z7qF1, 0.8877, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3463, d1rypF_, 0.8877, 1.49, 0.344, 233, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3464, d1g65E_, 0.8877, 1.50, 0.344, 233, 221, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3465, d4qw3U_, 0.8876, 2.00, 0.240, 241, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3466, d4qw3G_, 0.8876, 2.01, 0.240, 241, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3467, d3sdiE_, 0.8876, 1.50, 0.344, 230, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3468, d3mg0S_, 0.8876, 1.50, 0.344, 233, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3469, d1z7qT1, 0.8876, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3470, p5vfuLA_, 0.8875, 2.45, 0.332, 240, 232, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3471, p5vfuIA_, 0.8875, 2.11, 0.342, 239, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3472, p5vftm_, 0.8875, 2.45, 0.332, 240, 232, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3473, p5vftj_, 0.8875, 2.11, 0.342, 239, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3474, p4zzgT_, 0.8875, 1.50, 0.344, 232, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3475, d4inuE_, 0.8875, 1.50, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3476, d3d29S_, 0.8875, 1.50, 0.344, 233, 221, PROTEASOME INHIBITION BY FELLUTAMIDE B
3477, d5dkiU_, 0.8874, 2.00, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3478, d5dkiG_, 0.8874, 2.00, 0.240, 241, 229, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3479, d4inuS_, 0.8874, 1.50, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
3480, d4fzgS_, 0.8874, 1.50, 0.344, 233, 221, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3481, d4fzgE_, 0.8874, 1.50, 0.344, 233, 221, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3482, d4fzcE_, 0.8874, 1.50, 0.344, 233, 221, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3483, d3d29E_, 0.8874, 1.50, 0.344, 233, 221, PROTEASOME INHIBITION BY FELLUTAMIDE B
3484, d5lajS_, 0.8873, 1.51, 0.344, 231, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3485, d5lajE_, 0.8873, 1.51, 0.344, 231, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3486, d4jt0S_, 0.8873, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3487, d4jt0E_, 0.8873, 1.50, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3488, d4fzcS_, 0.8873, 1.51, 0.344, 233, 221, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
3489, p3un4S_, 0.8873, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3490, p3un4E_, 0.8873, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3491, d3nzwS_, 0.8873, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3492, d3nzwE_, 0.8873, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
3493, d3mg8S_, 0.8873, 1.50, 0.344, 233, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3494, d3mg8E_, 0.8873, 1.51, 0.344, 233, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3495, d3gpjS_, 0.8873, 1.50, 0.344, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3496, d3gpjE_, 0.8873, 1.50, 0.344, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
3497, d2fakE_, 0.8873, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3498, d1z7qO1, 0.8873, 2.03, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3499, d1z7qA1, 0.8873, 2.03, 0.239, 243, 230, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3500, p5vfoj_, 0.8872, 2.10, 0.342, 239, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3501, p5mp9A_, 0.8872, 2.00, 0.240, 241, 229, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3502, d4r18S_, 0.8872, 1.51, 0.344, 231, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3503, d4r18E_, 0.8872, 1.51, 0.344, 231, 221, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3504, d4q1sE_, 0.8872, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3505, d3shjE_, 0.8872, 1.51, 0.344, 233, 221, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3506, d3oevE_, 0.8872, 1.51, 0.344, 233, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3507, d3nzxS_, 0.8872, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3508, d3nzxE_, 0.8872, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
3509, d3mg0E_, 0.8872, 1.51, 0.344, 233, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3510, d3gpwE_, 0.8872, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3511, d2fakS_, 0.8872, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3512, p5nifT_, 0.8871, 1.51, 0.344, 232, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3513, p5ln3B_, 0.8871, 1.82, 0.311, 234, 225, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
3514, p4gk7E_, 0.8871, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3515, p4cr4G_, 0.8871, 2.35, 0.325, 245, 231, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3516, d3tddE_, 0.8871, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3517, d3shjS_, 0.8871, 1.51, 0.344, 233, 221, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
3518, d3mg6E_, 0.8871, 1.51, 0.344, 233, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3519, d3gpwS_, 0.8871, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
3520, d3dy4E_, 0.8871, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3521, d2gplS_, 0.8871, 1.51, 0.344, 233, 221, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3522, d2gplE_, 0.8871, 1.51, 0.344, 233, 221, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3523, p5mp9F_, 0.8870, 1.51, 0.348, 233, 221, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3524, d5lttS_, 0.8870, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3525, d5lttE_, 0.8870, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3526, d5fg7S_, 0.8870, 1.51, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3527, d5fg7E_, 0.8870, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3528, d4qzzS_, 0.8870, 1.52, 0.344, 231, 221, YCP IN COMPLEX WITH OMURALIDE
3529, d4qzzE_, 0.8870, 1.52, 0.344, 231, 221, YCP IN COMPLEX WITH OMURALIDE
3530, d4j70S_, 0.8870, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3531, d4j70E_, 0.8870, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
3532, p4gk7S_, 0.8870, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3533, d3wxrF_, 0.8870, 1.50, 0.344, 232, 221, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3534, d3tddS_, 0.8870, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
3535, d3mg7E_, 0.8870, 1.51, 0.344, 233, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3536, d3hyeS_, 0.8870, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3537, d3hyeE_, 0.8870, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
3538, d3gptS_, 0.8870, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3539, d3gptE_, 0.8870, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
3540, d3dy4S_, 0.8870, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
3541, d1g0uE_, 0.8870, 1.50, 0.344, 230, 221, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3542, p5mp9a_, 0.8869, 2.01, 0.240, 241, 229, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3543, d5l6cS_, 0.8869, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3544, d5l6cE_, 0.8869, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3545, d5l5uS_, 0.8869, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3546, d5l5uE_, 0.8869, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3547, d5l5pS_, 0.8869, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3548, d5l5pE_, 0.8869, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3549, d5l5bS_, 0.8869, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3550, d5l5bE_, 0.8869, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3551, d5fgaS_, 0.8869, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3552, d5fgaE_, 0.8869, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3553, d5fg9S_, 0.8869, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3554, d5fg9E_, 0.8869, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3555, d5dkjS_, 0.8869, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3556, d5dkjE_, 0.8869, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3557, d5czaS_, 0.8869, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3558, d5czaE_, 0.8869, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3559, d5cz7S_, 0.8869, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3560, d5cz7E_, 0.8869, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3561, d5cgfS_, 0.8869, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3562, d5cgfE_, 0.8869, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3563, d4ya1S_, 0.8869, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3564, d4ya1E_, 0.8869, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3565, d4qvyS_, 0.8869, 1.52, 0.344, 231, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3566, d4qvyE_, 0.8869, 1.52, 0.344, 231, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3567, d4qv8S_, 0.8869, 1.52, 0.344, 231, 221, YCP BETA5-C52F MUTANT
3568, d4qv8E_, 0.8869, 1.52, 0.344, 231, 221, YCP BETA5-C52F MUTANT
3569, d4qv7S_, 0.8869, 1.52, 0.344, 231, 221, YCP BETA5-A50V MUTANT
3570, d4qv7E_, 0.8869, 1.52, 0.344, 231, 221, YCP BETA5-A50V MUTANT
3571, d4quyS_, 0.8869, 1.52, 0.344, 231, 221, YCP BETA5-A49S-MUTANT
3572, d4quyE_, 0.8869, 1.52, 0.344, 231, 221, YCP BETA5-A49S-MUTANT
3573, d4lqiS_, 0.8869, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3574, d4lqiE_, 0.8869, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
3575, d4jsuS_, 0.8869, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3576, d4jsuE_, 0.8869, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
3577, d3mg4S_, 0.8869, 1.52, 0.344, 233, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3578, d3e47E_, 0.8869, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3579, d2zcyS_, 0.8869, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3580, d2f16S_, 0.8869, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3581, d2f16E_, 0.8869, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
3582, d1rypT_, 0.8869, 1.50, 0.344, 233, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3583, p1fntT_, 0.8869, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3584, p1fntF_, 0.8869, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3585, p5mpaf_, 0.8868, 1.51, 0.344, 231, 221, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3586, p5m32F_, 0.8868, 1.90, 0.350, 232, 226, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3587, d5l67S_, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3588, d5l67E_, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3589, d5l62S_, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3590, d5l62E_, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3591, d5l61S_, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3592, d5l61E_, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3593, d5l5vS_, 0.8868, 1.52, 0.344, 231, 221,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3594, d5l5vE_, 0.8868, 1.52, 0.344, 231, 221,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3595, d5l5qS_, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3596, d5l5qE_, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3597, d5l5hS_, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3598, d5l5hE_, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3599, d5l5aS_, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3600, d5l5aE_, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3601, d5bxlS_, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3602, d5bxlE_, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3603, d4z1lS_, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3604, d4z1lE_, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3605, d4y9yS_, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3606, d4y9yE_, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3607, d4y8rS_, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3608, d4y8rE_, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3609, d4y8mS_, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3610, d4y8mE_, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3611, p4y69S_, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3612, p4y69E_, 0.8868, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3613, d4r00S_, 0.8868, 1.52, 0.344, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3614, d4r00E_, 0.8868, 1.52, 0.344, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3615, d4qvlS_, 0.8868, 1.52, 0.344, 231, 221, YCP IN COMPLEX WITH BORTEZOMIB
3616, d4qvlE_, 0.8868, 1.52, 0.344, 231, 221, YCP IN COMPLEX WITH BORTEZOMIB
3617, d4qv9S_, 0.8868, 1.52, 0.344, 231, 221, YCP BETA5-C63F MUTANT
3618, d4qv9E_, 0.8868, 1.52, 0.344, 231, 221, YCP BETA5-C63F MUTANT
3619, d4qv3S_, 0.8868, 1.52, 0.344, 231, 221, YCP BETA5-M45V MUTANT
3620, d4qv3E_, 0.8868, 1.52, 0.344, 231, 221, YCP BETA5-M45V MUTANT
3621, d4quxS_, 0.8868, 1.52, 0.344, 231, 221, YCP BETA5-A49T-MUTANT
3622, d4quxE_, 0.8868, 1.52, 0.344, 231, 221, YCP BETA5-A49T-MUTANT
3623, d3oeuE_, 0.8868, 1.52, 0.344, 233, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3624, d3e47S_, 0.8868, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
3625, d2zcyE_, 0.8868, 1.51, 0.344, 233, 221, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
3626, d1g65S_, 0.8868, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3627, p5wvkU_, 0.8867, 2.22, 0.336, 244, 229, 
3628, d5l6aS_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3629, d5l6aE_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3630, d5l64S_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3631, d5l64E_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3632, d5l63S_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3633, d5l63E_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3634, d5l5zS_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3635, d5l5zE_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3636, d5l5tS_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3637, d5l5tE_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3638, d5l5sS_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3639, d5l5sE_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3640, d5l5rS_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3641, d5l5rE_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
3642, d5l5oS_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3643, d5l5oE_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3644, d5l5fS_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3645, d5l5fE_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3646, d5fgfS_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3647, d5fgfE_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3648, d5d0wS_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3649, d5d0wE_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT
3650, d5cz6S_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3651, d5cz6E_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3652, p5cggS_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3653, p5cggE_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3654, d5bouS_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3655, d5bouE_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3656, d4ya4S_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3657, d4ya4E_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT
3658, p4y6vS_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3659, p4y6vE_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3660, p4y6aS_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3661, p4y6aE_, 0.8867, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3662, p4x6zT_, 0.8867, 1.51, 0.344, 232, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3663, d4qv1S_, 0.8867, 1.52, 0.344, 231, 221, YCP BETA5-M45A MUTANT
3664, d4qv1E_, 0.8867, 1.52, 0.344, 231, 221, YCP BETA5-M45A MUTANT
3665, d4qv0S_, 0.8867, 1.52, 0.344, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3666, d4qv0E_, 0.8867, 1.52, 0.344, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3667, d3mg4E_, 0.8867, 1.52, 0.344, 233, 221, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
3668, p6gopS_, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3669, p6gopE_, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
3670, d5l6bS_, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3671, d5l6bE_, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3672, d5l66S_, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3673, d5l66E_, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3674, d5l65S_, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3675, d5l65E_, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3676, d5l60S_, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3677, d5l60E_, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3678, d5l5xS_, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3679, d5l5xE_, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3680, d5l5wS_, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3681, d5l5wE_, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3682, d5l5jE_, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3683, d5fgeS_, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3684, d5d0xS_, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3685, d5d0xE_, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3686, d5d0tS_, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3687, d5d0tE_, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3688, d5cz9S_, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3689, d5cz9E_, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3690, d5bxnS_, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3691, d5bxnE_, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
3692, p4ya5S_, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3693, p4ya5E_, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3694, p4y8uS_, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3695, p4y8uE_, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3696, p4y8nS_, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3697, p4y8nE_, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3698, p4x6zF_, 0.8866, 1.51, 0.344, 232, 221, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
3699, d4rurS_, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3700, d4rurE_, 0.8866, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3701, d4qvpS_, 0.8866, 1.52, 0.344, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3702, d4qvpE_, 0.8866, 1.52, 0.344, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3703, d4qv4S_, 0.8866, 1.52, 0.344, 231, 221, YCP BETA5-M45T MUTANT
3704, d4qv4E_, 0.8866, 1.52, 0.344, 231, 221, YCP BETA5-M45T MUTANT
3705, d4hrcS_, 0.8866, 1.51, 0.344, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3706, d4eu2T_, 0.8866, 1.52, 0.344, 232, 221, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3707, d3mg7S_, 0.8866, 1.51, 0.344, 233, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3708, d2fnyS_, 0.8866, 1.52, 0.344, 233, 221,  
3709, d2fnyE_, 0.8866, 1.51, 0.344, 233, 221,  
3710, d5m2bS_, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3711, d5m2bE_, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3712, d5l69S_, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3713, d5l69E_, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3714, d5l5yS_, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3715, d5l5yE_, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3716, d5l5jS_, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3717, d5l5iS_, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3718, d5l5iE_, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3719, d5l5eS_, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3720, d5l5eE_, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3721, d5jhsS_, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3722, d5jhsE_, 0.8865, 1.52, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3723, d5fggS_, 0.8865, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3724, d5fggE_, 0.8865, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3725, d5fgeE_, 0.8865, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3726, d5d0zS_, 0.8865, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3727, d5d0zE_, 0.8865, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3728, d5d0sS_, 0.8865, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3729, d5d0sE_, 0.8865, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3730, p5cghS_, 0.8865, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3731, p5cghE_, 0.8865, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3732, p4zzgF_, 0.8865, 1.52, 0.344, 232, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3733, p4y8kS_, 0.8865, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3734, p4y8kE_, 0.8865, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3735, d4qwgU_, 0.8865, 2.01, 0.240, 241, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3736, d4qw0S_, 0.8865, 1.53, 0.344, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3737, d4qw0E_, 0.8865, 1.53, 0.344, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3738, d4qvwS_, 0.8865, 1.52, 0.344, 231, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3739, d4qvwE_, 0.8865, 1.52, 0.344, 231, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3740, d4qvnS_, 0.8865, 1.53, 0.344, 231, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3741, d4qvnE_, 0.8865, 1.53, 0.344, 231, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3742, d4qv5S_, 0.8865, 1.53, 0.344, 231, 221, YCP BETA5-M45I MUTANT
3743, d4qv5E_, 0.8865, 1.53, 0.344, 231, 221, YCP BETA5-M45I MUTANT
3744, d4no8S_, 0.8865, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3745, d4no8E_, 0.8865, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3746, d3sdkF_, 0.8865, 2.08, 0.336, 236, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3747, d3okjE_, 0.8865, 1.52, 0.344, 233, 221, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3748, d5l68S_, 0.8864, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3749, d5l68E_, 0.8864, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3750, d5l5dS_, 0.8864, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3751, d5l5dE_, 0.8864, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3752, d5fhsS_, 0.8864, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3753, d5fhsE_, 0.8864, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3754, d5fgiS_, 0.8864, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3755, d5fgiE_, 0.8864, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3756, p5fghS_, 0.8864, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3757, p5fghE_, 0.8864, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3758, d5fgdS_, 0.8864, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3759, d5fgdE_, 0.8864, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3760, d4qz6S_, 0.8864, 1.53, 0.344, 231, 221, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3761, d4qz6E_, 0.8864, 1.53, 0.344, 231, 221, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3762, d4qz3S_, 0.8864, 1.53, 0.344, 231, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3763, d4qz3E_, 0.8864, 1.53, 0.344, 231, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3764, d4qwuS_, 0.8864, 1.53, 0.344, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3765, d4qwuE_, 0.8864, 1.53, 0.344, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3766, d4qwlS_, 0.8864, 1.53, 0.344, 231, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3767, d4qwlE_, 0.8864, 1.53, 0.344, 231, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3768, d4qwgG_, 0.8864, 2.01, 0.240, 241, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3769, d4qw1S_, 0.8864, 1.53, 0.344, 231, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3770, d4qw1E_, 0.8864, 1.53, 0.344, 231, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3771, d4qvmS_, 0.8864, 1.53, 0.344, 231, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3772, d4qvmE_, 0.8864, 1.53, 0.344, 231, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3773, d3wxrT_, 0.8864, 1.50, 0.344, 232, 221, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3774, d3okjS_, 0.8864, 1.52, 0.344, 233, 221, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
3775, d3oevS_, 0.8864, 1.52, 0.344, 233, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3776, p5nifF_, 0.8863, 1.52, 0.344, 232, 221, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3777, d5l55S_, 0.8863, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3778, d5l55E_, 0.8863, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3779, d5l52S_, 0.8863, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3780, d5l52E_, 0.8863, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3781, d5jhrS_, 0.8863, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3782, d5jhrE_, 0.8863, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3783, d5dkiS_, 0.8863, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3784, d5dkiE_, 0.8863, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3785, d5d0vS_, 0.8863, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3786, d5d0vE_, 0.8863, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3787, d5cz8S_, 0.8863, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3788, d5cz8E_, 0.8863, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3789, p4y8pS_, 0.8863, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3790, p4y8pE_, 0.8863, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3791, p4y8lS_, 0.8863, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3792, p4y8lE_, 0.8863, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3793, d4r17S_, 0.8863, 1.53, 0.344, 231, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3794, d4r17E_, 0.8863, 1.53, 0.344, 231, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3795, d4qz7S_, 0.8863, 1.53, 0.344, 231, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3796, d4qz7E_, 0.8863, 1.53, 0.344, 231, 221, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3797, d4qz5S_, 0.8863, 1.53, 0.344, 231, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3798, d4qz5E_, 0.8863, 1.53, 0.344, 231, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3799, d4qwrS_, 0.8863, 1.53, 0.344, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3800, d4qwrE_, 0.8863, 1.53, 0.344, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3801, d4qw7S_, 0.8863, 1.53, 0.344, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3802, d4qw7E_, 0.8863, 1.53, 0.344, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3803, d4qw6S_, 0.8863, 1.53, 0.344, 231, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3804, d4qw6E_, 0.8863, 1.53, 0.344, 231, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3805, d4qw5S_, 0.8863, 1.53, 0.344, 231, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3806, d4qw5E_, 0.8863, 1.53, 0.344, 231, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3807, d4qvvS_, 0.8863, 1.53, 0.344, 231, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3808, d4qvvE_, 0.8863, 1.53, 0.344, 231, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3809, d4qvqS_, 0.8863, 1.53, 0.344, 231, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3810, d4qvqE_, 0.8863, 1.53, 0.344, 231, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3811, d4nnnS_, 0.8863, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH MG132
3812, d5laiS_, 0.8862, 1.53, 0.344, 231, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3813, d5laiE_, 0.8862, 1.53, 0.344, 231, 221, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3814, d5cz5S_, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3815, d5cz5E_, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3816, d5cz4S_, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3817, d5cz4E_, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3818, d5ahjS_, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3819, d5ahjE_, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
3820, p4ya7S_, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3821, p4ya7E_, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
3822, p4ya3S_, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3823, p4ya3E_, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3824, p4y9zS_, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3825, p4y9zE_, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3826, p4y8qS_, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3827, p4y8qE_, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3828, p4y8jS_, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3829, p4y82S_, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3830, p4y82E_, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3831, p4y80E_, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3832, p4y77S_, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3833, p4y77E_, 0.8862, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3834, d4r02S_, 0.8862, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3835, d4qzwS_, 0.8862, 1.53, 0.344, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3836, d4qzwE_, 0.8862, 1.53, 0.344, 231, 221, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3837, d4qz0S_, 0.8862, 1.53, 0.344, 231, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3838, d4qz0E_, 0.8862, 1.53, 0.344, 231, 221, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3839, d4qwiS_, 0.8862, 1.53, 0.344, 231, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3840, d4qw4S_, 0.8862, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH CARFILZOMIB
3841, d4qw4E_, 0.8862, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH CARFILZOMIB
3842, d4qv6S_, 0.8862, 1.53, 0.344, 231, 221, YCP BETA5-A49V MUTANT
3843, d4qv6E_, 0.8862, 1.53, 0.344, 231, 221, YCP BETA5-A49V MUTANT
3844, d4nnnE_, 0.8862, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH MG132
3845, d3oeuS_, 0.8862, 1.52, 0.344, 233, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3846, p5cgiS_, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3847, p5cgiE_, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3848, p4ya9S_, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3849, p4ya9E_, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3850, p4y8jE_, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3851, p4y8iS_, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3852, p4y8iE_, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3853, p4y80S_, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3854, p4y7yS_, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3855, p4y7yE_, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3856, p4y7xS_, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3857, p4y7xE_, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3858, p4y7wS_, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3859, p4y7wE_, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3860, p4y75S_, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3861, p4y75E_, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3862, p4y70S_, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3863, p4y70E_, 0.8861, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3864, d4r02E_, 0.8861, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3865, d4qz4S_, 0.8861, 1.53, 0.344, 231, 221, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3866, d4qz4E_, 0.8861, 1.53, 0.344, 231, 221, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3867, d4qwjS_, 0.8861, 1.53, 0.344, 231, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3868, d4qwjE_, 0.8861, 1.53, 0.344, 231, 221, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3869, d4qwiE_, 0.8861, 1.53, 0.344, 231, 221, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3870, d4qwfS_, 0.8861, 1.53, 0.344, 231, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3871, d4qwfE_, 0.8861, 1.53, 0.344, 231, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3872, d4hrcE_, 0.8861, 1.52, 0.344, 233, 221, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3873, p4ya0S_, 0.8860, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3874, p4ya0E_, 0.8860, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3875, p4y81S_, 0.8860, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3876, p4y81E_, 0.8860, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3877, p4y74S_, 0.8860, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3878, p4y74E_, 0.8860, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3879, p4y6zS_, 0.8860, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3880, p4y6zE_, 0.8860, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3881, d4qz2S_, 0.8860, 1.53, 0.344, 231, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3882, d4qz2E_, 0.8860, 1.53, 0.344, 231, 221, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3883, d4qwxS_, 0.8860, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3884, d4qwxE_, 0.8860, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3885, d4qwkS_, 0.8860, 1.53, 0.344, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3886, d4qwkE_, 0.8860, 1.53, 0.344, 231, 221, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3887, d4qlsS_, 0.8860, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3888, d4qlsE_, 0.8860, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3889, d4q1sS_, 0.8860, 1.53, 0.344, 233, 221, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3890, p4y8sS_, 0.8859, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3891, p4y8sE_, 0.8859, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
3892, p4y8oS_, 0.8859, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3893, p4y8oE_, 0.8859, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3894, p4y78S_, 0.8859, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3895, p4y78E_, 0.8859, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3896, d4qzxS_, 0.8859, 1.53, 0.344, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3897, d4qzxE_, 0.8859, 1.53, 0.344, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3898, d4qw3S_, 0.8859, 1.53, 0.344, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3899, d4qw3E_, 0.8859, 1.53, 0.344, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3900, d3sdiS_, 0.8859, 1.52, 0.344, 230, 221, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3901, p5t0hH_, 0.8858, 1.80, 0.311, 232, 225, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3902, p4y8hS_, 0.8858, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3903, p4y8hE_, 0.8858, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3904, d4qz1S_, 0.8858, 1.53, 0.344, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3905, d4qz1E_, 0.8858, 1.53, 0.344, 231, 221, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3906, d4qxjS_, 0.8858, 1.53, 0.344, 231, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3907, d4qxjE_, 0.8858, 1.53, 0.344, 231, 221, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3908, d4qlqS_, 0.8858, 1.54, 0.344, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3909, d4qlqE_, 0.8858, 1.54, 0.344, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3910, d4no1S_, 0.8858, 1.54, 0.344, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3911, d4no1E_, 0.8858, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
3912, p6epcF_, 0.8857, 1.80, 0.316, 238, 225, GROUND STATE 26S PROTEASOME (GS2)
3913, p4y8gS_, 0.8857, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3914, p4y8gE_, 0.8857, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3915, p4y84E_, 0.8857, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3916, d4nnwS_, 0.8857, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3917, d4nnwE_, 0.8857, 1.53, 0.344, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3918, d5l54S_, 0.8856, 1.54, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3919, d5l54E_, 0.8856, 1.54, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3920, p4y84S_, 0.8856, 1.53, 0.344, 231, 221, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3921, d4qwsS_, 0.8856, 1.54, 0.344, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3922, d4qwsE_, 0.8856, 1.54, 0.344, 231, 221, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3923, d1g0uS_, 0.8856, 1.53, 0.344, 230, 221, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3924, p5l4gR_, 0.8855, 1.89, 0.356, 232, 225, 
3925, p4ya2E_, 0.8855, 1.54, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3926, p4ya2S_, 0.8854, 1.54, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
3927, p4y8tS_, 0.8854, 1.54, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3928, p4y8tE_, 0.8854, 1.54, 0.344, 231, 221, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
3929, d4qltS_, 0.8854, 1.54, 0.344, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3930, d4qltE_, 0.8854, 1.54, 0.344, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3931, p4r3oR_, 0.8853, 1.81, 0.357, 231, 224, HUMAN CONSTITUTIVE 20S PROTEASOME
3932, p4r3oD_, 0.8853, 1.81, 0.357, 231, 224, HUMAN CONSTITUTIVE 20S PROTEASOME
3933, d4qwgS_, 0.8853, 1.54, 0.344, 231, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3934, d4qwgE_, 0.8853, 1.54, 0.344, 231, 221, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3935, d4no9S_, 0.8853, 1.54, 0.344, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3936, d4no9E_, 0.8853, 1.54, 0.344, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
3937, p5gjrV_, 0.8852, 1.82, 0.353, 231, 224, 
3938, p5gjrJA_, 0.8852, 1.82, 0.357, 231, 224, 
3939, p5a5bG_, 0.8852, 2.33, 0.326, 245, 230, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
3940, d4qluS_, 0.8852, 1.55, 0.344, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3941, d4qluE_, 0.8852, 1.55, 0.344, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3942, d4no6S_, 0.8852, 1.54, 0.344, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3943, d4no6E_, 0.8852, 1.54, 0.344, 231, 221, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3944, p4cr3G_, 0.8852, 2.33, 0.326, 245, 230, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3945, p3jcpOA_, 0.8852, 1.52, 0.344, 233, 221, 
3946, p3jcpO_, 0.8852, 1.52, 0.344, 233, 221, 
3947, p5vfqCA_, 0.8851, 2.12, 0.342, 239, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3948, p5gjqE_, 0.8851, 1.83, 0.353, 231, 224, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3949, d4qlvS_, 0.8851, 1.55, 0.344, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3950, d4qlvE_, 0.8851, 1.55, 0.344, 231, 221, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3951, d4cr2A_, 0.8850, 2.05, 0.239, 243, 230, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3952, p4qbyS_, 0.8848, 1.54, 0.344, 231, 221, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3953, p4qbyE_, 0.8848, 1.54, 0.344, 231, 221, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
3954, d1jd2E_, 0.8847, 1.54, 0.344, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3955, d5lexG_, 0.8842, 1.83, 0.267, 241, 225, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3956, p6epfF_, 0.8841, 1.92, 0.314, 238, 226, GROUND STATE 26S PROTEASOME (GS1)
3957, p5vfpBA_, 0.8841, 2.13, 0.342, 239, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3958, p5mp9f_, 0.8841, 1.54, 0.344, 231, 221, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3959, p5t0gJ_, 0.8840, 2.23, 0.341, 239, 232, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3960, p5mpcU_, 0.8839, 2.26, 0.335, 243, 230, 
3961, p6epfG_, 0.8838, 2.26, 0.349, 245, 229, GROUND STATE 26S PROTEASOME (GS1)
3962, p5vfrj_, 0.8838, 2.14, 0.342, 239, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3963, p5vfqD_, 0.8838, 2.17, 0.341, 239, 232, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3964, d5lf3G_, 0.8838, 1.84, 0.267, 241, 225, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3965, p4v7oT_, 0.8838, 1.57, 0.344, 234, 221, 
3966, d3l5qW_, 0.8838, 1.57, 0.344, 234, 221,  
3967, p5m32G_, 0.8837, 2.01, 0.260, 233, 227, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3968, p4v7oNA_, 0.8837, 1.58, 0.344, 234, 221, 
3969, p4v7oF_, 0.8837, 1.58, 0.344, 234, 221, 
3970, p4v7oBB_, 0.8837, 1.58, 0.344, 234, 221, 
3971, d3l5qK_, 0.8837, 1.58, 0.344, 234, 221,  
3972, d1vsyT_, 0.8837, 1.58, 0.344, 234, 221,  
3973, d1vsyF_, 0.8837, 1.58, 0.344, 234, 221,  
3974, p6epeC_, 0.8836, 2.37, 0.325, 249, 234, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
3975, d3wxrG1, 0.8835, 2.11, 0.336, 236, 226, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3976, d3wxrU1, 0.8834, 2.20, 0.341, 236, 226, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3977, d1ya7F_, 0.8833, 1.61, 0.407, 227, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3978, d1jd2Z_, 0.8833, 1.56, 0.344, 233, 221, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3979, p5vfoJ_, 0.8831, 2.19, 0.336, 239, 232, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3980, d5le5G_, 0.8831, 1.85, 0.267, 241, 225, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3981, p5l4gD_, 0.8830, 1.87, 0.357, 231, 224, 
3982, p5wvkT_, 0.8829, 1.54, 0.348, 233, 221, 
3983, p5vfuHA_, 0.8829, 2.01, 0.333, 240, 228, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3984, p5vfti_, 0.8829, 2.01, 0.333, 240, 228, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3985, d5lf7G_, 0.8829, 1.85, 0.267, 241, 225, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3986, p5t0iK_, 0.8828, 1.96, 0.612, 228, 227, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3987, d5lf4G_, 0.8827, 1.85, 0.267, 241, 225, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3988, p5mpbG_, 0.8826, 2.31, 0.335, 243, 230, 
3989, p5a5bB_, 0.8826, 2.02, 0.326, 250, 227, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
3990, p4cr3B_, 0.8826, 2.02, 0.326, 250, 227, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3991, p3j9iU_, 0.8826, 1.51, 0.400, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3992, p3j9iT_, 0.8826, 1.51, 0.400, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3993, p3j9iS_, 0.8826, 1.51, 0.400, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3994, p3j9iR_, 0.8826, 1.51, 0.400, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3995, p3j9iQ_, 0.8826, 1.51, 0.400, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3996, p3j9iP_, 0.8826, 1.51, 0.400, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3997, p3j9iO_, 0.8826, 1.51, 0.400, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3998, p3j9iG_, 0.8826, 1.51, 0.400, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3999, p3j9iF_, 0.8826, 1.51, 0.400, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4000, p3j9iE_, 0.8826, 1.51, 0.400, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4001, p3j9iD_, 0.8826, 1.51, 0.400, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4002, p3j9iC_, 0.8826, 1.51, 0.400, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4003, p3j9iB_, 0.8826, 1.51, 0.400, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4004, p3j9iA_, 0.8826, 1.51, 0.400, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4005, d5lf1G_, 0.8825, 1.86, 0.267, 241, 225, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
4006, d1ya7C_, 0.8824, 1.62, 0.407, 227, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4007, d1ya7G_, 0.8822, 1.62, 0.407, 227, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4008, p5t0hM_, 0.8818, 2.42, 0.346, 240, 231, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4009, d1ya7A_, 0.8817, 1.62, 0.407, 227, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4010, p5mpcG_, 0.8814, 2.33, 0.335, 243, 230, 
4011, p5mpaa_, 0.8812, 2.07, 0.240, 241, 229, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4012, d2ku1F1, 0.8812, 1.60, 0.407, 233, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4013, p1fntO_, 0.8811, 2.02, 0.224, 238, 228, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4014, p5vfrJ_, 0.8810, 2.20, 0.336, 239, 232, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4015, p5mpcR_, 0.8810, 2.19, 0.351, 240, 231, 
4016, p1fntA_, 0.8810, 2.02, 0.224, 238, 228, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4017, d5le5Q_, 0.8806, 1.95, 0.356, 233, 225, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
4018, p5mpbF_, 0.8805, 1.73, 0.342, 231, 222, 
4019, d3jseG_, 0.8805, 1.63, 0.407, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4020, d2ku2F1, 0.8805, 1.62, 0.403, 233, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4021, d1ya7B_, 0.8805, 1.63, 0.407, 227, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4022, d3jseF_, 0.8804, 1.63, 0.407, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4023, d3jseE_, 0.8804, 1.63, 0.407, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4024, d2ku2G1, 0.8804, 1.61, 0.403, 233, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4025, d2ku1E1, 0.8804, 1.61, 0.403, 233, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4026, d3jseB_, 0.8803, 1.63, 0.407, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4027, d3jseA_, 0.8803, 1.63, 0.407, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4028, d1ya7D_, 0.8803, 1.65, 0.407, 227, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4029, p5gjqk_, 0.8802, 1.88, 0.357, 231, 224, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
4030, d3jseC_, 0.8802, 1.63, 0.407, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4031, p5m32B_, 0.8801, 1.94, 0.339, 234, 224, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4032, d3jseD_, 0.8801, 1.64, 0.407, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4033, p6epeA_, 0.8799, 2.11, 0.264, 246, 231, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4034, p5mpaF_, 0.8799, 1.62, 0.348, 233, 221, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4035, p5wviX_, 0.8798, 2.31, 0.335, 245, 230, 
4036, d5lexQ_, 0.8798, 1.96, 0.356, 233, 225, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
4037, p4cr4A_, 0.8797, 2.14, 0.235, 243, 230, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4038, d2ku1C1, 0.8797, 1.63, 0.407, 233, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4039, d2ku2D1, 0.8796, 1.62, 0.403, 233, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4040, d2ku2E1, 0.8793, 1.64, 0.403, 233, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4041, p5ln3G_, 0.8790, 2.25, 0.343, 242, 230, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4042, d3jrmC_, 0.8790, 1.64, 0.407, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4043, d3jrmA_, 0.8790, 1.64, 0.407, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4044, d3jrmG_, 0.8789, 1.64, 0.407, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4045, d3jrmF_, 0.8788, 1.65, 0.407, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4046, d3jrmE_, 0.8788, 1.65, 0.407, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4047, d3jrmD_, 0.8788, 1.65, 0.407, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4048, d3jrmB_, 0.8788, 1.65, 0.407, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4049, p5lezQ_, 0.8786, 1.99, 0.356, 234, 225, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4050, d2ku1D1, 0.8783, 1.65, 0.407, 233, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4051, d2ku1G1, 0.8781, 1.66, 0.407, 233, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4052, d1ya7E_, 0.8781, 1.70, 0.407, 227, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4053, p3jcoOA_, 0.8779, 1.63, 0.344, 233, 221, 
4054, p3jcoO_, 0.8779, 1.63, 0.344, 233, 221, 
4055, p5t0jM_, 0.8774, 2.45, 0.333, 240, 231, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4056, d1yauA_, 0.8770, 1.47, 0.408, 222, 218, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4057, p6epdE_, 0.8767, 1.91, 0.593, 233, 226, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4058, p5t0hJ_, 0.8765, 2.28, 0.336, 239, 232, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4059, p5a5bF_, 0.8763, 1.62, 0.344, 233, 221, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4060, p4cr3F_, 0.8763, 1.62, 0.344, 233, 221, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4061, d2ku2A1, 0.8763, 1.77, 0.403, 233, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4062, p3jtlC_, 0.8760, 1.73, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4063, p6epeF_, 0.8759, 2.00, 0.314, 238, 226, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4064, p3jtlD_, 0.8759, 1.73, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4065, p3jtlB_, 0.8759, 1.73, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4066, p3jtlA_, 0.8759, 1.73, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4067, d1yauF_, 0.8759, 1.48, 0.408, 222, 218, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4068, d4cr2F_, 0.8758, 1.72, 0.342, 233, 222, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4069, p3jtlG_, 0.8758, 1.73, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4070, p3jtlF_, 0.8757, 1.73, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4071, p3jtlE_, 0.8757, 1.73, 0.412, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4072, d2ku1A1, 0.8755, 1.80, 0.407, 233, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4073, d2ku1B1, 0.8754, 1.85, 0.407, 233, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4074, d1yauG_, 0.8753, 1.50, 0.408, 222, 218, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4075, p5mpbT_, 0.8752, 1.66, 0.344, 233, 221, 
4076, d1yauC_, 0.8751, 1.50, 0.408, 222, 218, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4077, p6epeE_, 0.8749, 2.06, 0.608, 233, 227, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4078, d2ku2C1, 0.8749, 1.69, 0.405, 233, 220, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4079, p6epeB_, 0.8747, 1.98, 0.304, 234, 224, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4080, p5mpbR_, 0.8747, 2.16, 0.355, 240, 228, 
4081, p6epfD_, 0.8746, 2.38, 0.323, 246, 232, GROUND STATE 26S PROTEASOME (GS1)
4082, p6epcG_, 0.8746, 2.40, 0.345, 245, 232, GROUND STATE 26S PROTEASOME (GS2)
4083, d2ku2B1, 0.8745, 1.70, 0.405, 233, 220, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
4084, p6epdB_, 0.8742, 2.09, 0.310, 234, 226, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4085, d5lexU_, 0.8740, 1.97, 0.269, 235, 223, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
4086, d1yauB_, 0.8736, 1.52, 0.408, 222, 218, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4087, d5lf7U_, 0.8735, 1.97, 0.269, 235, 223, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
4088, d5lf3U_, 0.8734, 1.97, 0.269, 235, 223, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
4089, d1yauE_, 0.8730, 1.54, 0.408, 222, 218, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4090, d5lf1U_, 0.8729, 1.97, 0.269, 235, 223, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
4091, p5lf6U_, 0.8727, 1.98, 0.269, 235, 223, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4092, d5lf4U_, 0.8726, 1.98, 0.269, 235, 223, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
4093, d1yauD_, 0.8726, 1.54, 0.408, 222, 218, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4094, p5mpbA_, 0.8724, 2.19, 0.240, 241, 229, 
4095, d1yarG_, 0.8724, 1.48, 0.410, 221, 217, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4096, d1yarC_, 0.8722, 1.48, 0.410, 221, 217, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4097, d1yarD_, 0.8719, 1.48, 0.410, 221, 217, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4098, p6epeG_, 0.8718, 2.44, 0.339, 245, 230, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4099, d1yarF_, 0.8717, 1.52, 0.410, 221, 217, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4100, p5mpcO_, 0.8715, 2.23, 0.223, 241, 229, 
4101, d1yarA_, 0.8715, 1.50, 0.410, 221, 217, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4102, d1yarB_, 0.8712, 1.50, 0.410, 221, 217, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4103, p5wviH_, 0.8703, 1.19, 0.995, 214, 213, 
4104, p4v7oP_, 0.8700, 1.24, 0.324, 231, 213, 
4105, p4v7oB_, 0.8700, 1.24, 0.324, 231, 213, 
4106, d3l5qS_, 0.8700, 1.24, 0.324, 231, 213,  
4107, d3l5qG_, 0.8700, 1.24, 0.324, 231, 213,  
4108, p5fmgS_, 0.8699, 1.45, 0.495, 217, 216, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4109, p5fmgE_, 0.8699, 1.45, 0.495, 217, 216, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4110, p5dsvC_, 0.8699, 2.10, 0.359, 234, 223, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
4111, p4v7oXA_, 0.8698, 1.24, 0.324, 231, 213, 
4112, p4v7oJA_, 0.8698, 1.24, 0.324, 231, 213, 
4113, d1vsyP_, 0.8698, 1.24, 0.324, 231, 213,  
4114, d1vsyB_, 0.8698, 1.24, 0.324, 231, 213,  
4115, p6bdfY_, 0.8696, 1.52, 0.410, 221, 217, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4116, p6bdfW_, 0.8696, 1.52, 0.410, 221, 217, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4117, p6bdfU_, 0.8696, 1.52, 0.410, 221, 217, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4118, p6bdfS_, 0.8696, 1.52, 0.410, 221, 217, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4119, p6bdfQ_, 0.8696, 1.52, 0.410, 221, 217, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4120, p6bdfO_, 0.8696, 1.52, 0.410, 221, 217, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4121, p6bdfM_, 0.8696, 1.52, 0.410, 221, 217, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4122, p6bdfK_, 0.8696, 1.52, 0.410, 221, 217, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4123, p6bdfI_, 0.8696, 1.52, 0.410, 221, 217, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4124, p6bdfG_, 0.8696, 1.52, 0.410, 221, 217, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4125, p6bdfE_, 0.8696, 1.52, 0.410, 221, 217, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4126, p6bdfC_, 0.8696, 1.52, 0.410, 221, 217, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4127, p6bdfA_, 0.8696, 1.52, 0.410, 221, 217, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4128, p6bdf0_, 0.8696, 1.52, 0.410, 221, 217, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4129, p5vy3Y_, 0.8694, 1.53, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4130, p5vy3W_, 0.8694, 1.53, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4131, p5vy3U_, 0.8694, 1.53, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4132, p5vy3S_, 0.8694, 1.53, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4133, p5vy3Q_, 0.8694, 1.53, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4134, p5vy3O_, 0.8694, 1.53, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4135, p5vy3M_, 0.8694, 1.53, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4136, p5vy3K_, 0.8694, 1.53, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4137, p5vy3I_, 0.8694, 1.53, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4138, p5vy3G_, 0.8694, 1.53, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4139, p5vy3E_, 0.8694, 1.53, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4140, p5vy3C_, 0.8694, 1.53, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4141, p5vy3A_, 0.8694, 1.53, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4142, p5vy30_, 0.8694, 1.53, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4143, d1yarE_, 0.8693, 1.53, 0.410, 221, 217, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4144, p5vy4Y_, 0.8687, 1.53, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4145, p5vy4W_, 0.8687, 1.53, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4146, p5vy4U_, 0.8687, 1.53, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4147, p5vy4S_, 0.8687, 1.53, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4148, p5vy4Q_, 0.8687, 1.53, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4149, p5vy4O_, 0.8687, 1.53, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4150, p5vy4M_, 0.8687, 1.53, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4151, p5vy4K_, 0.8687, 1.53, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4152, p5vy4I_, 0.8687, 1.53, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4153, p5vy4G_, 0.8687, 1.53, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4154, p5vy4E_, 0.8687, 1.53, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4155, p5vy4C_, 0.8687, 1.53, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4156, p5vy4AA_, 0.8687, 1.53, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4157, p5vy4A_, 0.8687, 1.53, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4158, p5vy40_, 0.8687, 1.53, 0.410, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4159, p5mpcF_, 0.8687, 1.74, 0.339, 231, 221, 
4160, p4v7oR_, 0.8685, 1.90, 0.326, 227, 221, 
4161, p4v7oLA_, 0.8685, 1.90, 0.326, 227, 221, 
4162, p4v7oD_, 0.8685, 1.90, 0.326, 227, 221, 
4163, d3l5qU_, 0.8685, 1.90, 0.326, 227, 221,  
4164, d3l5qI_, 0.8685, 1.90, 0.326, 227, 221,  
4165, d1vsyD_, 0.8685, 1.90, 0.326, 227, 221,  
4166, p4v7oZA_, 0.8684, 1.90, 0.326, 227, 221, 
4167, d1vsyR_, 0.8684, 1.90, 0.326, 227, 221,  
4168, p4cr4F_, 0.8681, 1.83, 0.342, 233, 222, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4169, p5vfqBA_, 0.8678, 1.85, 0.326, 232, 221, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4170, p5vfoi_, 0.8675, 1.86, 0.326, 232, 221, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4171, p5vfpAA_, 0.8672, 1.86, 0.326, 232, 221, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4172, p6epdF_, 0.8665, 2.10, 0.319, 238, 226, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4173, d5le5U_, 0.8664, 1.83, 0.273, 232, 220, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
4174, d1pmaO_, 0.8664, 1.58, 0.406, 221, 217, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4175, d1pmaN_, 0.8664, 1.58, 0.406, 221, 217, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4176, p5vfri_, 0.8662, 1.86, 0.326, 232, 221, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4177, d1pmaL_, 0.8662, 1.59, 0.406, 221, 217, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4178, d1pmaG_, 0.8662, 1.58, 0.406, 221, 217, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4179, d1pmaF_, 0.8662, 1.59, 0.406, 221, 217, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4180, d1pmaD_, 0.8662, 1.58, 0.406, 221, 217, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4181, d1pmaH_, 0.8660, 1.59, 0.406, 221, 217, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4182, d1pmaM_, 0.8659, 1.59, 0.406, 221, 217, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4183, d1pmaK_, 0.8659, 1.59, 0.406, 221, 217, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4184, d1pmaI_, 0.8659, 1.59, 0.406, 221, 217, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4185, d1pmaA_, 0.8657, 1.59, 0.406, 221, 217, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4186, d3c92U1, 0.8656, 1.59, 0.406, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4187, d3c92T1, 0.8656, 1.59, 0.406, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4188, d3c92S1, 0.8656, 1.59, 0.406, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4189, d3c92R1, 0.8656, 1.59, 0.406, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4190, d3c92Q1, 0.8656, 1.59, 0.406, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4191, d3c92P1, 0.8656, 1.59, 0.406, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4192, d3c92O1, 0.8656, 1.59, 0.406, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4193, d3c92G1, 0.8656, 1.59, 0.406, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4194, d3c92F1, 0.8656, 1.59, 0.406, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4195, d3c92E1, 0.8656, 1.59, 0.406, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4196, d3c92D1, 0.8656, 1.59, 0.406, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4197, d3c92C1, 0.8656, 1.59, 0.406, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4198, d3c92B1, 0.8656, 1.59, 0.406, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4199, d3c92A1, 0.8656, 1.59, 0.406, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4200, d1pmaJ_, 0.8656, 1.59, 0.406, 221, 217, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4201, d1pmaC_, 0.8656, 1.59, 0.406, 221, 217, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4202, d3c91U1, 0.8655, 1.60, 0.406, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4203, d3c91T1, 0.8655, 1.60, 0.406, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4204, d3c91S1, 0.8655, 1.60, 0.406, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4205, d3c91R1, 0.8655, 1.60, 0.406, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4206, d3c91Q1, 0.8655, 1.60, 0.406, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4207, d3c91P1, 0.8655, 1.60, 0.406, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4208, d3c91O1, 0.8655, 1.60, 0.406, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4209, d3c91G1, 0.8655, 1.60, 0.406, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4210, d3c91F1, 0.8655, 1.60, 0.406, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4211, d3c91E1, 0.8655, 1.60, 0.406, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4212, d3c91D1, 0.8655, 1.60, 0.406, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4213, d3c91C1, 0.8655, 1.60, 0.406, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4214, d3c91B1, 0.8655, 1.60, 0.406, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4215, d3c91A1, 0.8655, 1.60, 0.406, 221, 217, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4216, d1pmaE_, 0.8655, 1.60, 0.406, 221, 217, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4217, p5fmgQ_, 0.8651, 1.76, 0.406, 220, 217, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4218, p5fmgC_, 0.8651, 1.76, 0.406, 220, 217, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4219, p5mpcA_, 0.8645, 2.22, 0.220, 241, 227, 
4220, p6epcB_, 0.8638, 2.15, 0.304, 234, 224, GROUND STATE 26S PROTEASOME (GS2)
4221, p5t0iM_, 0.8620, 2.51, 0.348, 240, 230, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4222, p5wviG_, 0.8611, 1.91, 0.342, 233, 222, 
4223, p5wviZ_, 0.8592, 1.92, 0.342, 233, 222, 
4224, p3ipmF_, 0.8592, 1.91, 0.400, 227, 220, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4225, p3ipmE_, 0.8592, 1.91, 0.400, 227, 220, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4226, p3ipmD_, 0.8592, 1.91, 0.400, 227, 220, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4227, p3ipmC_, 0.8592, 1.91, 0.400, 227, 220, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4228, p3ipmA_, 0.8592, 1.91, 0.400, 227, 220, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4229, p3ipmG_, 0.8591, 1.91, 0.400, 227, 220, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4230, p3ipmB_, 0.8591, 1.91, 0.400, 227, 220, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4231, p5fmgT_, 0.8589, 1.55, 0.353, 219, 215, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4232, p5fmgF_, 0.8589, 1.55, 0.353, 219, 215, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4233, p5wvkX_, 0.8572, 1.83, 0.341, 225, 217, 
4234, p5a5bC_, 0.8563, 2.03, 0.339, 226, 218, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4235, p4cr3C_, 0.8563, 2.03, 0.339, 226, 218, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4236, p5a5bA_, 0.8549, 2.38, 0.218, 243, 229, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4237, p4cr3A_, 0.8549, 2.38, 0.218, 243, 229, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4238, p5gjrGA_, 0.8546, 1.69, 0.247, 221, 215, 
4239, p5gjqh_, 0.8540, 1.69, 0.247, 221, 215, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
4240, p5l4gO_, 0.8539, 1.68, 0.247, 221, 215, 
4241, p5gjrS_, 0.8538, 1.71, 0.247, 221, 215, 
4242, p5l4gA_, 0.8533, 1.70, 0.247, 221, 215, 
4243, p5gjqB_, 0.8530, 1.73, 0.247, 221, 215, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
4244, d4g4sD_, 0.8522, 1.61, 0.347, 220, 213, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
4245, p6epdG_, 0.8515, 2.64, 0.341, 245, 229, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4246, p5wvkQ_, 0.8507, 1.95, 0.341, 225, 217, 
4247, p6epcD_, 0.8503, 2.66, 0.312, 246, 231, GROUND STATE 26S PROTEASOME (GS2)
4248, p5wviI_, 0.8493, 2.11, 0.359, 231, 220, 
4249, p5t0jH_, 0.8475, 2.20, 0.306, 232, 222, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4250, p3unhU_, 0.8472, 1.74, 0.248, 220, 214, MOUSE 20S IMMUNOPROTEASOME
4251, p3unhG_, 0.8472, 1.74, 0.248, 220, 214, MOUSE 20S IMMUNOPROTEASOME
4252, p5ln3D_, 0.8459, 2.36, 0.330, 232, 224, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4253, p5a0qP_, 0.8459, 1.71, 0.322, 214, 211, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4254, p5a0qB_, 0.8459, 1.71, 0.322, 214, 211, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4255, p5t0iL_, 0.8440, 1.84, 0.313, 221, 214, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4256, p6avoR_, 0.8418, 1.86, 0.244, 217, 213, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
4257, p5wviAA_, 0.8417, 2.20, 0.355, 231, 220, 
4258, p5t0jK_, 0.8415, 1.64, 0.590, 212, 212, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4259, p6avoK_, 0.8408, 1.86, 0.244, 217, 213, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
4260, p5vfrG_, 0.8400, 1.75, 0.254, 220, 213, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4261, p5m32S_, 0.8395, 1.72, 0.308, 218, 211, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4262, p5vfoG_, 0.8393, 1.84, 0.248, 220, 214, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4263, p5vfqA_, 0.8389, 1.76, 0.254, 220, 213, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4264, p5mpcD_, 0.8389, 2.05, 0.341, 224, 217, 
4265, p5vfsA_, 0.8387, 1.77, 0.254, 220, 213, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4266, p5vfog_, 0.8387, 1.86, 0.248, 220, 214, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4267, p5a0qR_, 0.8386, 1.75, 0.363, 214, 212, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4268, p5a0qD_, 0.8386, 1.75, 0.363, 214, 212, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4269, p5vfpA_, 0.8383, 1.78, 0.254, 220, 213, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4270, p5vfsZ_, 0.8382, 1.79, 0.254, 220, 213, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4271, p5vfrg_, 0.8382, 1.86, 0.248, 220, 214, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4272, p5fmgO_, 0.8380, 1.88, 0.248, 219, 214, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4273, p5fmgA_, 0.8380, 1.88, 0.248, 219, 214, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4274, p5vfqZ_, 0.8375, 1.87, 0.248, 220, 214, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4275, p5vfpY_, 0.8370, 1.89, 0.248, 220, 214, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4276, p5t0cYA_, 0.8370, 1.90, 0.248, 220, 214, 
4277, p5t0cS_, 0.8370, 1.90, 0.248, 220, 214, 
4278, p5ln3C_, 0.8367, 2.10, 0.330, 225, 218, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4279, p5vfuR_, 0.8363, 1.91, 0.248, 220, 214, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4280, p5vftG_, 0.8363, 1.91, 0.248, 220, 214, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4281, p5vfuFA_, 0.8332, 1.95, 0.248, 220, 214, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4282, p5vftg_, 0.8332, 1.95, 0.248, 220, 214, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4283, p5t0gG_, 0.8325, 1.95, 0.248, 220, 214, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4284, p5fmgP_, 0.8325, 1.88, 0.314, 212, 210, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4285, p5fmgB_, 0.8325, 1.88, 0.314, 212, 210, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4286, p5m32U_, 0.8308, 1.77, 0.242, 218, 211, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4287, p5mpbO_, 0.8297, 2.01, 0.223, 225, 215, 
4288, p5t0jG_, 0.8293, 1.93, 0.248, 220, 214, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4289, p5mpaA_, 0.8291, 1.97, 0.220, 224, 214, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4290, p5fmgR_, 0.8291, 1.96, 0.311, 215, 212, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4291, p5fmgD_, 0.8291, 1.96, 0.311, 215, 212, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4292, p5lf0G_, 0.8286, 1.76, 0.248, 218, 210, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
4293, p5lezG_, 0.8285, 1.76, 0.248, 218, 210, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4294, p5leyG_, 0.8284, 1.76, 0.248, 218, 210, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4295, p5lf6G_, 0.8274, 1.78, 0.248, 218, 210, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4296, p5wviNA_, 0.8260, 2.14, 0.332, 222, 214, 
4297, p6epfA_, 0.8253, 2.12, 0.241, 222, 216, GROUND STATE 26S PROTEASOME (GS1)
4298, p5fmgU_, 0.8250, 2.08, 0.252, 219, 214, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4299, p5fmgG_, 0.8250, 2.08, 0.252, 219, 214, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4300, p6epdD_, 0.8231, 3.01, 0.345, 246, 232, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4301, p5t0hG_, 0.8212, 2.08, 0.248, 220, 214, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4302, p5wviY_, 0.8199, 2.11, 0.214, 225, 215, 
4303, p5t0jJ_, 0.8198, 2.21, 0.323, 222, 217, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4304, p5lf0U_, 0.8189, 1.89, 0.250, 212, 208, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
4305, p5mpcT_, 0.8186, 1.60, 0.325, 213, 206, 
4306, p5lezU_, 0.8183, 1.89, 0.250, 212, 208, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4307, p5leyU_, 0.8183, 1.90, 0.250, 212, 208, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4308, p6epcA_, 0.8174, 2.09, 0.222, 219, 212, GROUND STATE 26S PROTEASOME (GS2)
4309, p5t0iG_, 0.8174, 2.11, 0.248, 220, 214, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4310, p5vfpD_, 0.8173, 2.14, 0.313, 219, 214, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4311, p5a0qU_, 0.8173, 1.66, 0.356, 209, 205, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4312, p5a0qG_, 0.8173, 1.66, 0.356, 209, 205, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4313, p6epdA_, 0.8145, 2.27, 0.245, 223, 216, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4314, d5ts0G_, 0.8137, 2.24, 0.160, 220, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4315, d3mkaA_, 0.8136, 2.31, 0.164, 222, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4316, d5trgP_, 0.8134, 2.18, 0.161, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4317, p5ln3F_, 0.8124, 1.70, 0.311, 212, 206, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4318, p5wvkAA_, 0.8116, 1.53, 0.315, 210, 203, 
4319, d3mi0F_, 0.8115, 2.29, 0.165, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4320, d3mkaF_, 0.8105, 2.37, 0.164, 221, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4321, d5thoS_, 0.8103, 2.38, 0.160, 221, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4322, p2fhgW_, 0.8099, 2.26, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4323, p2fhgD_, 0.8099, 2.26, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4324, p2fhgA_, 0.8099, 2.26, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4325, d5trsA_, 0.8098, 2.23, 0.161, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4326, p2fhgU_, 0.8098, 2.26, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4327, p2fhgQ_, 0.8098, 2.26, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4328, p2fhgM_, 0.8098, 2.26, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4329, p2fhgI_, 0.8098, 2.26, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4330, p2fhgB_, 0.8098, 2.26, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4331, p2fhgS_, 0.8097, 2.26, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4332, p2fhgO_, 0.8097, 2.26, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4333, p2fhgK_, 0.8097, 2.26, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4334, p2fhg1_, 0.8097, 2.26, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4335, p6epeD_, 0.8094, 2.68, 0.321, 229, 218, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4336, p5wviF_, 0.8090, 2.35, 0.311, 223, 212, 
4337, d5thoG_, 0.8088, 2.21, 0.162, 218, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4338, d2fhhW_, 0.8088, 2.28, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4339, d2fhhD_, 0.8088, 2.28, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4340, d2fhhA_, 0.8088, 2.28, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4341, d2fhhU_, 0.8087, 2.28, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4342, d2fhhO_, 0.8087, 2.28, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4343, d2fhhM_, 0.8087, 2.28, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4344, d5trrA_, 0.8086, 2.19, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4345, d5trgA_, 0.8086, 2.19, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4346, d2fhhY_, 0.8086, 2.28, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4347, d2fhhS_, 0.8086, 2.28, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4348, d2fhhQ_, 0.8086, 2.28, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4349, d2fhhF_, 0.8086, 2.28, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4350, d2fhhB_, 0.8086, 2.28, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4351, p5ln3A_, 0.8085, 2.16, 0.235, 219, 213, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4352, d2fhhK_, 0.8085, 2.28, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4353, d2fhhI_, 0.8085, 2.28, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4354, d5trsP_, 0.8084, 2.28, 0.161, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4355, d2fhh1_, 0.8084, 2.29, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4356, d5tryA_, 0.8079, 2.20, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4357, d5thoA_, 0.8079, 2.20, 0.162, 218, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4358, p5wviD_, 0.8077, 2.12, 0.203, 222, 212, 
4359, d5ts0A_, 0.8077, 2.21, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4360, d3mkaK_, 0.8073, 2.34, 0.160, 221, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4361, d2h6jB1, 0.8068, 2.22, 0.156, 219, 211, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4362, p5t0iJ_, 0.8066, 2.41, 0.326, 222, 218, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4363, d3mkaU_, 0.8065, 2.39, 0.165, 221, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4364, d3mkaQ_, 0.8064, 2.37, 0.160, 222, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4365, d5ts0T_, 0.8063, 2.25, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4366, d3h6iQ_, 0.8063, 2.22, 0.162, 218, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4367, d2h6jG1, 0.8062, 2.22, 0.156, 219, 211, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4368, d2h6jF1, 0.8062, 2.22, 0.156, 219, 211, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4369, d2h6jA1, 0.8062, 2.22, 0.156, 219, 211, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4370, d5trsD_, 0.8061, 2.24, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4371, d2h6jE1, 0.8060, 2.23, 0.156, 219, 211, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4372, d2h6jD1, 0.8060, 2.22, 0.156, 219, 211, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4373, d5tryS_, 0.8059, 2.30, 0.161, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4374, d5thoO_, 0.8058, 2.25, 0.162, 218, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4375, d2h6jC1, 0.8058, 2.22, 0.156, 219, 211, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4376, d5tryF_, 0.8057, 2.23, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4377, d5trsC_, 0.8057, 2.26, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4378, d5thoE_, 0.8056, 2.25, 0.162, 218, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4379, d3mfeI_, 0.8056, 2.14, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4380, d5ts0Q_, 0.8055, 2.26, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4381, d5trrP_, 0.8055, 2.19, 0.162, 219, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4382, d3mka1_, 0.8055, 2.34, 0.166, 219, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4383, d5tryQ_, 0.8053, 2.27, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4384, d1q5rD_, 0.8053, 2.23, 0.156, 219, 211, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4385, d1q5rG_, 0.8052, 2.23, 0.156, 219, 211, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4386, d1q5rF_, 0.8052, 2.23, 0.156, 219, 211, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4387, d1q5rE_, 0.8052, 2.23, 0.156, 219, 211, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4388, d1q5rC_, 0.8052, 2.23, 0.156, 219, 211, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4389, d1q5rB_, 0.8052, 2.23, 0.156, 219, 211, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4390, d1q5rA_, 0.8051, 2.23, 0.156, 219, 211, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4391, d5ts0P_, 0.8050, 2.28, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4392, d5ts0U_, 0.8049, 2.20, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4393, d5tryP_, 0.8049, 2.25, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4394, d3mkaM_, 0.8048, 2.41, 0.165, 224, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4395, d1q5qD_, 0.8048, 2.29, 0.156, 219, 211, THE RHODOCOCCUS 20S PROTEASOME
4396, d1q5qC_, 0.8048, 2.29, 0.156, 219, 211, THE RHODOCOCCUS 20S PROTEASOME
4397, d1q5qA_, 0.8048, 2.29, 0.156, 219, 211, THE RHODOCOCCUS 20S PROTEASOME
4398, d5ts0E_, 0.8047, 2.27, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4399, d5trgS_, 0.8047, 2.27, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4400, d5trgO_, 0.8047, 2.27, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4401, d1q5qG_, 0.8047, 2.30, 0.156, 219, 211, THE RHODOCOCCUS 20S PROTEASOME
4402, d1q5qF_, 0.8047, 2.30, 0.156, 219, 211, THE RHODOCOCCUS 20S PROTEASOME
4403, d1q5qE_, 0.8047, 2.30, 0.156, 219, 211, THE RHODOCOCCUS 20S PROTEASOME
4404, d1q5qB_, 0.8047, 2.30, 0.156, 219, 211, THE RHODOCOCCUS 20S PROTEASOME
4405, d5trgE_, 0.8045, 2.26, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4406, d3mkaB_, 0.8044, 2.36, 0.161, 220, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4407, d5trrT_, 0.8042, 2.20, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4408, d5trrE_, 0.8042, 2.22, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4409, d5trrS_, 0.8040, 2.27, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4410, d3mkaS_, 0.8039, 2.36, 0.156, 219, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4411, d5ts0B_, 0.8038, 2.17, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4412, d5thoT_, 0.8038, 2.22, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4413, d3mfeK_, 0.8037, 2.14, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4414, d5trsE_, 0.8034, 2.23, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4415, d3mfeB_, 0.8034, 2.15, 0.159, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4416, d5ts0C_, 0.8033, 2.23, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4417, d5trsS_, 0.8032, 2.29, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4418, d5trgT_, 0.8032, 2.24, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4419, d3mkaD_, 0.8031, 2.37, 0.166, 222, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4420, d5trrC_, 0.8030, 2.21, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4421, d3mkaW_, 0.8030, 2.34, 0.162, 221, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4422, d3h6iF_, 0.8029, 2.21, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4423, d3mkaO_, 0.8028, 2.30, 0.157, 218, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4424, d5tryE_, 0.8026, 2.24, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4425, d5trsU_, 0.8026, 2.17, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4426, d5trrU_, 0.8026, 2.16, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4427, d5thoC_, 0.8026, 2.25, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4428, d5ts0D_, 0.8024, 2.24, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4429, d5trgU_, 0.8024, 2.18, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4430, d5thoR_, 0.8024, 2.26, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4431, d3mkaY_, 0.8024, 2.48, 0.160, 224, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4432, d5ts0S_, 0.8023, 2.31, 0.162, 218, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4433, d5trsT_, 0.8023, 2.23, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4434, d5thoF_, 0.8023, 2.25, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4435, p5lzpD_, 0.8023, 2.22, 0.163, 217, 209, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4436, d5tryR_, 0.8022, 2.25, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4437, d3h6fQ_, 0.8022, 2.21, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4438, d5trsB_, 0.8020, 2.19, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4439, d5thoP_, 0.8019, 2.27, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4440, d5tryU_, 0.8018, 2.18, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4441, d5thoU_, 0.8018, 2.19, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4442, d5ts0R_, 0.8017, 2.27, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4443, d3h6fW_, 0.8015, 2.21, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4444, d5trgQ_, 0.8013, 2.28, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4445, d5tryD_, 0.8011, 2.26, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4446, d5trgD_, 0.8011, 2.59, 0.156, 223, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4447, d3h6iW_, 0.8011, 2.24, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4448, d3h6iK_, 0.8011, 2.23, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4449, d5tryC_, 0.8008, 2.18, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4450, d5trrO_, 0.8004, 2.26, 0.158, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4451, d3h6iA_, 0.8002, 2.18, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4452, d5trsO_, 0.8001, 2.26, 0.163, 217, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4453, d5trrD_, 0.8001, 2.22, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4454, d5trgG_, 0.8001, 2.22, 0.159, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4455, d3hfaB_, 0.8001, 2.10, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4456, d5trrG_, 0.8000, 2.21, 0.159, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4457, d5thoQ_, 0.7999, 2.24, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4458, d5trsQ_, 0.7998, 2.24, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4459, d3mi0K_, 0.7997, 2.22, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4460, d3h6fF_, 0.7997, 2.19, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4461, d5trgB_, 0.7996, 2.16, 0.164, 215, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4462, d5tryT_, 0.7994, 2.22, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4463, d5tryG_, 0.7991, 2.22, 0.159, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4464, d5trsG_, 0.7991, 2.22, 0.159, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4465, d5ts0O_, 0.7990, 2.25, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4466, d3krdF_, 0.7989, 2.21, 0.159, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4467, d5thoB_, 0.7988, 2.18, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4468, d3mi0S_, 0.7988, 2.23, 0.159, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4469, d3mi0O_, 0.7987, 2.24, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4470, d5thoD_, 0.7986, 2.24, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4471, d3mi0I_, 0.7986, 2.24, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4472, d5trrB_, 0.7985, 2.18, 0.164, 215, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4473, d3mi0Y_, 0.7980, 2.23, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4474, d3mi0U_, 0.7980, 2.24, 0.159, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4475, d3mfeS_, 0.7980, 2.17, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4476, d3h6iM_, 0.7980, 2.22, 0.159, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4477, d3h6fK_, 0.7980, 2.14, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4478, d5tryB_, 0.7979, 2.19, 0.164, 215, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4479, d3mi0M_, 0.7978, 2.25, 0.163, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4480, d3krdY_, 0.7976, 2.24, 0.159, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4481, d3h6i1_, 0.7976, 2.16, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4482, d3h6iI_, 0.7975, 2.16, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4483, d5trsR_, 0.7973, 2.28, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4484, d3h6fA_, 0.7971, 2.16, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4485, d3h6f1_, 0.7971, 2.16, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4486, d5trgC_, 0.7970, 2.27, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4487, d5trgF_, 0.7969, 2.22, 0.164, 215, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4488, d3h6iU_, 0.7968, 2.18, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4489, d5trsF_, 0.7967, 2.26, 0.163, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4490, d3mi01_, 0.7965, 2.21, 0.164, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4491, d3krdI_, 0.7965, 2.21, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4492, d5trrQ_, 0.7963, 2.24, 0.164, 215, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4493, d3hfaA_, 0.7962, 2.15, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4494, d3mkaI_, 0.7960, 2.35, 0.163, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4495, d3h6fS_, 0.7959, 2.18, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4496, p5lzpH_, 0.7955, 2.21, 0.164, 215, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4497, d3hfaW_, 0.7955, 2.17, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4498, d3hfaM_, 0.7955, 2.17, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4499, d3h6fO_, 0.7955, 2.19, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4500, p5lzp2_, 0.7954, 2.21, 0.164, 215, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4501, d3mi0W_, 0.7954, 2.35, 0.159, 216, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4502, d3hfaQ_, 0.7954, 2.17, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4503, d3h6iO_, 0.7954, 2.20, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4504, p5lzp4_, 0.7953, 2.21, 0.164, 215, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4505, p5lzp0_, 0.7953, 2.21, 0.164, 215, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4506, d3mi0Q_, 0.7953, 2.23, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4507, d3h6iS_, 0.7953, 2.19, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4508, p5lzp6_, 0.7951, 2.21, 0.164, 215, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4509, d3hfaO_, 0.7951, 2.17, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4510, d3hfaK_, 0.7951, 2.17, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4511, p5lzpY_, 0.7950, 2.21, 0.164, 215, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4512, d3hfaS_, 0.7950, 2.19, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4513, p5lzpW_, 0.7949, 2.21, 0.164, 215, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4514, p5lzp8_, 0.7949, 2.21, 0.164, 215, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4515, d3hfaI_, 0.7948, 2.18, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4516, d3hfa1_, 0.7948, 2.19, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4517, d5ts0F_, 0.7947, 2.23, 0.159, 215, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4518, d3hfaF_, 0.7947, 2.18, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4519, p5lzpJ_, 0.7946, 2.23, 0.164, 215, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4520, d5trrR_, 0.7945, 2.25, 0.164, 215, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4521, d3h6fI_, 0.7945, 2.14, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4522, d3krdS_, 0.7944, 2.23, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4523, d5tryO_, 0.7942, 2.29, 0.159, 216, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4524, d5trgR_, 0.7941, 2.25, 0.164, 215, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4525, d3krd1_, 0.7941, 2.23, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4526, d3krdW_, 0.7939, 2.24, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4527, d3h6fM_, 0.7939, 2.22, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4528, p5lzpS_, 0.7938, 2.24, 0.164, 215, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4529, d3mi0A_, 0.7938, 2.24, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4530, d3hfaY_, 0.7938, 2.21, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4531, d3krdK_, 0.7937, 2.24, 0.159, 215, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4532, d5trrF_, 0.7936, 2.23, 0.159, 215, 207, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4533, d3hfaU_, 0.7936, 2.20, 0.165, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4534, d3mfeA_, 0.7931, 2.17, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4535, d3h6fB_, 0.7929, 2.18, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4536, d3mi0D_, 0.7926, 2.21, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4537, d3h6fD_, 0.7925, 2.17, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4538, d3krdQ_, 0.7920, 2.21, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4539, d3krdO_, 0.7920, 2.22, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4540, d3h6iB_, 0.7920, 2.19, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4541, d3mfeY_, 0.7919, 2.15, 0.161, 213, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4542, d3hfaD_, 0.7918, 2.17, 0.161, 213, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4543, d3h6fU_, 0.7917, 2.19, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4544, d3h6iD_, 0.7916, 2.13, 0.161, 213, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4545, p5lzpQ_, 0.7911, 2.22, 0.160, 214, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4546, p5lzpB_, 0.7911, 2.22, 0.160, 214, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4547, p5lzpM_, 0.7909, 2.22, 0.160, 214, 206, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4548, p2z5cF_, 0.7909, 0.76, 1.000, 189, 189, CRYSTAL STRUCTURE OF A NOVEL CHAPERONE COMPLEX FOR YEAST 20S PROTEASOME ASSEMBLY
4549, p2z5cC_, 0.7909, 0.76, 1.000, 189, 189, CRYSTAL STRUCTURE OF A NOVEL CHAPERONE COMPLEX FOR YEAST 20S PROTEASOME ASSEMBLY
4550, d3krdA_, 0.7905, 2.24, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4551, d3h6fY_, 0.7898, 2.16, 0.161, 213, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4552, d3mfeO_, 0.7894, 2.20, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4553, d3krdU_, 0.7894, 2.26, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4554, d3mfe1_, 0.7887, 2.15, 0.161, 213, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4555, d3hf9I_, 0.7884, 2.13, 0.162, 212, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4556, d3krdM_, 0.7882, 2.27, 0.160, 214, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4557, p6bgoI_, 0.7876, 2.28, 0.164, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4558, p6bgoH_, 0.7876, 2.28, 0.164, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4559, p6bgoG_, 0.7876, 2.28, 0.164, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4560, p6bgoF_, 0.7876, 2.28, 0.164, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4561, p6bgoE_, 0.7876, 2.28, 0.164, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4562, p6bgoD_, 0.7876, 2.28, 0.164, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4563, p6bgoC_, 0.7876, 2.28, 0.164, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4564, p6bglO_, 0.7876, 2.28, 0.164, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4565, p6bglN_, 0.7876, 2.28, 0.164, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4566, p6bglM_, 0.7876, 2.28, 0.164, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4567, p6bglL_, 0.7876, 2.28, 0.164, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4568, p6bglK_, 0.7876, 2.28, 0.164, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4569, p6bglJ_, 0.7876, 2.28, 0.164, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4570, p6bglI_, 0.7876, 2.28, 0.164, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4571, p6bglH_, 0.7876, 2.28, 0.164, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4572, p6bglG_, 0.7876, 2.28, 0.164, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4573, p6bglF_, 0.7876, 2.28, 0.164, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4574, p6bglE_, 0.7876, 2.28, 0.164, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4575, p6bglD_, 0.7876, 2.28, 0.164, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4576, p6bglC_, 0.7876, 2.28, 0.164, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4577, p6bglA_, 0.7876, 2.28, 0.164, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4578, d3mfeD_, 0.7875, 2.21, 0.161, 213, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4579, d3krdD_, 0.7875, 2.23, 0.161, 213, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4580, d3mfeQ_, 0.7871, 2.20, 0.161, 213, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4581, d3mi0B_, 0.7870, 2.23, 0.161, 213, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4582, d3krdB_, 0.7870, 2.23, 0.161, 213, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4583, p3hf9y_, 0.7859, 2.11, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4584, d3h6iY_, 0.7853, 2.24, 0.161, 213, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4585, p3hf9s_, 0.7848, 2.16, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4586, p3hf9i_, 0.7846, 2.12, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4587, p3hf9d_, 0.7844, 2.11, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4588, d3hf9B_, 0.7844, 2.08, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4589, p3hf9f_, 0.7843, 2.15, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4590, p3hf9b_, 0.7842, 2.09, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4591, p3hf9w_, 0.7839, 2.12, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4592, p3hf9u_, 0.7839, 2.15, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4593, d3hf9S_, 0.7838, 2.14, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4594, d3hf9K_, 0.7838, 2.11, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4595, d3hf91_, 0.7837, 2.13, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4596, d3mfeU_, 0.7834, 2.22, 0.162, 212, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4597, d3hf9A_, 0.7834, 2.15, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4598, p3hf9k_, 0.7833, 2.16, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4599, p3hf9a_, 0.7832, 2.14, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4600, d3hf9U_, 0.7829, 2.16, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4601, d3hf9O_, 0.7828, 2.14, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4602, p3hf9o_, 0.7827, 2.13, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4603, p3hf9q_, 0.7823, 2.15, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4604, d3hf9Q_, 0.7820, 2.16, 0.163, 211, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4605, d3hf9Y_, 0.7810, 2.12, 0.163, 210, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4606, d3hf93_, 0.7803, 2.13, 0.163, 210, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4607, d3mfeW_, 0.7787, 2.03, 0.164, 209, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4608, p2fhgF_, 0.7770, 2.06, 0.159, 209, 201, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4609, p2fhgY_, 0.7769, 2.06, 0.159, 209, 201, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4610, d3hf9D_, 0.7764, 2.20, 0.163, 210, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4611, p5a0qT_, 0.7733, 1.50, 0.333, 195, 192, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4612, p5a0qF_, 0.7727, 1.52, 0.333, 195, 192, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4613, p3hf9m_, 0.7725, 2.14, 0.160, 208, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4614, p6bgoN_, 0.7689, 2.01, 0.171, 207, 199, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4615, p6bgoM_, 0.7689, 2.01, 0.171, 207, 199, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4616, p6bgoL_, 0.7689, 2.01, 0.171, 207, 199, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4617, p6bgoK_, 0.7689, 2.01, 0.171, 207, 199, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4618, p6bgoJ_, 0.7689, 2.01, 0.171, 207, 199, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4619, p6bgoA_, 0.7689, 2.01, 0.171, 207, 199, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4620, p5a0qO_, 0.7673, 1.56, 0.293, 195, 191, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4621, p5a0qA_, 0.7673, 1.56, 0.293, 195, 191, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4622, p6bgoO_, 0.7654, 2.00, 0.172, 206, 198, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4623, d3hf9M_, 0.7651, 2.00, 0.162, 205, 197, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4624, p6bdfZ_, 0.7548, 2.23, 0.210, 201, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4625, p6bdfX_, 0.7548, 2.23, 0.210, 201, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4626, p6bdfV_, 0.7548, 2.23, 0.210, 201, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4627, p6bdfT_, 0.7548, 2.23, 0.210, 201, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4628, p6bdfR_, 0.7548, 2.23, 0.210, 201, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4629, p6bdfP_, 0.7548, 2.23, 0.210, 201, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4630, p6bdfN_, 0.7548, 2.23, 0.210, 201, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4631, p6bdfL_, 0.7548, 2.23, 0.210, 201, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4632, p6bdfJ_, 0.7548, 2.23, 0.210, 201, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4633, p6bdfH_, 0.7548, 2.23, 0.210, 201, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4634, p6bdfF_, 0.7548, 2.23, 0.210, 201, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4635, p6bdfD_, 0.7548, 2.23, 0.210, 201, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4636, p6bdfB_, 0.7548, 2.23, 0.210, 201, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4637, p6bdf1_, 0.7548, 2.23, 0.210, 201, 195, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4638, p3j9iZ_, 0.7540, 2.38, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4639, p3j9iY_, 0.7540, 2.38, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4640, p3j9iX_, 0.7540, 2.38, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4641, p3j9iW_, 0.7540, 2.38, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4642, p3j9iV_, 0.7540, 2.38, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4643, p3j9iN_, 0.7540, 2.38, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4644, p3j9iM_, 0.7540, 2.38, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4645, p3j9iL_, 0.7540, 2.38, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4646, p3j9iK_, 0.7540, 2.38, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4647, p3j9iJ_, 0.7540, 2.38, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4648, p3j9iI_, 0.7540, 2.38, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4649, p3j9iH_, 0.7540, 2.38, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4650, p3j9i2_, 0.7540, 2.38, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4651, p3j9i1_, 0.7540, 2.38, 0.209, 203, 196, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4652, p5vy3Z_, 0.7537, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4653, p5vy3X_, 0.7537, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4654, p5vy3V_, 0.7537, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4655, p5vy3T_, 0.7537, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4656, p5vy3R_, 0.7537, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4657, p5vy3P_, 0.7537, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4658, p5vy3N_, 0.7537, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4659, p5vy3L_, 0.7537, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4660, p5vy3J_, 0.7537, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4661, p5vy3H_, 0.7537, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4662, p5vy3F_, 0.7537, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4663, p5vy3D_, 0.7537, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4664, p5vy3B_, 0.7537, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4665, p5vy31_, 0.7537, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4666, p3h4pf_, 0.7537, 2.28, 0.246, 202, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4667, p3h4pe_, 0.7534, 2.29, 0.246, 202, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4668, p5vy4Z_, 0.7533, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4669, p5vy4X_, 0.7533, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4670, p5vy4V_, 0.7533, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4671, p5vy4T_, 0.7533, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4672, p5vy4R_, 0.7533, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4673, p5vy4P_, 0.7533, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4674, p5vy4N_, 0.7533, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4675, p5vy4L_, 0.7533, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4676, p5vy4J_, 0.7533, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4677, p5vy4H_, 0.7533, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4678, p5vy4F_, 0.7533, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4679, p5vy4D_, 0.7533, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4680, p5vy4BA_, 0.7533, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4681, p5vy4B_, 0.7533, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4682, p5vy41_, 0.7533, 2.24, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4683, d3h4pl_, 0.7533, 2.27, 0.246, 202, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4684, d3h4pj_, 0.7532, 2.27, 0.246, 202, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4685, p3h4pc_, 0.7532, 2.28, 0.246, 202, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4686, d3h4pn_, 0.7531, 2.28, 0.246, 202, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4687, d3h4pk_, 0.7531, 2.28, 0.246, 202, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4688, p3h4pg_, 0.7531, 2.27, 0.246, 202, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4689, p3h4pa_, 0.7531, 2.28, 0.246, 202, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4690, d1yauM_, 0.7531, 2.26, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4691, d3h4pi_, 0.7526, 2.29, 0.246, 202, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4692, p3h4pd_, 0.7526, 2.29, 0.246, 202, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4693, p3h4pb_, 0.7526, 2.28, 0.246, 202, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4694, d3h4ph_, 0.7525, 2.30, 0.246, 202, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4695, d1yarM_, 0.7525, 2.26, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4696, d1ya7M_, 0.7522, 2.27, 0.210, 203, 195, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4697, d3jrmM_, 0.7518, 2.28, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4698, d3jseM_, 0.7517, 2.28, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4699, d3h4pm_, 0.7517, 2.29, 0.246, 202, 195, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4700, d1yauJ_, 0.7517, 2.28, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4701, d1pmaX_, 0.7516, 2.28, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4702, d3jrmK_, 0.7515, 2.29, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4703, d3jrmJ_, 0.7515, 2.29, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4704, d3jrmI_, 0.7515, 2.29, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4705, d3jrmH_, 0.7515, 2.29, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4706, d1ya7K_, 0.7515, 2.28, 0.210, 203, 195, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4707, d3jseK_, 0.7514, 2.28, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4708, d3jrmL_, 0.7514, 2.29, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4709, d3c92W1, 0.7514, 2.28, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4710, d3c92I1, 0.7514, 2.28, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4711, d3c91W1, 0.7514, 2.28, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4712, d3c91I1, 0.7514, 2.28, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4713, d1pmaP_, 0.7514, 2.28, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4714, d3jrmN_, 0.7513, 2.29, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4715, d3c92X1, 0.7513, 2.28, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4716, d3c92N1, 0.7513, 2.28, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4717, d3c92J1, 0.7513, 2.28, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4718, d3c9221, 0.7513, 2.28, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4719, d3c91X1, 0.7513, 2.28, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4720, d3c91N1, 0.7513, 2.28, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4721, d3c91J1, 0.7513, 2.28, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4722, d3c9121, 0.7513, 2.28, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4723, d1ya7J_, 0.7513, 2.28, 0.210, 203, 195, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4724, d1pmaU_, 0.7513, 2.28, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4725, d1pmaQ_, 0.7513, 2.28, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4726, d3jseL_, 0.7512, 2.28, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4727, d3jseJ_, 0.7512, 2.28, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4728, d3c92M1, 0.7512, 2.28, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4729, d3c9211, 0.7512, 2.28, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4730, d3c91M1, 0.7512, 2.28, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4731, d3c9111, 0.7512, 2.28, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4732, d1ya7I_, 0.7512, 2.28, 0.210, 203, 195, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4733, d1pmaY_, 0.7512, 2.28, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4734, d1pmaT_, 0.7512, 2.28, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4735, d3jseI_, 0.7511, 2.28, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4736, d3jseH_, 0.7511, 2.28, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4737, d1yauK_, 0.7511, 2.29, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4738, d1pmaV_, 0.7511, 2.28, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4739, d1pma2_, 0.7511, 2.27, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4740, d1pma1_, 0.7511, 2.29, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4741, d3jseN_, 0.7510, 2.29, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4742, d1yauI_, 0.7510, 2.29, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4743, d1yauH_, 0.7510, 2.29, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4744, d1yarK_, 0.7510, 2.28, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4745, d1ya7L_, 0.7509, 2.28, 0.210, 203, 195, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4746, d1pmaZ_, 0.7509, 2.28, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4747, d1ya7H_, 0.7508, 2.29, 0.210, 203, 195, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4748, p3jtlM_, 0.7507, 2.29, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4749, d3c92Z1, 0.7507, 2.28, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4750, d3c92L1, 0.7507, 2.28, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4751, d3c91Z1, 0.7507, 2.28, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4752, d3c91L1, 0.7507, 2.28, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4753, d1yauL_, 0.7507, 2.29, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4754, d1yarJ_, 0.7507, 2.29, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4755, d1pmaS_, 0.7507, 2.28, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4756, p3jtlN_, 0.7506, 2.30, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4757, p3jtlK_, 0.7506, 2.30, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4758, p3jtlI_, 0.7506, 2.30, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4759, d3c92V1, 0.7506, 2.29, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4760, d3c92H1, 0.7506, 2.29, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4761, d3c91V1, 0.7506, 2.29, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4762, d3c91H1, 0.7506, 2.29, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4763, d1yarL_, 0.7506, 2.29, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4764, d1yarI_, 0.7506, 2.29, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4765, d1pmaW_, 0.7506, 2.29, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4766, d1pmaB_, 0.7506, 2.29, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4767, p3jtlL_, 0.7505, 2.30, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4768, p3jtlJ_, 0.7505, 2.30, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4769, p3jtlH_, 0.7505, 2.30, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4770, d1ya7N_, 0.7505, 2.30, 0.210, 203, 195, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4771, d3c92Y1, 0.7504, 2.29, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4772, d3c92K1, 0.7504, 2.29, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4773, d3c91Y1, 0.7504, 2.29, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4774, d3c91K1, 0.7504, 2.29, 0.210, 203, 195, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4775, d1pmaR_, 0.7504, 2.29, 0.210, 203, 195, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4776, d2h6jK1, 0.7502, 2.59, 0.204, 225, 201, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4777, d1yarH_, 0.7502, 2.30, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4778, d2h6jJ1, 0.7501, 2.59, 0.204, 225, 201, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4779, d1yarN_, 0.7501, 2.31, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4780, d2h6jN1, 0.7500, 2.59, 0.199, 225, 201, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4781, d2h6jM1, 0.7500, 2.59, 0.204, 225, 201, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4782, d1yauN_, 0.7500, 2.32, 0.210, 203, 195, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4783, d2h6jI1, 0.7498, 2.59, 0.204, 225, 201, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4784, d2h6jH1, 0.7497, 2.60, 0.204, 225, 201, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4785, d2h6jL1, 0.7496, 2.60, 0.204, 225, 201, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4786, d1q5rN_, 0.7478, 2.75, 0.193, 251, 202, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4787, d1q5rM_, 0.7478, 2.75, 0.193, 251, 202, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4788, d1q5rL_, 0.7478, 2.75, 0.193, 251, 202, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4789, d1q5rK_, 0.7477, 2.75, 0.193, 251, 202, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4790, d1q5rJ_, 0.7477, 2.75, 0.193, 251, 202, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4791, d1q5rI_, 0.7477, 2.75, 0.193, 251, 202, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4792, d1q5rH_, 0.7477, 2.75, 0.193, 251, 202, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4793, d5fgeY_, 0.7448, 2.99, 0.206, 218, 204, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4794, d1j2qN_, 0.7448, 2.38, 0.226, 202, 195, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4795, d1j2qL_, 0.7448, 2.38, 0.226, 202, 195, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4796, d1j2qJ_, 0.7448, 2.38, 0.226, 202, 195, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4797, d1j2qM_, 0.7447, 2.39, 0.226, 202, 195, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4798, d1j2qK_, 0.7447, 2.39, 0.226, 202, 195, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4799, d1j2qI_, 0.7447, 2.39, 0.226, 202, 195, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4800, d1j2qH_, 0.7447, 2.38, 0.226, 202, 195, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4801, d5fgeK_, 0.7446, 3.00, 0.206, 218, 204, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4802, d5fgdY_, 0.7446, 2.97, 0.211, 216, 204, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4803, d3hfaV_, 0.7443, 2.76, 0.147, 226, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4804, d5ts0K_, 0.7442, 2.72, 0.148, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4805, p3ipmM_, 0.7440, 2.41, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4806, p3ipmL_, 0.7440, 2.42, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4807, p3ipmK_, 0.7440, 2.41, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4808, p3ipmJ_, 0.7440, 2.41, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4809, p3ipmH_, 0.7440, 2.42, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4810, p3ipmN_, 0.7439, 2.42, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4811, p3ipmI_, 0.7439, 2.42, 0.210, 203, 195, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
4812, d5trsK_, 0.7437, 2.66, 0.149, 223, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4813, d5fgdK_, 0.7437, 2.93, 0.217, 215, 203, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4814, d5cz7Y_, 0.7434, 3.09, 0.206, 217, 204, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
4815, d3mkaL_, 0.7434, 3.08, 0.150, 251, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4816, d5cz7K_, 0.7433, 3.10, 0.206, 217, 204, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
4817, d5trgK_, 0.7430, 2.72, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4818, d3mkaV_, 0.7428, 2.91, 0.151, 249, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4819, d5trgL_, 0.7427, 2.79, 0.148, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4820, d3mkaN_, 0.7426, 2.91, 0.151, 252, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4821, d5thoL_, 0.7425, 2.78, 0.148, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4822, d3hfaZ_, 0.7425, 2.81, 0.147, 224, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4823, d5trrL_, 0.7424, 2.72, 0.148, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4824, d1q5qN_, 0.7424, 2.80, 0.186, 224, 204, THE RHODOCOCCUS 20S PROTEASOME
4825, d1q5qM_, 0.7424, 2.80, 0.186, 224, 204, THE RHODOCOCCUS 20S PROTEASOME
4826, d1q5qL_, 0.7423, 2.80, 0.186, 224, 204, THE RHODOCOCCUS 20S PROTEASOME
4827, d1q5qK_, 0.7423, 2.80, 0.186, 224, 204, THE RHODOCOCCUS 20S PROTEASOME
4828, d1q5qJ_, 0.7423, 2.81, 0.186, 224, 204, THE RHODOCOCCUS 20S PROTEASOME
4829, d1q5qH_, 0.7423, 2.80, 0.186, 224, 204, THE RHODOCOCCUS 20S PROTEASOME
4830, d5tryK_, 0.7422, 2.75, 0.148, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4831, d3mkaP_, 0.7422, 3.02, 0.151, 250, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4832, d3mi0L_, 0.7422, 2.73, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4833, d1q5qI_, 0.7422, 2.81, 0.186, 224, 204, THE RHODOCOCCUS 20S PROTEASOME
4834, d5trsL_, 0.7420, 2.77, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4835, d5fgfK_, 0.7420, 2.89, 0.208, 214, 202, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4836, d3hfaX_, 0.7420, 2.84, 0.147, 224, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4837, d3mka2_, 0.7419, 2.98, 0.151, 246, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4838, d5trsY_, 0.7418, 2.75, 0.153, 223, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4839, d5fgfY_, 0.7418, 2.90, 0.208, 214, 202, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4840, d3mkaJ_, 0.7418, 2.87, 0.152, 252, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4841, d5trgV_, 0.7417, 2.73, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4842, d3mkaT_, 0.7417, 3.02, 0.151, 250, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4843, d3mkaC_, 0.7417, 2.97, 0.151, 250, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4844, d5ts0W_, 0.7416, 2.74, 0.149, 223, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4845, d5trgY_, 0.7416, 2.79, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4846, d5thoK_, 0.7416, 2.74, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4847, d3mkaR_, 0.7416, 2.86, 0.152, 246, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4848, d5trrW_, 0.7415, 2.74, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4849, d5trrV_, 0.7415, 2.80, 0.148, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4850, d5trrK_, 0.7415, 2.75, 0.148, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4851, p5lzpI_, 0.7415, 2.74, 0.153, 223, 203, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4852, d5trrY_, 0.7413, 2.72, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4853, d5trsW_, 0.7412, 2.75, 0.149, 223, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4854, p5trrb_, 0.7412, 2.75, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4855, d5thoV_, 0.7412, 2.80, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4856, d3mi0V1, 0.7412, 2.80, 0.157, 234, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4857, d3hfaE_, 0.7412, 2.79, 0.148, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4858, d5trsV_, 0.7411, 2.82, 0.148, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4859, d5trrI_, 0.7411, 2.74, 0.149, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4860, d5thoW_, 0.7411, 2.80, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4861, d3mkaE_, 0.7411, 3.05, 0.150, 248, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4862, d3hfaT_, 0.7411, 2.76, 0.148, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4863, d3hfaH_, 0.7411, 2.76, 0.148, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4864, p5trra_, 0.7410, 2.75, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4865, d3mkaG_, 0.7410, 2.87, 0.152, 251, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4866, d3mi0R1, 0.7409, 2.80, 0.157, 234, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4867, d3mkaH_, 0.7408, 2.87, 0.152, 249, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4868, d5trgI_, 0.7407, 2.74, 0.149, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4869, p5lzpO_, 0.7407, 2.77, 0.149, 223, 202, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4870, d5ts0L_, 0.7406, 2.74, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4871, d5thoY_, 0.7406, 2.74, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4872, d5tryV_, 0.7405, 2.75, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4873, p5trga_, 0.7405, 2.77, 0.148, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4874, p5lzpU_, 0.7404, 2.76, 0.153, 223, 202, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4875, p5ts0a_, 0.7403, 2.77, 0.153, 223, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4876, d5tryL_, 0.7403, 2.73, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4877, p5trya_, 0.7403, 2.77, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4878, d3hfaG_, 0.7403, 2.76, 0.149, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4879, p5tryb_, 0.7402, 2.77, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4880, d5thoI_, 0.7402, 2.76, 0.149, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4881, d3mi0X_, 0.7402, 2.81, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4882, d5ts0V_, 0.7401, 2.82, 0.148, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4883, d5tryW_, 0.7401, 2.77, 0.148, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4884, p5thoa_, 0.7401, 2.76, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4885, p5lzpC_, 0.7401, 2.77, 0.153, 223, 203, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4886, d5trrZ_, 0.7400, 2.75, 0.149, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4887, p5lzpR_, 0.7400, 2.81, 0.153, 223, 203, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4888, p5lzpG_, 0.7400, 2.70, 0.149, 222, 201, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4889, d3mi0T_, 0.7400, 2.75, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4890, d3mi0E_, 0.7400, 2.71, 0.153, 223, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4891, d3mi02_, 0.7400, 2.76, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4892, d3hfaC_, 0.7400, 2.76, 0.149, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4893, p5trsa_, 0.7399, 2.84, 0.148, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4894, d3hfaL_, 0.7399, 2.76, 0.149, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4895, d3hfa2_, 0.7399, 2.76, 0.149, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4896, p5thob_, 0.7398, 2.83, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4897, d3hfaN_, 0.7398, 2.77, 0.149, 223, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4898, d3hfaJ_, 0.7398, 2.77, 0.149, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4899, d5ts0I_, 0.7397, 2.76, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4900, d5tryY_, 0.7397, 2.76, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4901, d5trgX_, 0.7397, 2.75, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4902, d3mi0J_, 0.7397, 2.74, 0.153, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4903, d3hfaR_, 0.7397, 2.76, 0.149, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4904, d3hfaP_, 0.7397, 2.77, 0.149, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4905, d5ts0Y_, 0.7396, 2.69, 0.153, 223, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4906, p5ts0b_, 0.7396, 2.84, 0.148, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4907, d5trsN_, 0.7395, 2.84, 0.148, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4908, p5lzpT_, 0.7395, 2.82, 0.153, 223, 203, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4909, p5trsb_, 0.7394, 2.84, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4910, p5lzpK_, 0.7394, 2.74, 0.153, 222, 202, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4911, d3mi0N_, 0.7394, 2.74, 0.153, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4912, d5tryI_, 0.7392, 2.77, 0.149, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4913, d5trgN_, 0.7390, 2.83, 0.148, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4914, p5lzpE_, 0.7390, 2.75, 0.153, 222, 202, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4915, p5lzpA_, 0.7390, 2.71, 0.149, 222, 201, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4916, d5trsI_, 0.7389, 2.76, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4917, p5lzpF_, 0.7389, 2.72, 0.149, 222, 201, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4918, d3mi0Z_, 0.7389, 2.83, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4919, d3krdV_, 0.7389, 2.79, 0.158, 229, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4920, d3krdR_, 0.7389, 2.79, 0.158, 229, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4921, p6bgoZ_, 0.7388, 2.72, 0.149, 222, 201, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4922, p6bgoY_, 0.7388, 2.72, 0.149, 222, 201, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4923, p6bgoX_, 0.7388, 2.72, 0.149, 222, 201, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4924, p6bgoW_, 0.7388, 2.72, 0.149, 222, 201, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4925, p6bgoV_, 0.7388, 2.72, 0.149, 222, 201, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4926, p6bgoU_, 0.7388, 2.72, 0.149, 222, 201, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4927, p6bgoT_, 0.7388, 2.72, 0.149, 222, 201, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4928, p6bgoS_, 0.7388, 2.72, 0.149, 222, 201, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4929, p6bgoR_, 0.7388, 2.72, 0.149, 222, 201, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4930, p6bgoQ_, 0.7388, 2.72, 0.149, 222, 201, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4931, p6bgoP_, 0.7388, 2.72, 0.149, 222, 201, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4932, p6bgoc_, 0.7388, 2.72, 0.149, 222, 201, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4933, p6bgob_, 0.7388, 2.72, 0.149, 222, 201, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4934, p6bgoa_, 0.7388, 2.72, 0.149, 222, 201, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4935, p6bglZ_, 0.7388, 2.72, 0.149, 222, 201, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4936, p6bglY_, 0.7388, 2.72, 0.149, 222, 201, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4937, p6bglX_, 0.7388, 2.72, 0.149, 222, 201, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4938, p6bglW_, 0.7388, 2.72, 0.149, 222, 201, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4939, p6bglV_, 0.7388, 2.72, 0.149, 222, 201, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4940, p6bglU_, 0.7388, 2.72, 0.149, 222, 201, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4941, p6bglT_, 0.7388, 2.72, 0.149, 222, 201, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4942, p6bglS_, 0.7388, 2.72, 0.149, 222, 201, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4943, p6bglR_, 0.7388, 2.72, 0.149, 222, 201, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4944, p6bglQ_, 0.7388, 2.72, 0.149, 222, 201, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4945, p6bglP_, 0.7388, 2.72, 0.149, 222, 201, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4946, p6bglc_, 0.7388, 2.72, 0.149, 222, 201, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4947, p6bglb_, 0.7388, 2.72, 0.149, 222, 201, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4948, p6bgla_, 0.7388, 2.72, 0.149, 222, 201, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4949, d5ts0Z_, 0.7388, 2.70, 0.149, 222, 201, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4950, d5trrN_, 0.7388, 2.78, 0.148, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4951, d5thoZ_, 0.7388, 2.76, 0.153, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4952, d3krdL_, 0.7388, 2.74, 0.149, 222, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4953, d5trgW_, 0.7387, 2.84, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4954, p5lzpL_, 0.7387, 2.72, 0.149, 222, 201, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4955, d3mi0G_, 0.7387, 2.75, 0.153, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4956, d3mi0H_, 0.7386, 2.70, 0.154, 222, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4957, d5ts0N_, 0.7385, 2.80, 0.148, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4958, d5tryZ_, 0.7385, 2.75, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4959, d5trsZ_, 0.7385, 2.69, 0.154, 222, 201, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4960, d5thoM_, 0.7385, 2.87, 0.153, 223, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4961, d5thoJ_, 0.7384, 2.77, 0.153, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4962, d5trgZ_, 0.7383, 2.77, 0.149, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4963, d5trgH_, 0.7382, 2.78, 0.149, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4964, p5trgb_, 0.7382, 2.86, 0.148, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4965, d5trrM_, 0.7381, 2.79, 0.149, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4966, d5thoN_, 0.7381, 2.76, 0.153, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4967, d3mi0C_, 0.7381, 2.77, 0.153, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4968, d5tryH_, 0.7380, 2.78, 0.149, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4969, d5trsH_, 0.7380, 2.78, 0.149, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4970, d5trrH_, 0.7380, 2.78, 0.149, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4971, d5thoH_, 0.7380, 2.77, 0.153, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4972, d5tryN_, 0.7379, 2.86, 0.153, 223, 203, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4973, p5lzpP_, 0.7379, 2.62, 0.150, 221, 200, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4974, d3mi0P_, 0.7379, 2.77, 0.153, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4975, p5lzpN_, 0.7377, 2.66, 0.154, 221, 201, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4976, d5ts0M_, 0.7376, 2.74, 0.149, 222, 201, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4977, d5trrJ_, 0.7376, 2.78, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4978, d5trsM_, 0.7375, 2.75, 0.149, 222, 201, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4979, d5trgM_, 0.7373, 2.80, 0.149, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4980, d5trsJ_, 0.7372, 2.79, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4981, d5d0vK_, 0.7372, 3.05, 0.208, 218, 202, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
4982, d5ts0J_, 0.7371, 2.79, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4983, d5ts0H_, 0.7370, 2.79, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4984, d5thoX_, 0.7367, 2.80, 0.153, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4985, d3wxrZ_, 0.7367, 3.00, 0.203, 212, 202, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4986, d3krdN_, 0.7367, 2.74, 0.154, 222, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4987, d5tryM_, 0.7366, 2.80, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4988, d3krd2_, 0.7366, 2.76, 0.149, 222, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4989, d5trgJ_, 0.7365, 2.80, 0.149, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4990, d3mfeP_, 0.7365, 2.69, 0.150, 221, 200, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4991, d3krdJ_, 0.7365, 2.81, 0.153, 222, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4992, d5trrX_, 0.7364, 2.80, 0.153, 222, 202, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4993, d3wxrL_, 0.7364, 2.94, 0.204, 212, 201, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4994, d3krdC_, 0.7364, 2.75, 0.154, 222, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4995, d5l5rY_, 0.7363, 2.84, 0.216, 211, 199, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4996, d5l5rK_, 0.7363, 2.84, 0.216, 211, 199, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4997, d5l5bY_, 0.7362, 2.85, 0.216, 211, 199, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4998, d5l5bK_, 0.7361, 2.85, 0.216, 211, 199, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4999, d3krdT_, 0.7361, 2.74, 0.154, 222, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
5000, d3krdE_, 0.7360, 2.76, 0.154, 222, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
